
<html lang="en"     class="pb-page"  data-request-id="e9dab992-0681-4068-b17b-ef58470d4c65"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.9b00271;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-9"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway" /></meta><meta name="dc.Creator" content="Rajeshri G.  Karki" /></meta><meta name="dc.Creator" content="James  Powers" /></meta><meta name="dc.Creator" content="Nello  Mainolfi" /></meta><meta name="dc.Creator" content="Karen  Anderson" /></meta><meta name="dc.Creator" content="David B.  Belanger" /></meta><meta name="dc.Creator" content="Donglei  Liu" /></meta><meta name="dc.Creator" content="Nan  Ji" /></meta><meta name="dc.Creator" content="Keith  Jendza" /></meta><meta name="dc.Creator" content="Christine F.  Gelin" /></meta><meta name="dc.Creator" content="Aengus  Mac Sweeney" /></meta><meta name="dc.Creator" content="Catherine  Solovay" /></meta><meta name="dc.Creator" content="Omar  Delgado" /></meta><meta name="dc.Creator" content="Maura  Crowley" /></meta><meta name="dc.Creator" content="Sha-Mei  Liao" /></meta><meta name="dc.Creator" content="Upendra A.  Argikar" /></meta><meta name="dc.Creator" content="Stefanie  Flohr" /></meta><meta name="dc.Creator" content="Laura R.  La Bonte" /></meta><meta name="dc.Creator" content="Edwige L.  Lorthiois" /></meta><meta name="dc.Creator" content="Anna  Vulpetti" /></meta><meta name="dc.Creator" content="Ann  Brown" /></meta><meta name="dc.Creator" content="Debby  Long" /></meta><meta name="dc.Creator" content="Melissa  Prentiss" /></meta><meta name="dc.Creator" content="Nathalie  Gradoux" /></meta><meta name="dc.Creator" content="Andrea  de Erkenez" /></meta><meta name="dc.Creator" content="Frederic  Cumin" /></meta><meta name="dc.Creator" content="Christopher  Adams" /></meta><meta name="dc.Creator" content="Bruce  Jaffee" /></meta><meta name="dc.Creator" content="Muneto  Mogi" /></meta><meta name="dc.Description" content="Complement factor D (FD), a highly specific S1 serine protease, plays a central role in the amplification of the alternative complement pathway (AP) of the innate immune system. Dysregulation of AP..." /></meta><meta name="Description" content="Complement factor D (FD), a highly specific S1 serine protease, plays a central role in the amplification of the alternative complement pathway (AP) of the innate immune system. Dysregulation of AP..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 17, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00271" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright Â© 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00271" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00271" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00271" /></link>
        
    
    

<title>Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00271" /></meta><meta property="og:title" content="Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0015.jpeg" /></meta><meta property="og:description" content="Complement factor D (FD), a highly specific S1 serine protease, plays a central role in the amplification of the alternative complement pathway (AP) of the innate immune system. Dysregulation of AP activity predisposes individuals to diverse disorders such as age-related macular degeneration, atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis type II, and paroxysmal nocturnal hemoglobinuria. Previously, we have reported the screening efforts and identification of reversible benzylamine-based FD inhibitors (1 and 2) binding to the open active conformation of FD. In continuation of our drug discovery program, we designed compounds applying structure-based approaches to improve interactions with FD and gain selectivity against S1 serine proteases. We report herein the design, synthesis, and medicinal chemistry optimization of the benzylamine series culminating in the discovery of 12, an orally bioavailable and selective FD inhibitor. 12 demonstrated systemic suppression of AP activation in a lipopolysaccharide-induced AP activation model as well as local ocular suppression in intravitreal injection-induced AP activation model in mice expressing human FD." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00271"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00271">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00271&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00271&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00271&amp;href=/doi/10.1021/acs.jmedchem.9b00271" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 4656-4668</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00241" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b00274" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Rajeshri G. Karki</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rajeshri G. Karki</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#790b18131c0a110b105712180b12103917160f180b0d100a571a1614"><span class="__cf_email__" data-cfemail="a6d4c7ccc3d5ced4cf88cdc7d4cdcfe6c8c9d0c7d4d2cfd588c5c9cb">[emailÂ protected]</span></a>. Tel: +1 617-871-3913.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rajeshri+G.++Karki">Rajeshri G. Karki</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2210-5789" title="Orcid link">http://orcid.org/0000-0003-2210-5789</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">James Powers</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James Powers</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James++Powers">James Powers</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Nello Mainolfi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nello Mainolfi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nello++Mainolfi">Nello Mainolfi</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Karen Anderson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karen Anderson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karen++Anderson">Karen Anderson</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">David B. Belanger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David B. Belanger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+B.++Belanger">David B. Belanger</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Donglei Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Donglei Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Donglei++Liu">Donglei Liu</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Nan Ji</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nan Ji</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nan++Ji">Nan Ji</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Keith Jendza</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Keith Jendza</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Keith++Jendza">Keith Jendza</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Christine F. Gelin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christine F. Gelin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christine+F.++Gelin">Christine F. Gelin</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Aengus Mac Sweeney</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aengus Mac Sweeney</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aengus++Mac+Sweeney">Aengus Mac Sweeney</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Catherine Solovay</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Catherine Solovay</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Catherine++Solovay">Catherine Solovay</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Omar Delgado</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Omar Delgado</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Omar++Delgado">Omar Delgado</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Maura Crowley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maura Crowley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maura++Crowley">Maura Crowley</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Sha-Mei Liao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sha-Mei Liao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sha-Mei++Liao">Sha-Mei Liao</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Upendra A. Argikar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Upendra A. Argikar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Upendra+A.++Argikar">Upendra A. Argikar</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0939-0813" title="Orcid link">http://orcid.org/0000-0002-0939-0813</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Stefanie Flohr</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefanie Flohr</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefanie++Flohr">Stefanie Flohr</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Laura R. La Bonte</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura R. La Bonte</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura+R.++La+Bonte">Laura R. La Bonte</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Edwige L. Lorthiois</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Edwige L. Lorthiois</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Edwige+L.++Lorthiois">Edwige L. Lorthiois</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6147-9321" title="Orcid link">http://orcid.org/0000-0002-6147-9321</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Anna Vulpetti</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anna Vulpetti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Vulpetti">Anna Vulpetti</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3114-8679" title="Orcid link">http://orcid.org/0000-0002-3114-8679</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Ann Brown</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ann Brown</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ann++Brown">Ann Brown</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Debby Long</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Debby Long</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Debby++Long">Debby Long</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Melissa Prentiss</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Melissa Prentiss</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Melissa++Prentiss">Melissa Prentiss</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Nathalie Gradoux</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nathalie Gradoux</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nathalie++Gradoux">Nathalie Gradoux</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Andrea de Erkenez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrea de Erkenez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++de+Erkenez">Andrea de Erkenez</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Frederic Cumin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frederic Cumin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Frederic++Cumin">Frederic Cumin</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Christopher Adams</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher Adams</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Adams">Christopher Adams</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5246-884X" title="Orcid link">http://orcid.org/0000-0002-5246-884X</a></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Bruce Jaffee</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bruce Jaffee</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bruce++Jaffee">Bruce Jaffee</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Muneto Mogi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Muneto Mogi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Muneto++Mogi">Muneto Mogi</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00271&amp;href=/doi/10.1021%2Facs.jmedchem.9b00271" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 4656â4668</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 17, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 February 2019</li><li><span class="item_label"><b>Published</b> online</span>17 April 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 May 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00271" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00271</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4656%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRajeshri%2BG.%2BKarki%252C%2BJames%2BPowers%252C%2BNello%2BMainolfi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D9%26contentID%3Dacs.jmedchem.9b00271%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BPreclinical%2BCharacterization%2Bof%2BSelective%2BFactor%2BD%2BInhibitors%2BTargeting%2Bthe%2BAlternative%2BComplement%2BPathway%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4668%26publicationDate%3DMay%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00271"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1607</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00271" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Rajeshri&quot;,&quot;last_name&quot;:&quot;G. Karki&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Powers&quot;},{&quot;first_name&quot;:&quot;Nello&quot;,&quot;last_name&quot;:&quot;Mainolfi&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;Anderson&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;B. Belanger&quot;},{&quot;first_name&quot;:&quot;Donglei&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Nan&quot;,&quot;last_name&quot;:&quot;Ji&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;Jendza&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;F. Gelin&quot;},{&quot;first_name&quot;:&quot;Aengus&quot;,&quot;last_name&quot;:&quot;Mac Sweeney&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;Solovay&quot;},{&quot;first_name&quot;:&quot;Omar&quot;,&quot;last_name&quot;:&quot;Delgado&quot;},{&quot;first_name&quot;:&quot;Maura&quot;,&quot;last_name&quot;:&quot;Crowley&quot;},{&quot;first_name&quot;:&quot;Sha-Mei&quot;,&quot;last_name&quot;:&quot;Liao&quot;},{&quot;first_name&quot;:&quot;Upendra&quot;,&quot;last_name&quot;:&quot;A. Argikar&quot;},{&quot;first_name&quot;:&quot;Stefanie&quot;,&quot;last_name&quot;:&quot;Flohr&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;R. La Bonte&quot;},{&quot;first_name&quot;:&quot;Edwige&quot;,&quot;last_name&quot;:&quot;L. Lorthiois&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Vulpetti&quot;},{&quot;first_name&quot;:&quot;Ann&quot;,&quot;last_name&quot;:&quot;Brown&quot;},{&quot;first_name&quot;:&quot;Debby&quot;,&quot;last_name&quot;:&quot;Long&quot;},{&quot;first_name&quot;:&quot;Melissa&quot;,&quot;last_name&quot;:&quot;Prentiss&quot;},{&quot;first_name&quot;:&quot;Nathalie&quot;,&quot;last_name&quot;:&quot;Gradoux&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;de Erkenez&quot;},{&quot;first_name&quot;:&quot;Frederic&quot;,&quot;last_name&quot;:&quot;Cumin&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Adams&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;Jaffee&quot;},{&quot;first_name&quot;:&quot;Muneto&quot;,&quot;last_name&quot;:&quot;Mogi&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;4656-4668&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00271&quot;},&quot;abstract&quot;:&quot;Complement factor D (FD), a highly specific S1 serine protease, plays a central role in the amplification of the alternative complement pathway (AP) of the innate immune system. Dysregulation of AP activity predisposes individuals to diverse disorders such as age-related macular degeneration, atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis type II, and paroxysmal nocturnal hemoglobinuria. Previously, we have reported the screening efforts and identification of reversible benzylamine-based FD inhibitors (1 and 2) binding to the open active conformation of FD. In continuation of our drug discovery program, we designed compounds applying structure-based approaches to improve interactions with FD and gain selectivity against S1 serine proteases. We report herein the design, synthesis, and medicinal chemistry optimization of the benzylamine series culminating in the discovery of 12, an orally bioavailable and selective FD inhibitor. 12 demonstrated systemic suppression of AP activation&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00271&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00271" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00271&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00271" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00271&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00271" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00271&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00271&amp;href=/doi/10.1021/acs.jmedchem.9b00271" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00271" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00271" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00271%26sid%3Dliteratum%253Aachs%26pmid%3D30995036%26genre%3Darticle%26aulast%3DKarki%26date%3D2019%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BPreclinical%2BCharacterization%2Bof%2BSelective%2BFactor%2BD%2BInhibitors%2BTargeting%2Bthe%2BAlternative%2BComplement%2BPathway%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D9%26spage%3D4656%26epage%3D4668%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292200" title="Layers">Layers</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/jmcmar.2019.62.issue-9/20190509/jmcmar.2019.62.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Complement factor D (FD), a highly specific S1 serine protease, plays a central role in the amplification of the alternative complement pathway (AP) of the innate immune system. Dysregulation of AP activity predisposes individuals to diverse disorders such as age-related macular degeneration, atypical hemolytic uremic syndrome, membranoproliferative glomerulonephritis type II, and paroxysmal nocturnal hemoglobinuria. Previously, we have reported the screening efforts and identification of reversible benzylamine-based FD inhibitors (<b>1</b> and <b>2</b>) binding to the open active conformation of FD. In continuation of our drug discovery program, we designed compounds applying structure-based approaches to improve interactions with FD and gain selectivity against S1 serine proteases. We report herein the design, synthesis, and medicinal chemistry optimization of the benzylamine series culminating in the discovery of <b>12</b>, an orally bioavailable and selective FD inhibitor. <b>12</b> demonstrated systemic suppression of AP activation in a lipopolysaccharide-induced AP activation model as well as local ocular suppression in intravitreal injection-induced AP activation model in mice expressing human FD.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48770" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48770" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The complement system is part of the innate immune system that has a central immunoregulatory function and also a pathogenic role during ischemic, inflammatory, and autoimmune diseases.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Depending on the molecular recognition pattern, activation of the complement system can be initiated by three distinct routes: the classical, the lectin, and the alternative pathways. Complement factor D (FD; also known as adipsin) is a member of the chymotrypsin family of serine proteases that is essential for alternative pathway (AP) activation (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> FD cleaves factor B when it is complexed with C3b or C3 (H<sub>2</sub>O) to generate an active C3 convertase (C3bBb) that cleaves C3 into C3a and C3b. C3b is deposited onto acceptor surfaces (opsonization). Further recruitment of a C3b molecule to the membrane-bound C3 convertase generates a C5 convertase (C3bBbC3b), leading to C5a release and membrane attack complex (MAC; C5b to C9) formation on targeted surfaces with subsequent membrane disruption and cell lysis.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic representation of the alternative complement pathway (AP) from initiation to cell lysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Dysregulation of AP activity by genetic mutations, neutralizing antibodies to complement regulatory proteins, or stabilizing antibodies to complement convertase predisposes individuals to diverse disorders including paroxysmal nocturnal hemoglobinuria, age-related macular degeneration (AMD), atypical hemolytic uremic syndrome, and C3 glomerulonephritis (C3G).<a onclick="showRef(event, 'ref4 ref5 ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7 ref8 ref9">(4â9)</a> We have a long standing interest identifying oral FD inhibitors, due in part to the array of diverse diseases involving AP activation.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10â13)</a> In addition to our efforts, others have also made significant progress in developing FD inhibitors culminating in the clinical investigation of ACH-4471.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> We have previously reported the discovery of the benzylamine-based FD inhibitors (<b>1</b> and <b>2</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) targeting an active conformation of FD.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In this report, we describe the structure-based optimization of <b>1</b> that led to the discovery of <b>12</b>, an orally bioavailable and selective FD inhibitor which demonstrated systemic suppression of AP activation in a lipopolysaccharide (LPS)-induced AP activation model as well as local ocular suppression in intravitreal injection (IVT)-induced AP activation model in mice expressing human FD.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of benzylamine-based FD inhibitors.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07577" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07577" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the native state, FD exists in an inactive conformation with a noncompetent arrangement of the catalytic triad: His57, Ser195, and Asp102 (chymotrypsinogen numbering has been used throughout this paper). FD is autoinhibited by its self-inhibitory loop (residues 214â219) with Arg218 forming a salt bridge with Asp189, thus trapping it at the bottom of the S1 pocket (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). When an arginine sidechain from the substrate (or potentially inhibitors containing a basic amine functionality) occupies the S1 pocket, the salt bridge between Asp189 and Arg218 is broken, thereby releasing Arg218 from the S1 pocket. The self-inhibitory loop undergoes a conformational change eventually leading to a productive arrangement of the catalytic triad<a onclick="showRef(event, 'ref3 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref3 ref12 ref13">(3,12,13)</a> and a catalytically active FD.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. FD conformational change upon a substrate or benzylamine binding. Crystal structure of inactive FD (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FBE">5FBE</a>.pdb,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> white) is shown relative to active FD (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FUT">6FUT</a>.pdb,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> green). The substrate binding sites are labeled S1âS2â². Salt bridge between Arg218 and Asp189 is shown in black dotted lines. His57, Asp102, and Ser195 form the catalytic triad. Inhibitors bound with FD in the crystal structures are not shown for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We sought to exploit this conformational flexibility by designing modifications of the benzylamine compounds with the goal of engaging FD in a unique conformation not seen in other serine proteases, thereby enabling selectivity. From the previously disclosed X-ray structure of <b>1</b> with FD<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (also represented in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a), it was clear that the tetrahydronaphthalene moiety was in close proximity to the key Arg218 residue. So we decided to replace the tetrahydronaphthalene moiety in <b>1</b> with substituents capable of hydrogen bonding with the sidechain of Arg218. For preliminary modeling from proteinâligand co-crystal structures, an interactive three-dimensional (3D)-editor tool in FOCUS<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (Molsoft, L.L.C.) was employed. The 3D-editor tool provides a simple interface to explore the modification of an initial ligand within a proteinâligand complex, followed by constrained local minimizations of ligand molecules in the protein pocket. Starting from the co-crystal structure of <b>1</b> with FD, compound <b>3</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) was designed in the absence of the succinic acid with aid of the 3D-editor tool, to interact with the Arg218 sidechain (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a). Acid <b>3</b> was synthesized (vide infra) and assessed for FD inhibition via a time-resolved fluorescence energy transfer (TR-FRET) in vitro assay. Compound <b>3</b> inhibited FD with a TR-FRET IC<sub>50</sub> = 120 nM, an almost 270-fold improvement in potency relative to <b>1</b>. In addition, <b>3</b> exhibited functional inhibition of AP activation in vitro in a membrane attack complex (MAC) deposition assay using 50% human whole blood (WB).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The significant improvement in potency with the first synthesized compound was very encouraging, hence we decided to determine the binding mode of the compound. Surprisingly, docking analysis of <b>3</b> using Glide<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (SchrÃ¶dinger Inc.) generated an alternate binding mode than was originally designed, with the phenyl acetic acid H-bonding with residues of the catalytic triad instead of Arg218. X-ray crystallography confirmed that the binding mode predicted by Glide was, in fact, accurate (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b). The 1.64 Ã resolution X-ray structure afforded two copies of FD in the asymmetric unit. In both the monomer copies, the benzylamine group of <b>3</b> makes direct or water-mediated H-bonding with Asp189 in addition to H-bonding interactions with Ser190 and water-mediated interactions with Thr214 and Ile227 in the S1 pocket. The carboxylic acid group of <b>3</b> is nestled in the catalytic site making H-bonding interactions with His57, Gly193, and Ser195. Upon comparison of the FD bound co-crystal structure of <b>3</b> with that of <b>1</b>, we observed differences in the conformation of the Arg218 sidechain. Also, the carboxylic acid group of <b>3</b> overlapped perfectly with the succinic acid from the co-crystal structure of <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Interactions of carboxylic acid and phosphonic acid at the oxyanion hole have been reported earlier with FD<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and other S1 serine proteases,<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18â20)</a> albeit with different chemotypes.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding mode of <b>3</b> complexed with FD (a) 3D-editor generated orientation of <b>3</b> (green) shown relative to X-ray of <b>1</b> (cyan, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FUT">6FUT</a>.pdb<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a>). Alternate positions of succinic acid co-crystallized with <b>1</b> are shown in two shades of orange. (b) Crystal structure <b>3</b> (yellow) illustrating a productive arrangement of the catalytic triad residues His57, Asp102, and Ser195. The ligand-binding pocket is shown in gray and H-bonding interactions are shown as back dotted lines. The sidechain of Arg218 has shifted upon binding of <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Profiling Data of FD Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0013.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compound</th><th class="colsep0 rowsep0" align="center">FDÂ TR-FRETÂ IC<sub>50</sub>Â (Î¼M)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">humanÂ 50%Â WBÂ MACÂ IC<sub>50</sub>Â (Î¼M)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">Logâ<i>P</i><sub>app</sub>,Â cm/sÂ (permeabilityÂ rank)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">â3.9 (high)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">0.120</td><td class="colsep0 rowsep0" align="left">4.80</td><td class="colsep0 rowsep0" align="left"><â5.3 (low)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left">13.6</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">â4.3 (high)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><â5.3 (low)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="left">8.2</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><â5.5 (low)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">0.02</td><td class="colsep0 rowsep0" align="left">â5.2 (medium)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="left">0.270</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">â5.0 (medium)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="left">0.008</td><td class="colsep0 rowsep0" align="left">0.270</td><td class="colsep0 rowsep0" align="left">â4.5 (high)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">â4.8 (medium)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Half-maximal inhibition of recombinant human complement FD as determined in a TR-FRET assay.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Half-maximal inhibition of soluble MAC complex formation, as determined in an enzyme-linked immunosorbent assay (ELISA).</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Permeability measurement by parallel artificial membrane permeability assay (PAMPA).</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">ND = not determined. Data represent mean values of duplicate measurements.</p></div></div></div><div class="NLM_p">Although the binding mode of <b>3</b> was different from the initial design rationale using FOCUS, the serendipitous discovery gave us new insights into improving potency. However, the high level of structural homology across serine proteases as it relates to this particular binding mode raised questions of selectivity. Hence, we profiled compound <b>3</b> in a panel of more than 50 proteases. Factor XIa (FXIa; IC<sub>50</sub> = 2.8 Î¼M; 23-fold) and tryptase-Î²2 (IC<sub>50</sub> = 2.3 Î¼M; 19-fold) were identified as the major off-targets. Activity against the rest of the proteases assessed was 100â1000-fold weaker relative to FD biochemical potency. Apart from the potency and selectivity, we also characterized the solubility, in vitro absorption, distribution, metabolism, and excretion (ADME) parameters and the in vivo mouse pharmacokinetic (PK) profile of compound <b>3</b>.</div><div class="NLM_p">Compound <b>3</b> had good solubility (0.22 mM at pH 6.8) but poor permeability as assessed by a PAMPA assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). When administered to C57BL6 mice at 1 mg/kg intravenously (IV) and 10 mg/kg orally (PO), <b>3</b> exhibited a moderate clearance (22 mL/min/kg) and 10% oral bioavailability. The low oral bioavailability was presumed to be due to permeability limitations consistent with relatively low <i>P</i><sub>app</sub> value in the PAMPA assay.</div><div class="NLM_p">With this profile in hand, the goal for medicinal chemistry optimization became improving permeability, protease selectivity, and potency. To this end, we routinely used in vitro permeability (PAMPA assay) to guide our optimization efforts and prioritize compounds for pharmacokinetic studies.</div><div class="NLM_p">Initial efforts to improve permeability focused on carboxylic acid of <b>3</b>. Methyl ester analog <b>4</b> resulted in a 113-fold (IC<sub>50</sub> = 13.6 Î¼M) reduction in the activity compared to <b>3</b>. Replacing the carboxylic acid with bioisosteres also negatively impacted the biochemical potency (<b>5</b> and <b>6</b>). Compound <b>7</b> was synthesized with the goal of restricting exposure of polar functional groups by promoting intramolecular H-bonding of the pyridine nitrogen with the amide NâH. Although <b>7</b> showed a significant improvement in potency (TR-FRET IC<sub>50</sub> = 0.03 Î¼M and MAC IC<sub>50</sub> = 0.02 Î¼M), it showed only a marginal improvement in permeability (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). We next turned our attention toward removing the amide linker of <b>3</b> altogether, as it was not directly interacting with FD and posed a potential liability as it pertains to permeability. Compound <b>8</b>, lacking the carbonyl group showed a significant improvement in permeability while maintaining modest biochemical potency. Compound <b>9</b> with an ether linker provided the breakthrough in potency and permeability (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, TR-FRET IC<sub>50</sub> = 0.008 Î¼M; MAC IC<sub>50</sub> = 0.27 Î¼M, <i>P</i><sub>app</sub> = â4.5âlogâcm/s). Interestingly, the position of the oxygen in the ether linker (i.e. <b>9</b> vs <b>10</b>) had a significant impact on biochemical and functional potency for reasons that are not clear at this time.</div><div class="NLM_p">To study the impact of the improved PAMPA permeability, <b>9</b> was assessed in a mouse pharmacokinetic study (1 mg/kg IV and PO at 10 mg/kg; C57BL6 mice), where <b>9</b> showed low clearance (â¼14 mL/(min kg)) and excellent oral bioavailability (100%). With regards to protease selectivity, <b>9</b> exhibited <100-fold selectivity on only 3 of 50 proteases evaluated (FXIa IC<sub>50</sub> = 0.630 Î¼M, 80-fold; tryptase-Î²2 IC<sub>50</sub> = 0.360 Î¼M, 45-fold; and urokinase IC<sub>50</sub> = 0.77 Î¼M, 96-fold). Although encouraged by the off-target profile, we recognized an opportunity to further enhance the selectivity while maintaining permeability.</div><div class="NLM_p">In an attempt to address the selectivity question, we compared the FD bound <b>3</b> X-ray structure with a reported FXIa structure<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Upon close examination of the loop spanning residues Ser214âGly218 in FXIa, we observed Gly216 of FXIa making a van der Waals contact (3.5 Ã) with the benzylic carbon atom of <b>3</b>, which may account for the weaker activity against FXIa. The corresponding residue in FD is at a distance of 6.3 Ã because of the conformational difference of the self-inhibitory loop spanning residues Thr214âVal219 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Upon analysis of this loop in published crystal structures of other key off-targets tryptase-Î²2<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and urokinase,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> we found the loops of these proteases to be more similar to FXIa than FD, presenting an opportunity to confer selectivity by focusing on the Gly216 region.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of <b>3</b> bound with FD (yellow and white carbons) and FXIa<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (green carbons). Only selected residues in the ligand-binding pocket are shown. FD residues are labeled in black and FXIa in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We designed and analyzed substitutions on the benzylic carbon atom of <b>9</b> and predicted that even a methyl substituent would make enough of a steric clash to further attenuate affinity with off-target proteases while maintaining FD binding affinity. We also rationalized that the extra space offered by FD may enable placement of a moiety capable of H-bonding with Thr214. Furthermore, we were cognizant of the potential metabolic liability associated with an unsubstituted benzylamine.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Thus, compounds <b>11</b>â<b>14</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) were synthesized with the aim of improving potency, selectivity, and metabolic profile. In practice, we found that the off-target protease potency was in fact reduced, with compounds becoming >200-fold weaker relative to FD biochemical potency. Interestingly, despite the extra space offered by FD, the FD potency of compounds <b>11</b>â<b>14</b> was sensitive to the stereochemistry of the substituent with only one isomer showing favorable potency. Furthermore, consistent with the design rationale, the hydroxyl methyl group in <b>12</b> when crystallized with FD, occupied the small pocket created in the active conformation of FD making H-bonding interactions with Thr214 and Ile227 (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). However, despite this additional interaction, the biochemical and functional potency of <b>12</b> was similar to <b>9</b>, but encouragingly selectivity was substantially enhanced (FXIa IC<sub>50</sub> = 7.7 Î¼M, 640-fold; tryptase-Î²2 IC<sub>50</sub> = 6.5 Î¼M, 540-fold; and urokinase IC<sub>50</sub> > 30 Î¼M, >2500-fold). Further homologating the hydroxyl group as in <b>13</b> led to an even greater enhancement in selectivity but at the expense of a modest decline in FD potency.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray of <b>12</b> (yellow) complexed with FD (white). The ligand-binding pocket is shown in gray and H-bonding interactions are shown as black dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Profiling Data of Benzylamine FD Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0014.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="â" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compound</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center" char=".">FD TR-FRET IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">human 50% WB MAC IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">FXIa IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">tryptase Î²2 IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="â">Logâ<i>P</i><sub>app</sub> PAMPA, cm/s (permeabilityÂ rank)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>9</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td><td class="colsep0 rowsep0" align="char" char=".">0.270</td><td class="colsep0 rowsep0" align="left">0.60</td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="char" char="â">â4.5 (high)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>11</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.025</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="left">5.20</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="char" char="â">â4.5 (high)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>12</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="char" char=".">0.012</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="left">7.7</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="char" char="â">â5.1 (medium)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>13</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(CH<sub>2</sub>)<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="char" char=".">0.030</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">55</td><td class="colsep0 rowsep0" align="char" char="â">â5.2 (medium)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>14</b></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.160</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="char" char="â">â5.0 (medium)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>15</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="left">8.09</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="char" char="â">â5.4 (low)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>16</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="char" char=".">0.010</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="char" char="â">â5.3 (low)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>17</b></td><td class="colsep0 rowsep0" align="left">C(CH<sub>3</sub>)<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td><td class="colsep0 rowsep0" align="char" char=".">0.013</td><td class="colsep0 rowsep0" align="left">0.65</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="char" char="â">â5.5 (low)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>18</b></td><td class="colsep0 rowsep0" align="left">NHiPr</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">8.7</td><td class="colsep0 rowsep0" align="char" char="â">â5.5 (low)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Half-maximal inhibition of recombinant human complement FD as determined in a TR-FRET assay.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Half-maximal inhibition of soluble MAC complex formation, as determined in an ELISA assay.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Permeability measurement by PAMPA.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Screening assay with >50 protease targets. Data represent mean values of duplicate measurements.</p></div></div></div><div class="NLM_p">We next turned our attention toward improving interactions in the S1Î² subsite with the aim of enhancing functional potency. Compounds <b>14</b>â<b>18</b> were synthesized with diverse substituents to occupy different regions in S1Î² subsite. Although modifications in the S1Î² subsite did, in fact, lead to modest improvements in biochemical and functional potency in most instances (e.g., <b>15</b>â<b>18</b>), it also resulted in a reduction in permeability in the PAMPA assay with the introduction of polar substituents (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). With this data in hand, compounds <b>12</b>, <b>13</b>, and <b>14</b> were selected for in vivo pharmacokinetic assessment (1 mg/kg IV and PO at 10 mg/kg; C57BL6 mice <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). All three compounds exhibited low clearance upon IV administration, but only <b>12</b> afforded a robust oral bioavailability (83%). In light of the encouraging mouse PK profile, compound <b>12</b> was selected for in vivo pharmacology assessment (vide infra).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Parameters of <b>12</b>, <b>13</b>, and <b>14</b> in C57BL6 Mice Dosed at 1 mg/kg IV and 10 mg/kg PO</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">compound</th><th class="colsep0 rowsep0" align="center">oral <i>C</i><sub>max</sub> (nM)</th><th class="colsep0 rowsep0" align="center">AUC<sub>(0â7)</sub>Â (nMÂ h)Â IV/PO</th><th class="colsep0 rowsep0" align="center" char=".">CL (mL/(minÂ kg))</th><th class="colsep0 rowsep0" align="center" char=".">Vd<sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">elimination <i>t</i><sub>1/2</sub> (IV) (h)</th><th class="colsep0 rowsep0" align="center" char=".">%<i>F</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>12</b></td><td class="colsep0 rowsep0" align="left">31â000</td><td class="colsep0 rowsep0" align="left">16â100/125â000</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>13</b></td><td class="colsep0 rowsep0" align="left">10â700</td><td class="colsep0 rowsep0" align="left">4970/19â500</td><td class="colsep0 rowsep0" align="char" char=".">8.7</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char="."><b>14</b></td><td class="colsep0 rowsep0" align="left">26â000</td><td class="colsep0 rowsep0" align="left">48â700/11â600</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr></tbody></table></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04761" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04761" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>3</b>â<b>7</b> can be generally accessed from three primary building blocks: benzylamines of type <b>A</b>, 3-halobenzoic acids of type <b>B</b>, and the appropriate aminophenyl acetate derivatives of type <b>C</b> via two separate routes. Route <b>A</b>, as exemplified by the synthesis of <b>4</b>, begins with a Suzuki cross-coupling between <b>A</b> and <b>B</b> followed by a peptide coupling with aniline <b>C</b>. Alternatively, route <b>B</b> can be used to access compounds such as <b>7</b> by first coupling building blocks <b>B</b> and <b>C</b> to afford the requisite amides which are then subjected to Suzuki cross-coupling with <b>A</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The core of compounds <b>9</b>â<b>18</b>, which are devoid of the amide linkage, were typically prepared from methyl 2-(2-hydroxyphenyl)acetate and the corresponding 3-bromobenzyl bromide to furnish cores such as <b>25</b>. Alternatively, for the opposite regioisomer (e.g., <b>26</b>), by starting from methyl 2-(2-(chloromethyl)phenyl)acetate and coupling with the corresponding 3-bromophenol, as outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. With the cores in place, final compounds can then be accessed via Suzuki coupling with the appropriate boronic acid. In the case of <b>9</b> and <b>10</b>, (3-(aminomethyl)phenyl)boronic acid hydrochloride was utilized avoiding the need for the protection of the basic amine.</div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">More elaborate building blocks of type <b>A</b> needed to access compounds <b>11</b>â<b>18</b> were readily accessed from the corresponding bromide, which are either commercially available or known in the literature, by employing Miyaura-type conditions, as depicted in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. Similarly, more complex building blocks of type <b>B</b> required for compounds <b>14</b>â<b>18</b> could be accessed from commercial sources or from standard transformations, as delineated in the <a class="ref internalNav" href="#sec6" aria-label="Experimental Section">Experimental Section</a>.</div><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">In Vivo Pharmacology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41143" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41143" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As stated above, the FD inhibitory potency of <b>12</b>, combined with favorable protease selectivity and pharmacokinetic profile, led to its selection for the evaluation in vivo pharmacology studies.</div><div class="NLM_p">To enable in vivo efficacy assessment, it was necessary to generate mice expressing human FD in place of the murine enzyme (human FD knock-in mice) as previously described<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> due to compounds in this chemical series lacking species cross-reactivity. A pharmacodynamic model was developed with these mice by the administration of lipopolysaccharide (LPS), a component of the outer membrane of Gram-negative bacteria. Intraperitoneal administration of LPS induces the activation of the AP, as detected by increased levels of AP breakdown products, in particular Ba which is a direct product of the FD-mediated cleavage of C3bB.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> When <b>12</b> was administered in this model by oral gavage at 3 and 10 mg/kg, AP modulation was observed in a dose responsive manner, as measured by plasma Ba levels (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Encouragingly, the AP pathway was fully inhibited for up to 10 h at the 10 mg/kg dose.</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Inhibitor <b>12</b> tested at 3 and 10 mg/kg in the human FD knock-in mouse pharmacodynamic model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Given the evidence of the role of AP in AMD,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> we also investigated the ability of <b>12</b> to achieve exposure in posterior tissues of the eye, specifically the retina and the posterior eye cup (PEC), which consists of the primary target tissue for AMD the retinal pigment epithelium (RPE)/choroid as well as the posterior sclera. Due to the small size of the mouse eye, which hampers precise tissue dissection, the ocular tissue distribution profile of <b>12</b> was evaluated in brown Norway rats. Upon oral administration of <b>12</b> (10 mg/kg) to brown Norway rats, absolute plasma exposure was lower relative to the mouse (<i>C</i><sub>max</sub> = â¼4Ã lower; AUC = â¼54Ã lower), but encouragingly exposure in the posterior eye cup was above the IC<sub>50</sub> of <b>12</b> in the 50% whole blood MAC deposition functional assay (260 nM) for over 24 h (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Concentration vs time profile for <b>12</b> in the retina, PEC, and plasma and PK parameters after a single dose (PO 10 mg/kg) in brown Norway rats. DN = dose normalized.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In light of the encouraging ocular PK profile of <b>12</b>, we examined the ability to suppress AP activation in ocular tissues. To examine ocular efficacy, we chose a model where AP is activated locally via ocular injury, specifically an intravitreal injection (IVT). This model has previously been described<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and shown to increase AP locally in ocular tissues. Oral administration of <b>12</b> showed a dose-dependent decrease in the ocular Ba levels (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) with up to 86% inhibition at 10 mg/kg dose.</div><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0009.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Ocular efficacy of <b>12</b> after a single oral dose in a model where AP is activated locally via intravitreal injection; efficacy assessments were made 4 h post-intravitreal injection.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The encouraging in vivo pharmacology profile wherein <b>12</b> demonstrates suppression of AP activation both in plasma and in ocular tissues warranted advanced in vitro and in vivo profiling of <b>12</b>. Compound <b>12</b> was evaluated in an internal panel of over 70 enzymes, receptors, and ion channels, and it did not exhibit any activity against these off-targets at concentrations â¤10 Î¼M. <b>12</b> also did not inhibit CYP3A4, CYP2C9, CYP2D6, or hERG (Q-patch assay) at concentrations â¤30 Î¼M in vitro. The PK profile of <b>12</b> was also evaluated in beagle dogs at doses of 1 mg/kg IV and 10 mg/kg PO. Consistent with the observed rodent PK profiles, <b>12</b> exhibited a low clearance in dogs (3.8 mL/(min kg)) and an excellent oral bioavailability (â¼70%) (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic Parameters of <b>12</b> in Beagle Dogs Dosed at 1 mg/kg IV and 10 mg/kg PO Represented as Mean Values (<i>n</i> = 3)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PK parameters</th><th class="colsep0 rowsep0" align="center">mean</th><th class="colsep0 rowsep0" align="center">Â±SD</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/(minÂ kg))</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Vd<sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0âlast</sub>Â (nMÂ h)Â 10Â mg/kgÂ PO</td><td class="colsep0 rowsep0" align="left">85â000</td><td class="colsep0 rowsep0" align="left">16â100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub>Â (nM)Â 10Â mg/kgÂ PO</td><td class="colsep0 rowsep0" align="left">16â500</td><td class="colsep0 rowsep0" align="left">2000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">%<i>F</i></td><td class="colsep0 rowsep0" align="left">70%</td><td class="colsep0 rowsep0" align="left">N/A<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">N/A denotes not applicable.</p></div></div></div><div class="NLM_p last">The acceptable pharmacokinetic profile in two species combined with the ability of <b>12</b> to suppress AP activation both systemically and in ocular tissue led to its progression into a more advanced preclinical evaluation, which will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A rationally conceived approach exploiting the FD conformational dynamics to optimize the benzylamine FD inhibitors<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> led to the discovery of lead molecule <b>3</b>. The novel serendipitous binding mode of <b>3</b> while offering acceptable potency presented challenges related to protease selectivity. Structure-based optimization for selectivity in combination with optimization of ADME properties culminated in the discovery of <b>12</b>, an orally bioavailable, selective FD inhibitor. Compound <b>12</b> has demonstrated suppression of AP activation both in plasma and ocular tissues in mice. Compound <b>12</b> has been selected for an advanced preclinical evaluation.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Experimental Procedures and Compound Characterization for Novel Compounds</h3><div id="sec6_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> General Chemistry Information</h4><div class="NLM_p last">Unless otherwise specified, all solvents and reagents were obtained from commercial suppliers and used without further drying or purification. NMR spectra were recorded on a Bruker Avance II 400 MHz spectrometer. All chemical shifts are reported in parts per million (Î´) relative to tetramethylsilane. The following abbreviations are used to denote signal patterns: s = singlet, d = doublet, t = triplet, m = multiplet, and br = broad. Flash chromatography was conducted using grade 60 230â400 mesh silica gel from Fisher Chemical (S825-1) or by utilizing the CombiFlash Companion from Teledyne Isco, Inc. and RediSep Rf disposable normal phase silica gel columns (4â300 g). Thin-layer chromatography (TLC) was performed using 2.5 Ã 7.5 cm<sup>2</sup> glass-backed TLC silica gel 60 F<sub>254</sub> plates from EMD Chemicals, Inc. (15341-1) and visualized by UV light. High-performance liquid chromatography (HPLC) purifications were performed on a Gilson preparative HPLC system controlled by the Unipoint software using XBridge Phenyl, C8, C18, or RP18 30 Ã 50 mm<sup>2</sup> columns with 5 Î¼m particle size. Low-resolution mass spectra were recorded using an Agilent 1100 series liquid chromatographyâmass spectrometry (LCâMS) spectrometer. The purity of all exemplified compounds was â¥95%, as determined by both <sup>1</sup>H NMR and HPLC-UV at a wavelength of 214 nm, unless otherwise stated. Unless otherwise stated, chiral starting materials were commercially available with enantiomeric excess â¥98%.</div></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Experimentals</h3><div id="sec6_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> 2-(2-(3â²-(Aminomethyl)-[1,1â²-biphenyl]-3-carboxamido)phenyl)acetic Acid (<b>3</b>)</h4><div class="NLM_p last">Triethylamine (0.276 mL, 1.984 mmol) was added to a mixture of 3-bromobenzoic acid (199 mg, 0.992 mmol) and hexafluorophosphate azabenzotriazole tetramethyl uronium (HATU) (415 mg, 1.091 mmol) in dimethylformamide (DMF) at 23 Â°C. In a separate vial, methyl 2-(2-aminophenyl)acetate hydrochloride (CAS # 49851-36-7) (200 mg, 0.992 mmol) was stirred with tetraethylammonium (TEA) (0.276 mL, 1.980 mmol) in DMF (0.5 mL). After 5 min, the solution of methyl 2-(2-aminophenyl)acetate hydrochloride (200 mg, 0.992 mmol) was added to the 3-bromobenzoic acid (199 mg, 0.992 mmol) mixture, and the resulting mixture was stirred at room temperature (rt) for 30 min. The reaction mixture was diluted with EtOAc and washed with water. The aqueous (aq) layer was extracted with EtOAc. The combined organics were washed with 5% aq LiCl, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The resulting residue was purified by silica gel chromatography (EtOAc/heptane 0â60%) to provide methyl 2-(2-(3-bromobenzamido)phenyl)acetate (194 mg, 94%). MS (electrospray ionization (ESI)<sup>+</sup>) <i>m</i>/<i>z</i> 348.0, 350.0 (M + H). A mixture of methyl 2-(2-(3-bromobenzamido)phenyl)acetate (90 mg, 0.258 mmol), prepared as described above, (3-(aminomethyl)phenyl)boronic acid hydrochloride (CAS # 146285-80-5) (63.0 mg, 0.336 mmol), PdCl<sub>2</sub>(dppf)Â·CH<sub>2</sub>Cl<sub>2</sub> adduct (CAS # 95464-05-4) (10.55 mg, 0.013 mmol), and 2 M aq K<sub>3</sub>PO<sub>4</sub> (0.388 mL, 0.775 mmol) in 9:1 MeCN/H<sub>2</sub>O (2.8 mL) was heated in a microwave reactor at 110 Â°C for 60 min. The organic layer was filtered, and the filtrate was directly purified by reverse phase HPLC (stationary phase: Gemini NX 5 Î¼m C18 110 Ã 100 Ã 30 mm<sup>2</sup>; mobile phase: acetonitrile gradient, water with 0.1% (28% ammonium hydroxide)/acetonitrile). Fractions containing the desired product were pooled, the pooled fractions were frozen and lyophilized to provide the title compound (0.063 g, yield 68%). <sup>1</sup>H NMR (400 MHz, dimethyl sulfoxide (DMSO)-<i>d</i><sub>6</sub>, one drop of trifluoroacetyl (TFA) added) Î´ ppm 10.13 (s, 1H) 8.28 (s, 1H) 8.23 (br s, 3H) 7.98 (d, <i>J</i> = 7.83 Hz, 1H) 7.87â7.94 (m, 2H) 7.81 (d, <i>J</i> = 7.83 Hz, 1H) 7.66 (t, <i>J</i> = 7.77 Hz, 1H) 7.54â7.61 (m, 1H) 7.46â7.53 (m, 2H) 7.30â7.39 (m, 2H) 7.21â7.28 (m, 1H) 4.15 (q, <i>J</i> = 5.81 Hz, 2H) 3.70 (s, 2H) high-resolution mass spectrometry (HRMS) calcd for C<sub>22</sub>H<sub>20</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 361.1552, found 361.1550.</div></div><div id="sec6_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Methyl 2-(2-(3â²-(Aminomethyl)-[1,1â²-biphenyl]-3-ylcarboxamido)phenyl)acetate (<b>4</b>)</h4><div class="NLM_p last">Triethylamine (0.255 mL, 1.833 mmol) was added to a mixture of 3â²-(((<i>tert</i>-butoxycarbonyl)amino)methyl)-[1,1â²-biphenyl]-3-carboxylic acid (200 mg, 0.611 mmol), <b>20</b>, and HATU (256 mg, 0.672 mmol) in DMF at 23 Â°C. After 15 min, methyl 2-(2-aminophenyl)acetate hydrochloride (CAS # 35613-44-6) (130 mg, 0.611 mmol) was added, and the resulting mixture was stirred at room temperature overnight. The resulting mixture was partitioned between EtOAc and H<sub>2</sub>O. The layers were separated, and the aqueous layer was extracted with 4:1 EtOAc/heptane. The combined organics were washed with 5% aqueous LiCl solution, the washed organics were dried with Na<sub>2</sub>SO<sub>4</sub>, the dried solution was filtered, and the filtered solution was concentrated. The resulting crude was purified by silica gel chromatography (10â70% EtOAc/heptane) to provide methyl 2-(2-(3â²-(((<i>tert</i>-butoxycarbonyl)amino)methyl)-[1,1â²-biphenyl]-3-ylcarboxamido)phenyl)acetate (63 mg, 22%). MS (ESI<sup>â</sup>) <i>m</i>/<i>z</i> 473.4 (MâH). Methyl 2-(2-(3â²-(((<i>tert</i>-butoxycarbonyl)amino)methyl)-[1,1â²-biphenyl]-3-ylcarboxamido)phenyl)acetate (50 mg, 0.105 mmol) was added to a solution of HCl (2 M in Et<sub>2</sub>O, 1.05 mL, 2.11 mmol). The resulting mixture was stirred at room temperature overnight, then concentrated. The residue was purified by reverse phase HPLC (Waters SunFire Prep C18 OBDTM 5 Î¼m, 30 Ã 100 mm<sup>2</sup>; mobile phase: MeCN gradient, water with 0.1% TFA/acetonitrile). Fractions containing the desired product were pooled, the pooled fractions were frozen and lyophilized to provide the title compound as a TFA salt (11 mg, yield 23%). <sup>1</sup>H NMR (TFA salt, 400 MHz, methanol-<i>d</i><sub>4</sub>) Î´ ppm 8.26 (s, 1H), 7.98 (d, <i>J</i> = 7.7 Hz, 1H), 7.88â7.94 (m, 1H), 7.77â7.84 (m, 2H), 7.65 (t, <i>J</i> = 7.8 Hz, 1H), 7.59 (t, <i>J</i> = 7.8 Hz, 1H), 7.47â7.55 (m, 2H), 7.34â7.42 (m, 2H), 7.25â7.32 (m, 1H), 4.22 (s, 2H), 3.78 (s, 2H), 3.63 (s, 3H). HRMS calcd for C<sub>23</sub>H<sub>22</sub>N<sub>2</sub>O<sub>3</sub> (M + H)<sup>+</sup> 375.1700, found 375.1696.</div></div><div id="sec6_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> <i>N</i>-(2-((2<i>H</i>-Tetrazol-5-yl)methyl)phenyl)-3â²-(aminomethyl)-[1,1â²-biphenyl]-3-carboxamide (<b>5</b>)</h4><div class="NLM_p last">To a solution of 5-[(2-nitrophenyl)methyl]-1<i>H</i>-1,2,3,4-tetrazole (CAS # 177595-29-8, 280 mg, 1.27 mmol) in tetrahydrofuran (THF) (6.8 mL) was added TEA (0.43 mL, 3.1 mmol). The mixture was cooled to 0 Â°C, and 2-(trimethylsilyl)ethoxymethyl chloride (0.3 mL, 1.7 mmol) was added. After â¼1.5 h, the mixture was partially purified by directly absorbing onto a plug of silica gel and eluting with 0â50% EtOAc/heptane, the eluent was concentrated, and the resulting residue was dissolved in THF (4.8 mL), charged with PtO<sub>2</sub> (11 mg, 0.05 mmol), and placed under a H<sub>2</sub> gas atmosphere. After â¼2 h, the mixture was filtered through a plug of Celite and concentrated to which a solution of <b>20</b> (125 mg, 0.38 mmol) in DMF (1.9 mL) was added, followed by HATU (174 mg, 0.458 mmol) and TEA (133 Î¼L, 0.96 mmol) and the mixture was stirred for â¼14 h at which time it was passed through a plug of silica (0â50% EtOAc/heptane) and concentrated, the resulting oil was then diluted with dichloromethane (DCM) (1 mL) and treated with TFA (300 Î¼L, 3.8 mmol) and stirred for 3 h. The mixture was concentrated to dryness and purified directly by reversed-phase HPLC (stationary phase: Gemini NX 5 Î¼m C18 110 Ã 100 Ã 30 mm<sup>2</sup>; mobile phase: MeCN gradient, water with 0.1% (28% ammonium hydroxide)/acetonitrile) to afford the title compound in 85% purity by <sup>1</sup>H NMR (40 mg, yield 18%): <sup>1</sup>H NMR (TFA salt, 400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 16.15 (s, 1H), 10.15 (s, 1H), 8.21 (t, <i>J</i> = 1.9 Hz, 3H), 7.95â7.87 (m, 3H), 7.82 (dt, <i>J</i> = 7.9, 1.3 Hz, 1H), 7.65 (t, <i>J</i> = 7.7 Hz, 1H), 7.61â7.53 (m, 1H), 7.49 (dt, <i>J</i> = 7.7, 1.4 Hz, 1H), 7.46â7.41 (m, 1H), 7.37 (ddd, <i>J</i> = 7.9, 6.3, 2.5 Hz, 1H), 7.33â7.25 (m, 2H), 4.37 (s, 2H), 4.16 (d, <i>J</i> = 5.7 Hz, 2H). HRMS calcd for C<sub>22</sub>H<sub>21</sub>N<sub>6</sub>O (M + H)<sup>+</sup> 385.1776, found 385.1766.</div></div><div id="sec6_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> <i>N</i>-(2-((<i>N</i>-Acetylsulfamoyl)methyl)phenyl)-3â²-(aminomethyl)-[1,1â²-biphenyl]-3-carboxamide (<b>6</b>)</h4><div class="NLM_p last">It was prepared in a similar fashion as <b>5</b>, by starting with <i>N</i>-((2-aminobenzyl)sulfonyl)acetamide, which can be prepared as follows. To a solution of (2-nitrophenyl)methanesulfonamide (CAS # 51145-00-7; 230 mg, 1.064 mmol) in DCM (10 mL) were added bismuth(III) trifluoromethanesulfonate (40 mg, 0.061 mmol) and acetyl chloride (600 Î¼L, 8.44 mmol), and the mixture was stirred at rt for 40 min at which time it was filtered and the eluent was concentrated to dryness and the resulting crude <i>N</i>-((2-aminobenzyl)sulfonyl)acetamide, which could be used without further purification in the subsequent step. Spectroscopic data for the title compound, <i>N</i>-(2-((<i>N</i>-acetylsulfamoyl)methyl)phenyl)-3â²-(aminomethyl)-[1,1â²-biphenyl]-3-carboxamide (<b>6</b>): <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.25 (s, 1H), 8.54 (t, <i>J</i> = 1.8 Hz, 1H), 8.22 (s, 3H), 8.04 (dt, <i>J</i> = 7.8, 1.5 Hz, 1H), 8.00â7.90 (m, 3H), 7.86 (dt, <i>J</i> = 7.6, 1.5 Hz, 1H), 7.66 (t, <i>J</i> = 7.7 Hz, 1H), 7.55 (t, <i>J</i> = 7.6 Hz, 1H), 7.47 (dt, <i>J</i> = 7.7, 1.3 Hz, 1H), 7.35 (ddd, <i>J</i> = 15.0, 7.4, 1.6 Hz, 2H), 7.17 (td, <i>J</i> = 7.5, 1.3 Hz, 1H), 4.42 (s, 2H), 4.15 (s, 2H), 1.56 (s, 3H). HRMS calcd for C<sub>23</sub>H<sub>24</sub>N<sub>3</sub>O<sub>4</sub>S (M + H)<sup>+</sup> 438.1487, found 438.1469.</div></div><div id="sec6_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 2-(2-(6-(3-(Aminomethyl)phenyl)picolinamido)phenyl)acetic Acid (<b>7</b>)</h4><div class="NLM_p last">The title compound was prepared from methyl 2-(2-(6-chloropicolinamido)phenyl)acetate (<b>22</b>) and 3-aminomethylphenyl boronic acid HCl (CAS # 146285-80-5) using a method similar to that described for <b>3</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 12.22 (br s, 1H), 9.32 (br s, 1H), 9.13 (br s, 2H), 8.32 (d, <i>J</i> = 7.5 Hz, 1H), 8.20â8.06 (m, 1H), 7.84 (d, <i>J</i> = 8.0 Hz, 1H), 7.54â7.41 (m, 2H), 7.29â7.17 (m, 3H), 7.09 (t, <i>J</i> = 6.9 Hz, 1H), 4.10 (s, 2H), 3.41 (s, 2H). HRMS calcd for C<sub>21</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub> (M + H)<sup>+</sup> 362.1505, found 362.1502.</div></div><div id="sec6_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 2-(2-(((3â²-(Aminomethyl)-[1,1â²-biphenyl]-3-yl)amino)methyl)phenyl)acetic Acid (<b>8</b>)</h4><div class="NLM_p last">A degassed mixture of 3-bromoaniline (600 mg, 3.49 mmol), 3-((<i>tert</i>-butoxycarbonylamino)methyl)phenylboronic acid (1051 mg, 4.19 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (202 mg, 0.174 mmol), and 2 M aq K<sub>3</sub>PO<sub>4</sub> (1481 mg, 6.98 mmol) in dioxane (15 mL) and water (3 mL) was heated at 100 Â°C for 1.5 h. The reaction mixture was diluted with EtOAc and washed with water. The aqueous layer was washed with EtOAc. The combined organics were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified by silica gel chromatography (EtOAc/heptane 0â100%) to provide <i>tert</i>-butyl ((3â²-amino-[1,1â²-biphenyl]-3-yl)methyl)carbamate (552 mg, yield 53%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 7.30â7.51 (m, 4H) 7.18 (d, <i>J</i> = 7.20 Hz, 1H) 7.09 (t, <i>J</i> = 7.77 Hz, 1H) 6.81 (t, <i>J</i> = 1.83 Hz, 1H) 6.74 (d, <i>J</i> = 7.58 Hz, 1H) 6.55 (dt, <i>J</i> = 6.92, 1.15 Hz, 1H) 5.14 (s, 2H) 4.17 (d, <i>J</i> = 6.06 Hz, 2H) 1.40 (s, 9H). Sodium triacetoxyborohydride (111 mg, 0.523 mmol) was added to a solution of <i>tert</i>-butyl ((3â²-amino-[1,1â²-biphenyl]-3-yl)methyl)carbamate (104 mg, 0.349 mmol) and methyl 2-(2-formylphenyl)acetate (CAS # 63969-83-5) (74.5 mg, 0.418 mmol) in DCE (4 mL) at rt. The reaction mixture was stirred at rt for 2.5 h. The reaction mixture was partitioned between EtOAc and sat. aq NH<sub>4</sub>Cl. The aqueous layer was extracted with EtOAc. The combined organics were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified by silica gel chromatography (EtOAc/heptane 0â50%) to provide methyl 2-(2-(((3â²-(((<i>tert</i>-butoxycarbonyl)amino)methyl)-[1,1â²-biphenyl]-3-yl)amino)methyl)phenyl)acetate (132 mg, yield 82%). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 461.4 (M + H). A solution of methyl 2-(2-(((3â²-(((<i>tert</i>-butoxycarbonyl)amino)methyl)-[1,1â²-biphenyl]-3-yl)amino)methyl)phenyl)acetate (110 mg, 0.239 mmol) in DCM (1 mL) and TFA (1 mL) was stirred at room temperature for 15 h. DCM (10 mL) and sat. aqueous NaHCO<sub>3</sub> solution (15 mL) were added. Then, solid NaHCO<sub>3</sub> was added until pH â¼ 8. The two layers were separated, the organic layer was concentrated, the resulting residue was dissolved in THF (1 mL), and aq LiOH (2 M solution, 0.598 mL, 1.195 mmol) was added. The mixture was stirred at room temperature for 2 h. The mixture was evaporated, and the residue was diluted in 2 mL of water. HCl was added until pH = 4, and the aqueous layer was extracted with EtOAc. Then, NH<sub>4</sub>OH was added until pH = 10, and the aqueous layer was extracted with EtOAc. The organic layer was dried (sodium sulfate), filtered, evaporated, and purified by reverse phase HPLC (stationary phase: Agilent Eclipse XDB-C18; particle size 1.8 Î¼m; column size 4.6 Ã 50 mm<sup>2</sup>; mobile phase: eluent/gradient 20â100% CH<sub>3</sub>CN/H<sub>2</sub>O (CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% of TFA)) to give the title compound, 2-(2-(((3â²-(aminomethyl)-[1,1â²-biphenyl]-3-yl)amino)methyl)phenyl)acetic acid, (60 mg, yield 73%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) Î´ ppm 7.80 (s, 1H) 7.52â7.61 (m, 1H) 7.30â7.41 (m, 2H) 7.03â7.26 (m, 5H) 6.85â6.91 (m, 1H) 6.81 (t, <i>J</i> = 1.96 Hz, 1H) 6.77 (ddd, <i>J</i> = 8.02, 2.34, 0.88 Hz, 1H) 4.52 (s, 2H) 4.09 (s, 2H) 3.59 (s, 2H). HRMS calcd for C<sub>22</sub>H<sub>22</sub>N<sub>2</sub>O<sub>2</sub> (M + H)<sup>+</sup> 347.1760, found 347.1756.</div></div><div id="sec6_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 2-(2-((3â²-(Aminomethyl)-[1,1â²-biphenyl]-3-yl)methoxy)phenyl)acetic Acid (<b>9</b>)</h4><div class="NLM_p last">A microwave vial was charged with methyl 2-(2-((3-bromobenzyl)oxy)phenyl)acetate (<b>25</b>) (109 mg, 0.325 mmol), PdCl<sub>2</sub>(dppf)Â·CH<sub>2</sub>Cl<sub>2</sub> (13.28 mg, 0.016 mmol), and (3-(aminomethyl)phenyl)boronic acid hydrochloride (CAS # 146285-80-5) (76 mg, 0.406 mmol). Acetonitrile (1.3 mL), 2 M aqueous K<sub>3</sub>PO<sub>4</sub> (0.488 mL, 0.976 mmol), and water (0.130 mL) were added, the vial was flushed with nitrogen, sealed, and heated in the microwave for 60 min at 110 Â°C. THF (4 mL) and 2 M aqueous LiOH (0.813 mL, 1.626 mmol) were added, and the mixture was heated at 50 Â°C for 4 h. Additional 2 M aqueous LiOH (0.813 mL, 1.626 mmol) was added, and the reaction was heated at 50 Â°C overnight. The mixture was acidified to pH 4â5 with 2 N HCl, extracted with ethyl acetate, washed with water and brine, dried with sodium sulfate, filtered, and concentrated. The crude was purified by preparative HPLC (stationary phase: Gemini NX 5 Î¼m C18 110 Ã 100 Ã 30 mm<sup>2</sup>; mobile phase: MeCN gradient, water with 0.1% (28% ammonium hydroxide)/acetonitrile) to provide the title compound (30 mg, yield 25%). <sup>1</sup>H NMR (400 MHz, acetonitrile-<i>d</i><sub>3</sub>) Î´ ppm 7.89â7.84 (m, 1H), 7.84â7.80 (m, 1H), 7.62 (d, <i>J</i> = 8.0 Hz, 1H), 7.57 (d, <i>J</i> = 7.2 Hz, 1H), 7.40 (dt, <i>J</i> = 1.8, 7.6 Hz, 2H), 7.27â7.19 (m, 2H), 7.16 (d, <i>J</i> = 7.5 Hz, 2H), 6.88 (dt, <i>J</i> = 0.9, 7.4 Hz, 1H), 6.83 (d, <i>J</i> = 7.8 Hz, 1H), 5.00 (s, 2H), 3.92 (s, 2H), 3.57 (s, 2H). HRMS calcd for C<sub>22</sub>H<sub>21</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 348.1600, found 348.1589.</div></div><div id="sec6_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2-(2-(((3â²-(Aminomethyl)-[1,1â²-biphenyl]-3-yl)oxy)methyl)phenyl)acetic Acid (<b>10</b>)</h4><div class="NLM_p last">The title compound was prepared in a similar fashion as (<b>9</b>), by starting with the coupling of 3-bromophenol (CAS # 591-20-8) and methyl 2-(2-(chloromethyl)phenyl)acetate (CAS # 95360-33-1). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) Î´ ppm 7.71 (s, 1H) 7.54 (d, <i>J</i> = 7.83 Hz, 1H) 7.13â7.43 (m, 9H) 7.02 (ddd, <i>J</i> = 8.21, 2.53, 0.88 Hz, 1H) 5.33 (s, 2H) 3.96 (s, 2H) 3.60 (s, 2H). HRMS calcd for C<sub>22</sub>H<sub>21</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 348.1600, found 348.1593.</div></div><div id="sec6_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>R</i>)-2-(2-((3â²-(1-Aminoethyl)-[1,1â²-biphenyl]-3-yl)methoxy)phenyl)acetic Acid (<b>11</b>)</h4><div class="NLM_p last">Methyl 2-(2-((3-bromobenzyl)oxy)phenyl)acetate (<b>25</b>) (124 mg, 0.370 mmol), (<i>R</i>)-<i>tert</i>-butyl (1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)carbamate, (CAS # 887254-66-2, 135 mg, 0.388 mmol), and PdCl<sub>2</sub>(dppf)Â·CH<sub>2</sub>Cl<sub>2</sub> (15.11 mg, 0.018 mmol) were added to a microwave vial. Acetonitrile (1.5 mL), 2 M aqueous K<sub>3</sub>PO<sub>4</sub> (0.555 mL, 1.110 mmol), and water (0.300 mL) were added, the vial head space was flushed with nitrogen, and the suspension was heated in a microwave for 60 min at 110 Â°C. At this point, 2 mL of 2 M aq LiOH solution was added, and the reaction was heated at 60 Â°C for 2 h. The mixture was acidified with 2 N HCl, extracted with ethyl acetate, dried over sodium sulfate, filtered, and concentrated. The crude product was dissolved in 1:1 TFA/DCM (2 mL) and stirred at room temperature for 2 h. The reaction was concentrated and purified by preparative HPLC (stationary phase: Gemini NX 5 Î¼m C18 110 Ã 100 Ã 30 mm<sup>2</sup>; mobile phase: MeCN gradient, water with 0.1% (28% ammonium hydroxide)/acetonitrile) to provide the title compound (16.5 mg, yield 12%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 8.36 (s, 1H), 8.12â8.09 (m, 1H), 7.69â7.62 (m, 2H), 7.47â7.35 (m, 3H), 7.33â7.26 (m, 1H), 7.13â7.06 (m, 2H), 6.93 (d, <i>J</i> = 8.5 Hz, 1H), 6.81 (t, <i>J</i> = 1.0 Hz, 1H), 5.21â5.17 (m, 2H), 4.32â4.24 (m, 1H), 3.45â3.35 (m, 2H), 1.52 (d, <i>J</i> = 6.7 Hz, 3H). HRMS calcd for C<sub>23</sub>H<sub>23</sub>NO<sub>3</sub> (M + H)<sup>+</sup> 362.1756, found 362.1756.</div></div><div id="sec6_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>S</i>)-2-(2-((3â²-(1-Amino-2-hydroxyethyl)-[1,1â²-biphenyl]-3-yl)methoxy)phenyl)acetic Acid (<b>12</b>)</h4><div class="NLM_p last">To a solution of methyl 2-(2-((3-bromobenzyl)oxy)phenyl)acetate (<b>25</b>) (21 g, 62.7 mmol) in DMF (100 mL) were added 4,4,4â²,4â²,5,5,5â²,5â²-octamethyl-2,2â²-bi(1,3,2-dioxaborolane) (CAS # 73183-34-3) (22.27 g, 88 mmol), potassium acetate (18.45 g, 188 mmol), and PdCl<sub>2</sub>(dppf)Â·CH<sub>2</sub>Cl<sub>2</sub> adduct (CAS # 95464-05-4) (1.834 g, 2.506 mmol). The reaction was heated at 110 Â°C for 90 min. The organic phase was washed with water, brine, and then dried over Na<sub>2</sub>SO<sub>4</sub> before filtration and evaporation. The crude material was purified by flash column chromatography (FCC) on silica gel (heptane/EtOAc with 10% MeOH = 100:0â70:30) to give methyl 2-(2-((3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)oxy)phenyl)acetate (22 g, 72%). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 383.1 (M + H). A mixture of methyl 2-(2-((3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)oxy)phenyl)acetate (8.82 g, 24.3 mmol) and (<i>S</i>)-<i>tert</i>-butyl (1-(3-bromophenyl)-2-hydroxyethyl)carbamate (CAS # 910308-92-8; 8.14 g, 24.3 mmol) in CH<sub>3</sub>CN (50 mL)/water (25 mL) with solid K<sub>3</sub>PO<sub>4</sub> (15.5 g, 73 mmol) and PdCl<sub>2</sub>(dppf)Â·CH<sub>2</sub>Cl<sub>2</sub> adduct (CAS # 95464-05-4) (0.45 g, 0.62 mmol) was heated to 45 Â°C for ca. 15 h and then diluted with EtOAc and water. The layers were separated, and the aqueous phase was extracted with EtOAc. The combined organic phase was washed with water and brine and then dried over Na<sub>2</sub>SO<sub>4</sub>. The crude material was purified by flash column chromatography on silica gel (heptane/EtOAc 4:1â2:1) to give (<i>S</i>)-methyl 2-(2-((3â²-(1-((<i>tert</i>-butoxycarbonyl)amino)-2-hydroxyethyl)-[1,1â²-biphenyl]-3-yl)methoxy)phenyl)acetate (9.25 g, yield 77%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 7.70 (s, 1H), 7.56â7.67 (m, 2H), 7.44â7.56 (m, 2H), 7.37â7.44 (m, 2H), 7.18â7.33 (m, 4H) 7.09 (d, <i>J</i> = 8.2 Hz, 1H), 6.91 (t, <i>J</i> = 7.4 Hz, 1H), 5.18 (s, 2H), 4.79 (t, <i>J</i> = 5.6 Hz, 1H), 4.57. HCl in 1,4-dioxane (27.5 mL, 110 mmol) was then added to (<i>S</i>)-methyl 2-(2-((3â²-(1-((<i>tert</i>-butoxycarbonyl)amino)-2-hydroxyethyl)-[1,1â²-biphenyl]-3-yl)methoxy)phenyl)acetate (9.0 g, 18.3 mmol) and the mixture was stirred 2 h. The mixture was then directly concentrated to dryness, and to the resulting solid was added THF (30 mL), MeOH (30 mL), water (40 mL) followed by LiOH (1.75 g, 73.2 mmol). The mixture was stirred for 15 h and then diluted with Et<sub>2</sub>O (350 mL) and the resulting white precipitate was collected by filtration. The resulting solid was then added to a stirring solution of 1 N aqueous HCl (40 mL) and the mixture was then further diluted with EtOAc. The resulting layers were separated and the aqueous layer was extracted two additional times with EtOAc. The organic layers were combined washed with brine, dried over MgSO<sub>4</sub>, filtered and concentrated. The resulting solid was then neutralized by suspending in MeOH (15 mL) and water (15 mL) and then charging with 7 M NH<sub>3</sub> in MeOH (2.091 mL, 14.64 mmol) to afford a solution with a pH of â¼7. After stirring for 1 h, a precipitate formed which was collected by filtration. To the resulting solid was added MeOH and the mixture was heated at reflux for 2 h and then allowed to cool to room temperature to afford a white precipitate that was collected by filtration to furnish the title compound, (<i>S</i>)-2-(2-((3â²-(1-amino-2-hydroxyethyl)-[1,1â²-biphenyl]-3-yl)methoxy)phenyl)acetic acid (3.7 g, 54%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) 8.24 (s, 1H), 8.01 (s, 1H), 7.67 (t, <i>J</i> = 9.3 Hz, 2H), 7.48â7.38 (m, 3H), 7.30 (d, <i>J</i> = 7.6 Hz, 1H), 7.13â7.07 (m, 2H), 6.94 (d, <i>J</i> = 8.2 Hz, 1H), 6.81 (t, <i>J</i> = 7.0 Hz, 1H), 5.20 (s, 2H), 4.17 (dd, <i>J</i> = 4.6, 6.6 Hz, 1H), 3.77â3.65 (m, 2H), 3.46 (d, <i>J</i> = 15.3 Hz, 1H), 3.36 (d, <i>J</i> = 15.4 Hz, 1H). HRMS calcd for C<sub>23</sub>H<sub>23</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 378.1706, found 378.1721.</div></div><div id="sec6_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>R</i>)-2-(2-((3â²-(1-Amino-3-hydroxypropyl)-[1,1â²-biphenyl]-3-yl)methoxy)phenyl)acetic Acid (<b>13</b>)</h4><div class="NLM_p last">The title compound was prepared in a similar fashion as <b>12</b>, employing (<i>R</i>)-3-amino-3-(3-bromophenyl)propan-1-ol hydrochloride (CAS # 1213637-86-5). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) Î´ ppm 8.12 (s, 1H) 8.03 (s, 1H) 7.66 (dt, <i>J</i> = 7.95, 1.28 Hz, 1H) 7.60 (d, <i>J</i> = 7.58 Hz, 1H) 7.43 (q, <i>J</i> = 7.74 Hz, 2H) 7.35â7.39 (m, 1H) 7.32 (d, <i>J</i> = 7.58 Hz, 1H) 7.17 (qd, <i>J</i> = 7.44, 1.65 Hz, 2H) 6.96 (d, <i>J</i> = 7.70 Hz, 1H) 6.87 (td, <i>J</i> = 7.40, 0.98 Hz, 1H) 5.13â5.24 (m, 2H) 4.41 (t, <i>J</i> = 7.21 Hz, 1H) 3.59â3.69 (m, 2H) 3.45â3.58 (m, 2H) 2.21â2.32 (m, 1H) 2.09â2.19 (m, 1H). HRMS calcd for C<sub>24</sub>H<sub>25</sub>NO<sub>4</sub> (M + H)<sup>+</sup> 392.1862, found 392.1852.</div></div><div id="sec6_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<i>S</i>)-2-(2-((3â²-(1-amino)-2-hydroxyethyl)-5-bromo-[1,1'-biphenyl]-3-yl)methoxy)phenyl)acetic acid (<b>14</b>)</h4><div class="NLM_p">The synthesis of the title compound was accomplished via the union of (<i>S</i>)-<i>tert</i>-butyl (2-hydroxy-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)carbamate and <i>tert</i>-butyl 2-(2-((3,5-dibromobenzyl)oxy)phenyl)acetate, as described below.</div><div class="NLM_p">(<i>S</i>)-<i>tert</i>-Butyl (2-hydroxy-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)carbamate was prepared as follows: to a solution of (<i>S</i>)-<i>tert</i>-butyl (1-(3-bromophenyl)-2-hydroxyethyl)carbamate (CAS # 910308-92-8; 5.8 g, 18.34 mmol) and 4,4,4â²,4â²,5,5,5â²,5â²-octamethyl-2,2â²-bi(1,3,2-dioxaborolane) (CAS # 73183-34-3; 9.32 g, 36.7 mmol) in DMF (55.0 mL) was added KOAc (5.4 g, 55.0 mmol); this mixture was degassed for 10 min with N<sub>2</sub>(gas), and then PdCl<sub>2</sub>(dppf)Â·CH<sub>2</sub>Cl<sub>2</sub> adduct (0.750 g, 0.917 mmol) was added. The reaction was sealed and heated at 110 Â°C in an oil bath for 16 h. The reaction was cooled to room temperature, filtered over a plug of Celite, the filtrate was partitioned between EtOAc/H<sub>2</sub>O and the layers separated; the organic phase was washed with brine, combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (heptane/EtOAc = 100:0â50:50) to afford the desired boronic ester (5.0 g, 75%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 7.61 (s, 1H) 7.53 (d, <i>J</i> = 7.20 Hz, 1H) 7.37â7.42 (m, 1H) 7.29â7.34 (m, 1H) 7.27 (d, <i>J</i> = 8.46 Hz, 1H) 4.74 (t, <i>J</i> = 5.81 Hz, 1H) 4.49 (d, <i>J</i> = 5.68 Hz, 1H) 3.41â3.57 (m, 2H) 1.36 (br s, 9H), 1.30 (s, 12 H).</div><div class="NLM_p"><i>tert</i>-Butyl 2-(2-((3,5-dibromobenzyl)oxy)phenyl)acetate was prepared as follows: <i>tert</i>-butyl 2-(2-hydroxyphenyl)acetate (CAS # 258331-10-1; 0.84 g, 4.0 mmol) was dissolved in DMF (20.2 mL), and K<sub>2</sub>CO<sub>3</sub> (0.641 g, 4.64 mmol) was added followed by 1,3-dibromo-5-(bromomethyl)benzene (CAS # 56908-88-4; 1.46 g, 4.44 mmol). After stirring overnight at room temperature, the reaction was diluted with ethyl acetate and water. The organic phase was washed with water, dried with MgSO<sub>4</sub>, filtered, and concentrated. The reaction was purified by flash chromatography (0â30% EtOAc/heptane) to provide the requisite dibromo intermediate (1.78 g, yield 97%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 7.79 (t, <i>J</i> = 1.77 Hz, 1H) 7.66 (d, <i>J</i> = 1.77 Hz, 2H) 7.16â7.29 (m, 2H) 6.98 (d, <i>J</i> = 7.58 Hz, 1H) 6.92 (td, <i>J</i> = 7.42, 0.95 Hz, 1H) 5.13 (s, 2H) 3.55 (s, 2H) 1.34 (s, 9H).</div><div class="NLM_p last">To a solution of (<i>S</i>)-<i>tert</i>-butyl (2-hydroxy-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)carbamate (0.98 g, 2.3 mmol) and <i>tert</i>-butyl 2-(2-((3,5-dibromobenzyl)oxy)phenyl)acetate (1.0 g, 2.19 mmol) in acetonitrile (20 mL) and water (2 mL) were added 2 M aq K<sub>3</sub>PO<sub>4</sub> (3.3 mL, 6.6 mmol) and PdCl<sub>2</sub>(dppf)Â·CH<sub>2</sub>Cl<sub>2</sub> adduct (0.090 g, 0.110 mmol). The mixture was stirred at 100 Â°C for 1 h, at which time the mixture was cooled to rt, diluted with EtOAc and water, and the layers were separated. The aq layer was extracted two times with EtOAc, and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The resulting residue was purified by flash chromatography (0â100% EtOAc/heptane) to provide <i>tert</i>-butyl (<i>S</i>)-2-(2-((5-bromo-3â²-(1-((<i>tert</i>-butoxycarbonyl)amino)-2-hydroxyethyl)-[1,1â²-biphenyl]-3-yl)methoxy)phenyl)acetate (568 mg, 42%). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 612.1, 614.1 (M + H). Finally, the title compound was prepared as follows, <i>tert</i>-butyl (<i>S</i>)-2-(2-((5-bromo-3â²-(1-((<i>tert</i>-butoxycarbonyl)amino)-2-hydroxyethyl)-[1,1â²-biphenyl]-3-yl)methoxy)phenyl)acetate (100 mg, 0.16 mmol) in DCM (1.5 mL) was treated with TFA (1.5 mL) and stirred for 45 min at which time the mixture was concentrated to dryness and purified by preparative HPLC (stationary phase: Gemini NX 5 Î¼m C18 110 Ã 100 Ã 30 mm<sup>2</sup>; mobile phase: acetonitrile gradient, water with 0.1% (28% ammonium hydroxide)/acetonitrile) to provide <b>14</b> (46 mg, yield 92%). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) Î´ ppm 8.17 (s, 1H) 8.06 (s, 1H) 7.74â7.80 (m, 1H) 7.69 (d, <i>J</i> = 7.96 Hz, 1H) 7.55 (s, 1H) 7.48 (t, <i>J</i> = 7.71 Hz, 1H) 7.36 (d, <i>J</i> = 7.71 Hz, 1H) 7.12â7.23 (m, 2H) 6.95 (d, <i>J</i> = 7.71 Hz, 1H) 6.82â6.92 (m, 1H) 5.11â5.25 (m, 2H) 4.36 (dd, <i>J</i> = 8.72, 4.55 Hz, 1H) 3.95 (dd, <i>J</i> = 11.68, 8.78 Hz, 1H) 3.86 (dd, <i>J</i> = 11.68, 4.61 Hz, 1H) 3.50â3.68 (m, 2H). HRMS calcd for C<sub>23</sub>H<sub>22</sub>BrNO<sub>4</sub> (M + H)<sup>+</sup> 456.0810 and 458.0790, found 456.0804 and 458.0809.</div></div><div id="sec6_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (<i>S</i>)-2-(2-((3â²-(1-Amino-2-hydroxyethyl)-5-(hydroxymethyl)-[1,1â²-biphenyl]-3-yl)methoxy)phenyl)acetic Acid (<b>15</b>)</h4><div class="NLM_p last">The title compound was prepared as described for <b>14</b>. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) Î´ ppm 8.17 (s, 1H) 7.99 (s, 1H) 7.73 (d, <i>J</i> = 8.07 Hz, 1H) 7.61 (s, 1H) 7.46 (t, <i>J</i> = 7.70 Hz, 1H) 7.29â7.38 (m, 2H) 7.12â7.21 (m, 2H) 6.96 (d, <i>J</i> = 7.70 Hz, 1H) 6.87 (td, <i>J</i> = 7.37, 0.92 Hz, 1H) 5.14â5.26 (m, 2H) 4.70 (s, 2H) 4.35 (dd, <i>J</i> = 8.86, 4.58 Hz, 1H) 3.95 (dd, <i>J</i> = 11.74, 8.93 Hz, 1H) 3.86 (dd, <i>J</i> = 11.68, 4.58 Hz, 1H) 3.51â3.68 (m, 2H). HRMS calcd for C<sub>24</sub>H<sub>25</sub>NO<sub>5</sub> (M + H)<sup>+</sup> 408.1811, found 408.1802. This synthesis required employment of <i>tert</i>-butyl 2-(2-((3-bromo-5-(hydroxymethyl)benzyl)oxy)phenyl)acetate which is prepared as follows: To a mixture of (5-bromo-1,3-phenylene)dimethanol (CAS # 51760-22-6 0.208 g, 0.960 mmol), <i>tert</i>-butyl 2-(2-hydroxyphenyl)acetate (CAS # 258331-10-1; 0.20 g, 0.96 mmol), and PPh<sub>3</sub> (0.25 g, 0.96 mmol) at 0 Â°C was added diisopropyl azodicarboxylate (0.187 mL, 0.960 mmol). The mixture was allowed to warm to rt and stirred overnight, an then was quenched with water, extracted with EtOAc, dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was partially purified by flash chromatography (40 g, 0â60% EtOAc/heptane), and the semipurified material could be used directly in the next step without the need for further purification MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 350.9, 352.9 (M â (<i>t-</i>Bu)).</div></div><div id="sec6_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (<i>S</i>)-2-(2-((3â²-(1-Amino-2-hydroxyethyl)-5-(methoxymethyl)-[1,1â²-biphenyl]-3-yl)methoxy)phenyl)acetic Acid (<b>16</b>)</h4><div class="NLM_p last">The title compound was prepared in a similar manner as <b>15</b>. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) Î´ ppm 7.91 (s, 1H) 7.82 (s, 1H) 7.73 (dt, <i>J</i> = 8.08, 1.26 Hz, 1H) 7.59 (s, 1H) 7.52 (t, <i>J</i> = 7.77 Hz, 1H) 7.36â7.45 (m, 2H) 7.16â7.25 (m, 2H) 6.97â7.06 (m, 1H) 6.90 (td, <i>J</i> = 7.45, 1.01 Hz, 1H) 5.20 (s, 2H) 4.55 (s, 2H) 4.41 (dd, <i>J</i> = 7.83, 4.93 Hz, 1H) 3.85â3.98 (m, 2H) 3.59â3.73 (m, 2H) 3.42 (s, 3H). HRMS calcd for C<sub>25</sub>H<sub>27</sub>NO<sub>5</sub> (M + H)<sup>+</sup> 422.1967, found 422.1954.</div></div><div id="sec6_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>S</i>)-2-(2-((3â²-(1-Amino-2-hydroxyethyl)-5-(2-hydroxypropan-2-yl)-[1,1â²-biphenyl]-3-yl)methoxy)phenyl)acetic Acid (<b>17</b>)</h4><div class="NLM_p last">The title compound was prepared in a similar manner as <b>15</b>. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) Î´ ppm 8.17 (s, 1H) 7.95 (s, 1H) 7.67â7.78 (m, 2H) 7.42â7.52 (m, 2H) 7.32 (d, <i>J</i> = 7.71 Hz, 1H) 7.11â7.22 (m, 2H) 6.97 (d, <i>J</i> = 7.83 Hz, 1H) 6.83â6.91 (m, 1H) 5.13â5.26 (m, 2H) 4.35 (dd, <i>J</i> = 8.97, 4.55 Hz, 1H) 3.96 (dd, <i>J</i> = 11.62, 8.97 Hz, 1H) 3.86 (dd, <i>J</i> = 11.68, 4.61 Hz, 1H) 3.50â3.69 (m, 2H) 1.60 (s, 6H). HRMS calcd for C<sub>26</sub>H<sub>29</sub>NO<sub>5</sub> (M + H)<sup>+</sup> 436.2124, found 436.2121. This synthesis required employment of <i>tert</i>-butyl 2-(2-((3-bromo-5-(2-hydroxypropan-2-yl)benzyl)oxy)phenyl)acetate which was prepared by the following procedure. To a solution of <i>tert</i>-butyl 2-(2-((3-bromo-5-(hydroxymethyl)benzyl)oxy)phenyl)acetate, prepared as described in <b>14</b> (28.5 g, 70.0 mmol) in DCM (350 mL) under nitrogen at room temperature, MnO<sub>2</sub> (122 g, 1399 mmol) was added, and this was heated at 40 Â°C. After overnight, the reaction was filtered through Celite, concentrated, and purified directly by flash chromatography (100% DCM) to provide <i>tert</i>-butyl 2-(2-((3-bromo-5-formylbenzyl)oxy)phenyl)acetate (10.3 g, yield 36%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 9.99 (s, 1H) 8.05 (s, 1H) 7.97 (s, 2H) 7.16â7.30 (m, 2H) 7.03 (d, <i>J</i> = 8.08 Hz, 1H) 6.93 (t, <i>J</i> = 7.33 Hz, 1H) 5.23 (s, 2H) 3.57 (s, 2H) 1.32 (s, 9H). To a suspension of <i>tert</i>-butyl 2-(2-((3-bromo-5-formylbenzyl)oxy)phenyl)acetate (0.30 g, 0.74 mmol) in MeOH (7.40 mL) under nitrogen, a solution of KOH (0.125 g, 2.22 mmol) in MeOH (3 mL) was added. This was cooled to 0 Â°C, and a solution of iodine (0.244 g, 0.962 mmol) in MeOH (3 mL) was added. After stirring overnight, the reaction was quenched with saturated aqueous sodium thiosulfate, extracted with EtOAc, washed with water, dried with MgSO<sub>4</sub>, filtered, and concentrated to give methyl 3-bromo-5-((2-(2-(<i>tert</i>-butoxy)-2-oxoethyl)phenoxy)methyl)benzoate (0.28 g, yield 87%), without the need for further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 7.97â8.06 (m, 2H) 7.94 (t, <i>J</i> = 1.71 Hz, 1H) 7.15â7.31 (m, 2H) 7.02 (d, <i>J</i> = 7.58 Hz, 1H) 6.92 (td, <i>J</i> = 7.42, 0.95 Hz, 1H) 5.21 (s, 2H) 3.87 (s, 3H) 3.55 (s, 2H) 1.32 (s, 9H). To a solution of methyl 3-bromo-5-((2-(2-(<i>tert</i>-butoxy)-2-oxoethyl)phenoxy)methyl)benzoate (0.28 g, 0.643 mmol) in THF (6.43 mL) at 0 Â°C under nitrogen, MeMgBr (3.0 M in ether, 0.643 mL, 1.93 mmol) was added, and the reaction was warmed to room temperature. After 30 min, additional MeMgBr (0.107 mL) was added. After 10 more min, the reaction was quenched with saturated aqueous NH<sub>4</sub>Cl, extracted 2Ã with EtOAc, washed with water, dried with MgSO<sub>4</sub>, filtered, and concentrated. The reaction was purified by flash chromatography (0â60% EtOAc/heptane) to provide the <i>tert</i>-butyl 2-(2-((3-bromo-5-(2-hydroxypropan-2-yl)benzyl)oxy)phenyl)acetate (0.26 g, yield 93%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 7.60 (t, <i>J</i> = 1.71 Hz, 1H) 7.50 (s, 1H) 7.43â7.49 (m, 1H) 7.15â7.29 (m, 2H) 7.01 (d, <i>J</i> = 7.70 Hz, 1H) 6.85â6.94 (m, 1H) 5.18 (s, 1H) 5.10 (s, 2H) 3.54 (s, 2H) 1.42 (s, 6H) 1.32 (s, 9H).</div></div><div id="sec6_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (<i>S</i>)-2-(2-((3â²-(1-Amino-2-hydroxyethyl)-5-(isopropylamino)-[1,1â²-biphenyl]-3-yl)methoxy)phenyl)acetic Acid (<b>18</b>)</h4><div class="NLM_p">The title compound was prepared in a similar fashion as <b>14</b>, using <i>tert</i>-butyl 2-(2-((3-chloro-5-(isopropylamino)benzyl)oxy)phenyl)acetate. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) Î´ ppm 7.80 (s, 1H) 7.72â7.77 (m, 1H) 7.64 (s, 1H) 7.57 (t, <i>J</i> = 7.71 Hz, 1H) 7.45â7.50 (m, 1H) 7.37 (s, 1H) 7.29 (s, 1H) 7.20â7.26 (m, 2H) 7.00 (d, <i>J</i> = 7.83 Hz, 1H) 6.94 (td, <i>J</i> = 7.45, 1.01 Hz, 1H) 5.25 (s, 2H) 4.45 (dd, <i>J</i> = 8.02, 4.36 Hz, 1H) 3.77â4.04 (m, 3H) 3.71 (s, 2H) 1.32 (d, <i>J</i> = 6.44 Hz, 6H). HRMS calcd for C<sub>26</sub>H<sub>30</sub>N<sub>2</sub>O<sub>4</sub> (M + H)<sup>+</sup> 435.2239, found 435.2270.</div><div class="NLM_p last"><i>tert</i>-Butyl 2-(2-((3-chloro-5-(isopropylamino)benzyl)oxy)phenyl)acetate was prepared as follows. A pressure vessel was charged with a solution of <i>tert</i>-butyl 2-(2-((3-bromo-5-chlorobenzyl)oxy)phenyl)acetate [prepared in a similar manner as <i>tert</i>-butyl 2-(2-((3,5-dibromobenzyl)oxy)phenyl)acetate described for the synthesis of <b>14</b>] (400 mg, 0.972 mmol) in MeCN (2 mL) was added Cs<sub>2</sub>CO<sub>3</sub> (950 ng, 2.91 mmol) followed by BrettPhos Pd G1, methyl <i>t</i>-butyl ether adduct (39 mg, 0.05 mmol) and isopropylamine (0.16 mL, 1.94 mmol). The vessel was sealed and heated at 110 Â°C for 1 h. The mixture was then cooled to rt and diluted with EtOAc and water. The layers were separated, and the organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The resulting residue was purified by flash chromatography (0â60% EtOAc/heptane) to provide <i>tert</i>-butyl 2-(2-((3-chloro-5-(isopropylamino)benzyl)oxy)phenyl)acetate (150 mg, 40%). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 390.1 (M + H).</div></div><div id="sec6_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 3â²-(((<i>tert</i>-Butoxycarbonyl)amino)methyl)-[1,1â²-biphenyl]-3-carboxylic Acid (<b>20</b>)</h4><div class="NLM_p last">A degassed mixture of 3-bromobenzoic acid (CAS # 585-76-2) (1 g, 4.97 mmol), 3-((<i>tert</i>-butoxycarbonylamino)methyl)phenylboronic acid (<b>19</b>, CAS # 832114-05-3) (1.25 g, 4.97 mmol), PdCl<sub>2</sub>(dppf)Â·CH<sub>2</sub>Cl<sub>2</sub> adduct (CAS # 95464-05-4) (0.20 g, 0.249 mmol), and 2 M aq K<sub>3</sub>PO<sub>4</sub> (7.46 mL, 14.92 mmol) in CH<sub>3</sub>CN (25 mL) was heated at 90 Â°C for 2 h. The reaction mixture was diluted with EtOAc and washed with water. The aqueous layer was extracted with EtOAc. The combined organics were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated. The residue was purified by FCC (EtOAc/heptane 0â100%) to provide the title compound (1.3 g, 80%). MS (ESI<sup>â</sup>) <i>m</i>/<i>z</i> 326.2 (M â H).</div></div><div id="sec6_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Methyl 2-(2-(6-Chloropicolinamido)phenyl)acetate (<b>22</b>)</h4><div class="NLM_p last">HATU (2.26 g, 5.95 mmol) was added in one portion at room temperature to a DMF solution (10 mL) of methyl 2-(2-aminophenyl)acetate hydrochloride (CAS # 49851-36-7) (1 g, 4.96 mmol), 6-chloropyridine-2-carboxylic acid (CAS # 4684-94-0) (0.938 g, 5.95 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (2.165 mL, 12.40 mmol). The resulting solution was allowed to stir at room temperature (2.5 h). The reaction was diluted with ethyl acetate, washed with water (twice) and a saturated aq NaCl solution. The organic phase was dried over sodium sulfate, filtered, and concentrated. The residue was purified via FCC (10:1 heptane/ethyl acetate to 1:1 heptane/ethyl acetate) to give the title compound (1.07 g, yield 71%). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 305.3 (M + H).</div></div><div id="sec6_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Methyl 2-(2-((3-Bromobenzyl)oxy)phenyl)acetate (<b>25</b>)</h4><div class="NLM_p last">To a DMF (100 mL) suspension of methyl 2-(2-hydroxyphenyl)acetate (CAS # 22446-37-3) (10 g, 60.2 mmol) and K<sub>2</sub>CO<sub>3</sub> (9.56 g, 69.2 mmol) was added 3-bromobenzyl bromide (CAS # 823-78-9) (16.54 g, 66.2 mmol). The mixture was stirred at room temperature for 18 h. The mixture was diluted with EtOAc and water. The organic phase was washed four times with water, once with brine, and then dried over Na<sub>2</sub>SO<sub>4</sub> before filtration and evaporation. The resulting title compound could be used without the need for further purification of the compound (21 g, yield 94%). MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 334.9, 336.9 (M + H).</div></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Biological and in Vivo Experiments</h3><div class="NLM_p last">The Membrane attack complex (MAC) formation assay in 50% human whole blood (WB), the generation of the human FD knock-in mouse, and the LPS challenge model have previously been described in ref <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a>. Protocols, handling and care of animals were in accordance with the policy of the NIBR Cambridge Animal Care and Use Committee.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Human Complement FD TR-FRET Assay</h3><div class="NLM_p last">Recombinant human FD (expressed in <i>Escherichia coli</i> and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptavidin (2 nM) and 2-((1<i>E</i>,3<i>E</i>,5<i>E</i>)-5-(1-(6-((((3<i>S</i>,5<i>S</i>)-1-((1-carbamoyl-1<i>H</i>-indol-3-yl)carbamoyl)-5-((3-chloro-2-fluorobenzyl)carbamoyl)-3-fluoropyrrolidin-3-yl)methyl)amino)-6-oxohexyl)-3,3-dimethyl-5-sulfoindolin-2-ylidene)penta-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-5-sulfo-3<i>H</i>-indol-1-ium (Example 2.1.1, <a href="/doi/suppl/10.1021/acs.jmedchem.9b00271/suppl_file/jm9b00271_si_001.csv" class="ext-link">Supporting Information</a>) (10 nM) was incubated with test compound at various concentrations up to 2 h at room temperature in 50 mM <i>N</i>-(2-hydroxyethyl)piperazine-<i>N</i>â²-ethanesulfonic acid buffer, pH 7.4, containing 2.5 mM MgCl<sub>2</sub>, 0.01% (w/v) bovine serum albumin and 0.05% (w/v) CHAPS. The time-gated decrease in fluorescence intensity related to the competition between labeled and unlabeled FD ligands was recorded at both 620 and 665 nm, 70 Î¼s after excitation at 337 nm using a microplate spectrofluorimeter. IC<sub>50</sub> values were calculated from percentage of inhibition of FD-2-((1<i>E</i>,3<i>E</i>,5<i>E</i>)-5-(1-(6-((((3<i>S</i>,5<i>S</i>)-1-((1-carbamoyl-1<i>H</i>-indol-3-yl)carbamoyl)-5-((3-chloro-2-fluorobenzyl)carbamoyl)-3-fluoropyrrolidin-3-yl)methyl)amino)-6-oxohexyl)-3,3-dimethyl-5-sulfoindolin-2-ylidene)penta-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-5-sulfo-3<i>H</i>-indol-1-ium (Example 2.1.1, <a href="/doi/suppl/10.1021/acs.jmedchem.9b00271/suppl_file/jm9b00271_si_001.csv" class="ext-link">Supporting Information</a>) displacement as a function of test compound concentration.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Local Ocular Injury Model of Complement Activation</h3><div class="NLM_p last">The local ocular injury model of complement activation has been previously described.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Briefly, compound <b>12</b> was administered via oral gavage in human FD knock-in mice at time 0. After 2 h, mice were anesthetized, and 1 Î¼L of sterile phosphate-buffered saline (PBS) was injected intravitreally per mouse eye. Eye tissues were collected 4 h post-intravitreal injection. Eye lysates were prepared and analyzed for complement Ba levels by Western blot.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Plasma Pharmacokinetic Studies in Mice</h3><div class="NLM_p last">The pharmacokinetics of compounds <b>3</b>, <b>9</b>, and <b>12</b>â<b>14</b> were determined in C57BL/6 mice. The compounds were dosed intravenously (IV, via injection into jugular vein, 1 mg/kg, <i>n</i> = 2 animals/compound); orally (PO, via oral gavage, 10 mg/kg, <i>n</i> = 3 animals/compound). The IV solution formulations were prepared at 1 mg/mL as described in the parenthesis for each compound â<b>3</b> (30% poly(ethylene glycol) (PEG)300, 50% of 20% Cremophor EL, phosphate-buffered saline), <b>9</b> (2 equiv 1 N HCl, 20% poly(ethylene glycol), 50% of 20% Cremophor EL, phosphate-buffered saline), <b>12</b> (2 equiv of 1 N HCl, 10% propylene glycol, 25% of a 20% Solutol solution), <b>13</b> (10% poly(ethylene glycol) 300, 25% of a 20% Cremophor EL solution, phosphate-buffered saline), and <b>14</b> (10% propylene glycol, 50% of a 20% Solutol solution, phosphate-buffered saline). The PO formulations were prepared as suspensions at 5 mg/mL as described in the parenthesis for each compound â<b>3</b> (30% PEG300, 50% of 20% Cremophor EL, phosphate-buffered saline), <b>9</b> (0.1% Tween 80 and 0.5% methyl cellulose), <b>12</b> (0.5% Tween 80 and 0.5% methyl cellulose), <b>13</b> (0.5% Tween 80 and 0.5% methyl cellulose), and <b>14</b> (0.5% Pluronic F68 and 0.5% hydroxypropyl cellulose). Approximately, 50 Î¼L of whole blood was collected from the tails at 5 min (IV dose only), 15 min (PO dose only), 0.5, 1, 2, 4, and 7 h postdose and was transferred to ethylenediaminetetraacetic acid (EDTA) tubes. Blood was centrifuged at 3000 rpm, and the resultant plasma was transferred to a capped polymerase chain reaction (PCR) 96-well plate and frozen at â20 Â°C until subsequent analysis by high-performance liquid chromatography coupled with tandem mass spectrometry (HPLCâtandem mass spectrometry (MS/MS)). The relevant pharmacokinetic parameters were estimated using noncompartmental methods using WinNonlin (Enterprise, version 5.2) purchased from Pharsight Corporation (St. Louis, MO) or Watson LIMS (Thermo, Waltham, MA).</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Plasma Pharmacokinetic Studies in Rats</h3><div class="NLM_p last">The pharmacokinetics of compound <b>12</b> was determined in Wistar Han rats. The compound was dosed intravenously (IV, via injection into the jugular vein catheter; 1 mg/kg, <i>n</i> = 3 animals) and orally (PO, via oral gavage; 10 mg/kg, <i>n</i> = 2 animals). The IV solution formulation was prepared in phosphate-buffered saline containing 2% 1 N HCl, poly(ethylene glycol) 300, 50% of a 20% Solutol solution. The PO formulation was a suspension in 20% captisol. Approximately, 200 Î¼L of whole blood was collected from the tails at 5 min (IV dose only), 15 min, 0.5 h, 1 h, 2 h, 4 h, 7 h, and 24 h postdose and was transferred to EDTA tubes. Blood was centrifuged at 3000 rpm and the resultant plasma was transferred to a capped PCR 96-well plate, and frozen at â20 Â°C until subsequent analysis by HPLCâMS/MS. The relevant pharmacokinetic parameters were estimated using noncompartmental methods using WinNonlin (Enterprise, version 5.2) purchased from Pharsight Corporation (St. Louis, MO) or Watson LIMS (Thermo, Waltham, MA).</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Ocular Pharmacokinetic Studies in Rats</h3><div class="NLM_p last">Old brown Norway rats (3 months old) were administered, <b>12</b> via oral gavage as a suspension in 0.5% hydroxypropyl methyl cellulose and 0.1% Tween 80. Ocular tissues from both eyes and plasma were collected from two rats per time point at 0.25, 0.5, 1, 3, 6, and 24 h after administration. The ocular tissues collected were the retina and the posterior eye cup (RPE/choroid and posterior sclera). The tissues were diluted with phosphate-buffered saline containing 10% acetonitrile and homogenized, centrifuged prior to analyses. The concentrations of the test article were measured in plasma and supernatants of ocular homogenates by HPLCâMS/MS in four individual retinas, four individual posterior eye cups, and two individual plasma samples at each time point. The relevant pharmacokinetic parameters were estimated using noncompartmental methods using WinNonlin (Enterprise, version 5.2) purchased from Pharsight Corporation (St. Louis, MO) or Watson LIMS (Thermo, Waltham, MA).</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Plasma Pharmacokinetic Studies in Dogs</h3><div class="NLM_p last">The pharmacokinetics of compound <b>12</b> was determined in beagle dogs. The compound was dosed intravenously (1 mg/kg, <i>n</i> = 3 animals) and orally (10 mg/kg, <i>n</i> = 3 animals/compound) by gavage. The IV formulation was a solution consisting of 2% 1 N HCl, 20% poly(ethylene glycol) 300, 50% of 20% Solutol in phosphate-buffered saline, whereas the PO formulation was a solution consisting of 20% poly(ethylene glycol) 300, 10% Solutol HS15, and 70% citrate buffer pH 3. Blood was collected at 5 min (IV dose only), 15 min, 0.5 h, 1 h, 2 h, 4 h, 7 h, and 24 h postdose. The subsequent blood or plasma samples were analyzed by HPLCâMS/MS under electrospray ionization in the positive mode. Similarly, the relevant pharmacokinetic parameters were estimated using noncompartmental methods using WinNonlin (Enterprise, version 5.2) purchased from Pharsight Corporation (St. Louis, MO) or Watson LIMS (Thermo, Waltham, MA). Other relevant calculations were performed in the Microsoft Excel.</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Molecular Modeling</h3><div class="NLM_p last">Docking poses were generated in a high-resolution crystal structure of FD bound with <b>1</b> (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FUT">6FUT</a><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a>) using Glide (version 5.8)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> from SchrÃ¶dinger. The crystal structure was first prepared using the standard protein preparation wizard within the Maestro interface.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Grid files were generated for docking after deleting the crystallographic water molecules and the succinic acid, a reagent used for crystallization. Three-dimensional geometries of compounds were generated using LigPrep.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Compounds were docked in the pregenerated grid files in the standard precision mode. Three docking poses were saved for each compound, and the docking results were analyzed visually.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00271" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25806" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25806" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00271" class="ext-link">10.1021/acs.jmedchem.9b00271</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Crystallographic structure determination of FD in complex with compounds <b>3</b> and <b>12</b>; preparation of reagents for TR-FRET assay (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00271/suppl_file/jm9b00271_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00271/suppl_file/jm9b00271_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00271/suppl_file/jm9b00271_si_001.csv">jm9b00271_si_001.csv (1.63 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00271/suppl_file/jm9b00271_si_002.pdf">jm9b00271_si_002.pdf (719.87 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for the crystal structures of FD with compounds <b>3</b> and <b>12</b> are deposited in the protein data bank with accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QMT">6QMT</a>.pdb and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QMR">6QMR</a>.pdb, respectively.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b00271" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37411" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37411" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajeshri G. Karki</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2210-5789" title="Orcid link">http://orcid.org/0000-0003-2210-5789</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3d4f5c57584e554f5413565c4f56547d53524b5c4f49544e135e5250"><span class="__cf_email__" data-cfemail="f486959e91879c869dda9f95869f9db49a9b829586809d87da979b99">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Powers</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nello Mainolfi</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span>;Â 
    <span>Present Address:
                        Kymera Therapeutics, 300 Technology Square, Cambridge, Massachusetts 02139, United States (N.M. and N.J.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen Anderson</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span>;Â 
    <span>Present Address:
                        Biogen, 225 Binney Street, Cambridge, Massachusetts 02142, United States (K.A.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David B. Belanger</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span>;Â 
    <span>Present Address:
                        Kaleido Biosciences, 65 Hayden Avenue, Lexington, Massachusetts 02421, United States (D.B.B.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donglei Liu</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nan Ji</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span>;Â 
    <span>Present Address:
                        Kymera Therapeutics, 300 Technology Square, Cambridge, Massachusetts 02139, United States (N.M. and N.J.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith Jendza</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine F. Gelin</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span>;Â 
    <span>Present Address:
                        Janssen Research & Development, 3210 Merryfield Row, San Diego, California 92121, United States (C.F.G.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aengus Mac Sweeney</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span>;Â 
    <span>Present Address:
                        Drug Discovery Biology, Idorsia Pharmaceuticals Ltd., 4123 Allschwil, Switzerland (A.M.S.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine Solovay</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Omar Delgado</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maura Crowley</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sha-Mei Liao</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Upendra A. Argikar</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0939-0813" title="Orcid link">http://orcid.org/0000-0002-0939-0813</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefanie Flohr</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura R. La Bonte</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edwige L. Lorthiois</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6147-9321" title="Orcid link">http://orcid.org/0000-0002-6147-9321</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Vulpetti</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3114-8679" title="Orcid link">http://orcid.org/0000-0002-3114-8679</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ann Brown</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Debby Long</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melissa Prentiss</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathalie Gradoux</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea de Erkenez</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederic Cumin</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Adams</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5246-884X" title="Orcid link">http://orcid.org/0000-0002-5246-884X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce Jaffee</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Muneto Mogi</span> - <span class="hlFld-Affiliation affiliation">Novartis
Institutes for BioMedical Research, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>The authors declare no competing financial interest and all work described was funded by Novartis Institutes for BioMedical Research Inc.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e3894-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75307" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75307" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors would like to thank Frederic Villard, Wendy Lee, Jakal Amin, Timothy Drew, Adam Amaral, Julia Kamholz, Peter Wipfli, Roland Feifel, Viral Kansara, and Jaimie Spear for their excellent technical assistance, JÃ¼rgen Maibaum, Richard Sedrani, JosÃ© Duca, and JÃ¶rg Eder for guidance and support.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">FD</td><td class="NLM_def"><p class="first last">complement factor D</p></td></tr><tr><td class="NLM_term">FXIa</td><td class="NLM_def"><p class="first last">factor XIa</p></td></tr><tr><td class="NLM_term">AP</td><td class="NLM_def"><p class="first last">alternative complement pathway</p></td></tr><tr><td class="NLM_term">AMD</td><td class="NLM_def"><p class="first last">age-related macular degeneration</p></td></tr><tr><td class="NLM_term">MAC</td><td class="NLM_def"><p class="first last">membrane attack complex</p></td></tr><tr><td class="NLM_term">FCC</td><td class="NLM_def"><p class="first last">flash column chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 27 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thurman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holers, V. M.</span></span> <span> </span><span class="NLM_article-title">The central role of the alternative complement pathway in human disease</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">1305</span>â <span class="NLM_lpage">1310</span>, <span class="refDoi">Â DOI: 10.4049/jimmunol.176.3.1305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.4049%2Fjimmunol.176.3.1305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=16424154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFyjug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=1305-1310&author=J.+M.+Thurmanauthor=V.+M.+Holers&title=The+central+role+of+the+alternative+complement+pathway+in+human+disease&doi=10.4049%2Fjimmunol.176.3.1305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Central Role of the Alternative Complement Pathway in Human Disease</span></div><div class="casAuthors">Thurman, Joshua M.; Holers, V. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1305-1310</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">A review.  The complement system is increasingly recognized as important in the pathogenesis of tissue injury in vivo following immune, ischemic, or infectious insults.  Within the complement system, three pathways are capable of initiating the processes that result in C3 activation: classical, alternative, and lectin.  Although the roles that proinflammatory peptides and complexes generated during complement activation play in mediating disease processes have been studied extensively, the relative contributions of the three activating pathways is less well understood.  Herein we examine recent evidence that the alternative complement pathway plays a key and, in most instances, obligate role in generating proinflammatory complement activation products in vivo.  In addn., we discuss new concepts regarding the mechanisms by which the alternative pathway is activated in vivo, as recent clin. findings and exptl. results have provided evidence that continuous active control of this pathway is necessary to prevent unintended targeting and injury to self tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_FVfCz2QYDrVg90H21EOLACvtfcHk0lisr3aKo88ixg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFyjug%253D%253D&md5=f6db4b8f56a8a99d3a74acc8de1298b0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.176.3.1305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.176.3.1305%26sid%3Dliteratum%253Aachs%26aulast%3DThurman%26aufirst%3DJ.%2BM.%26aulast%3DHolers%26aufirst%3DV.%2BM.%26atitle%3DThe%2520central%2520role%2520of%2520the%2520alternative%2520complement%2520pathway%2520in%2520human%2520disease%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D176%26spage%3D1305%26epage%3D1310%26doi%3D10.4049%2Fjimmunol.176.3.1305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lesavre, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullereberhard, H. J.</span></span> <span> </span><span class="NLM_article-title">Mechanism of action of factor-D of alternative complement pathway</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">1498</span>â <span class="NLM_lpage">1509</span>, <span class="refDoi">Â DOI: 10.1084/jem.148.6.1498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1084%2Fjem.148.6.1498" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=1978&pages=1498-1509&author=P.+H.+Lesavreauthor=H.+J.+Mullereberhard&title=Mechanism+of+action+of+factor-D+of+alternative+complement+pathway&doi=10.1084%2Fjem.148.6.1498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1084%2Fjem.148.6.1498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.148.6.1498%26sid%3Dliteratum%253Aachs%26aulast%3DLesavre%26aufirst%3DP.%2BH.%26aulast%3DMullereberhard%26aufirst%3DH.%2BJ.%26atitle%3DMechanism%2520of%2520action%2520of%2520factor-D%2520of%2520alternative%2520complement%2520pathway%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1978%26volume%3D148%26spage%3D1498%26epage%3D1509%26doi%3D10.1084%2Fjem.148.6.1498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volanakis, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayana, S. V. L.</span></span> <span> </span><span class="NLM_article-title">Complement factor D, a novel serine protease</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">553</span>â <span class="NLM_lpage">564</span>, <span class="refDoi">Â DOI: 10.1002/pro.5560050401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1002%2Fpro.5560050401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=8845746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADyaK28XitFShu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1996&pages=553-564&author=J.+E.+Volanakisauthor=S.+V.+L.+Narayana&title=Complement+factor+D%2C+a+novel+serine+protease&doi=10.1002%2Fpro.5560050401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Complement factor D, a novel serine protease</span></div><div class="casAuthors">Volanakis, John E.; Narayana, Sthanam V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">553-64</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review with many refs.  Factor D is unique among serine proteases in that it requires neither enzymic cleavage for expression of proteolytic activity nor inactivation by a serpin for its control.  Regulation of factor D activity is instead attained by a novel mechanism that depends on reversible conformational changes for expression and control of catalytic activity.  These conformational changes are believed to be induced by the single natural substrate, C3bB, and to result in realignment of the catalytic triad, the specificity pocket, and the nonspecific substrate binding site, all of which have atypical conformations.  Mutational studies have defined structural determinants responsible for these unique structural features of factor D and for the resultant low reactivity with synthetic esters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR-WO4fTyq7LVg90H21EOLACvtfcHk0liAKXvMr9-aog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitFShu7g%253D&md5=d55e7afa5c827b02023dd94994690eaa</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560050401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560050401%26sid%3Dliteratum%253Aachs%26aulast%3DVolanakis%26aufirst%3DJ.%2BE.%26aulast%3DNarayana%26aufirst%3DS.%2BV.%2BL.%26atitle%3DComplement%2520factor%2520D%252C%2520a%2520novel%2520serine%2520protease%26jtitle%3DProtein%2520Sci.%26date%3D1996%26volume%3D5%26spage%3D553%26epage%3D564%26doi%3D10.1002%2Fpro.5560050401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holers, V. M.</span></span> <span> </span><span class="NLM_article-title">The spectrum of complement alternative pathway-mediated diseases</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>223</i></span>,  <span class="NLM_fpage">300</span>â <span class="NLM_lpage">316</span>, <span class="refDoi">Â DOI: 10.1111/j.1600-065X.2008.00641.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1111%2Fj.1600-065X.2008.00641.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=18613844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlGltr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2008&pages=300-316&author=V.+M.+Holers&title=The+spectrum+of+complement+alternative+pathway-mediated+diseases&doi=10.1111%2Fj.1600-065X.2008.00641.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The spectrum of complement alternative pathway-mediated diseases</span></div><div class="casAuthors">Holers, V. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">300-316</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The complement system has once again come into prominence in the therapeutic development arena.  The recent approval of an inhibitory monoclonal antibody, eculizumab, which is directed against complement component C5 for the disease paroxysmal nocturnal hemoglobinuria has provided the initial validation of this system as a therapeutic target.  Preclin. studies using animal models and human-derived samples demonstrate that inhibition of complement ameliorates many inflammatory and autoimmune disease manifestations.  Major efforts continue to define the most optimal means to block complement activation in a cost-effective manner.  Because the system is initiated through three pathways and generates at least six immunoregulatory and pro-inflammatory mediators, there is substantial complexity to this problem.  One pathway, designated the alternative pathway, has recently been shown to play a particularly important role in preclin. disease models.  Further evidence of the importance of the alternative pathway has been provided by studies of human diseases, where mutations or dysfunctional polymorphisms that promote activation of this pathway are highly assocd. with the diseases atypical hemolytic uremic syndrome, dense deposit disease, and age-related macular degeneration.  This article reviews evidence in support of the essential role of the alternative pathway in the generation of tissue injury and the rationale for development of therapies that modulate its activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3u8J-53XDOrVg90H21EOLACvtfcHk0liAKXvMr9-aog"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlGltr4%253D&md5=41da6ad206500c88595f6d8cba76ce50</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00641.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00641.x%26sid%3Dliteratum%253Aachs%26aulast%3DHolers%26aufirst%3DV.%2BM.%26atitle%3DThe%2520spectrum%2520of%2520complement%2520alternative%2520pathway-mediated%2520diseases%26jtitle%3DImmunol.%2520Rev.%26date%3D2008%26volume%3D223%26spage%3D300%26epage%3D316%26doi%3D10.1111%2Fj.1600-065X.2008.00641.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Risitano, A. M.</span></span> <span> </span><span class="NLM_article-title">Paroxysmal Nocturnal Hemoglobinuria and the Complement System: Recent Insights and Novel Anticomplement Strategies</span>. In  <i>Complement Therapeutics</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambris, J.</span>, <span class="NLM_string-name">Holers, V.</span>, <span class="NLM_string-name">Ricklin, D.</span></span>, Eds.; <span class="NLM_series">Advances in Experimental Medicine and Biology</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Boston</span>, <span class="NLM_year">2013</span>; Vol.  <span class="NLM_volume">735</span>, pp  <span class="NLM_fpage">155</span>â <span class="NLM_lpage">172</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1007%2F978-1-4614-4118-2_10" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=155-172&author=A.+M.+Risitanoauthor=J.+Lambris&author=V.+Holers&author=D.+Ricklin&title=Complement+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2F978-1-4614-4118-2_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4614-4118-2_10%26sid%3Dliteratum%253Aachs%26aulast%3DRisitano%26aufirst%3DA.%2BM.%26atitle%3DParoxysmal%2520Nocturnal%2520Hemoglobinuria%2520and%2520the%2520Complement%2520System%253A%2520Recent%2520Insights%2520and%2520Novel%2520Anticomplement%2520Strategies%26btitle%3DComplement%2520Therapeutics%26aulast%3DLambris%26aufirst%3DJ.%26pub%3DSpringer%26date%3D2013%26volume%3D735%26spage%3D155%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zipfel, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">JÃ³zsi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skerka, C.</span></span> <span> </span><span class="NLM_article-title">Complement and diseases: Defective alternative pathway control results in kidney and eye diseases</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">97</span>â <span class="NLM_lpage">106</span>, <span class="refDoi">Â DOI: 10.1016/j.molimm.2005.06.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1016%2Fj.molimm.2005.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=16026839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A280%3ADC%252BD2MzosFyiuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2006&pages=97-106&author=P.+F.+Zipfelauthor=S.+Heinenauthor=M.+J%C3%B3zsiauthor=C.+Skerka&title=Complement+and+diseases%3A+Defective+alternative+pathway+control+results+in+kidney+and+eye+diseases&doi=10.1016%2Fj.molimm.2005.06.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Complement and diseases: defective alternative pathway control results in kidney and eye diseases</span></div><div class="casAuthors">Zipfel Peter F; Heinen Stefan; Jozsi Mihaly; Skerka Christine</div><div class="citationInfo"><span class="NLM_cas:title">Molecular immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">97-106</span>
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    </div><div class="casAbstract">The complement system is a central part of innate immunity and in its normal setting aimed to recognize and eliminate microbes.  For elimination toxic activation products are generated locally and are reported directly of the surface of the invading microbe.  A deregulation of the alternative pathway results in defective recognition and toxic activation products can be formed on the surface of host tissues and structures.  Recent studies have shown that mutated or defective regulators of the alternative pathway of complement are associated with auto immune diseases of the kidney, including the atypical form of hemolytic uremic syndrome (HUS), membranoproliferative glomerulonephritis (MPGN) and also of the eye, such as age-related macular degeneration (ARMD).  Current research provides clues how mutations occurring in genes coding for single complement components or the inactivation of single regulators lead to defective alternative pathway amplification, via the convertase C3bBb.  These scenarios explain how defects of a single regulator lead to local, organ specific damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR5HinA2w0N1Ff1XRtfYM0dfW6udTcc2eZdYq0FlVyzDLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzosFyiuw%253D%253D&md5=648b06395eccfac4995174522bd2ee8e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2005.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2005.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DZipfel%26aufirst%3DP.%2BF.%26aulast%3DHeinen%26aufirst%3DS.%26aulast%3DJ%25C3%25B3zsi%26aufirst%3DM.%26aulast%3DSkerka%26aufirst%3DC.%26atitle%3DComplement%2520and%2520diseases%253A%2520Defective%2520alternative%2520pathway%2520control%2520results%2520in%2520kidney%2520and%2520eye%2520diseases%26jtitle%3DMol.%2520Immunol.%26date%3D2006%26volume%3D43%26spage%3D97%26epage%3D106%26doi%3D10.1016%2Fj.molimm.2005.06.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zipfel, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skerka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiech, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodship, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeaux-Bacchi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nester, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de CÃ³rdoba, S.
R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noris, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickering, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span> <span> </span><span class="NLM_article-title">The role of complement in C3 glomerulopathy</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">21</span>â <span class="NLM_lpage">30</span>, <span class="refDoi">Â DOI: 10.1016/j.molimm.2015.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1016%2Fj.molimm.2015.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=25929733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsl2iurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=21-30&author=P.+F.+Zipfelauthor=C.+Skerkaauthor=Q.+Chenauthor=T.+Wiechauthor=T.+Goodshipauthor=S.+Johnsonauthor=V.+Fremeaux-Bacchiauthor=C.+Nesterauthor=S.%0AR.+de+C%C3%B3rdobaauthor=M.+Norisauthor=M.+Pickeringauthor=R.+Smith&title=The+role+of+complement+in+C3+glomerulopathy&doi=10.1016%2Fj.molimm.2015.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The role of complement in C3 glomerulopathy</span></div><div class="casAuthors">Zipfel, Peter F.; Skerka, Christine; Chen, Qian; Wiech, Thorsten; Goodship, Tim; Johnson, Sally; Fremeaux-Bacchi, Veronique; Nester, Clara; Cordoba, Santiago Rodriguez de; Noris, Marina; Pickering, Matthew; Smith, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-30</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  C3 glomerulopathy describes a spectrum of disorders with glomerular pathol. assocd. with C3 cleavage product deposition and with defective complement action and regulation (Fakhouri et al., 2010; Sethi et al., 2012b).  Kidney biopsies from these patients show glomerular accumulation or deposition of C3 cleavage fragments, but no or minor deposition of Igs (Appel et al., 2005; D'Agati and Bomback, 2012; Servais et al., 2007; Sethi and Fervenza, 2011).  At present the current situation asks for a better definition of the underlining disease mechanisms, for precise biomarkers, and for a treatment for this disease.  The complement system is a self activating and propelling enzymic cascade type system in which inactive, sol. plasma components are activated spontaneously and lead into an amplification loop (Zipfel and Skerka, 2009).  Activation of the alternative pathway is spontaneous, occurs by default, and cascade progression leads to amplification by complement activators.  The system however is self-controlled by multiple regulators and inhibitors, like Factor H that control cascade progression in fluid phase and on surfaces.  The activated complement system generates a series of potent effector components and activation products, which damage foreign-, as well as modified self cells, recruit innate immune cells to the site of action, coordinate inflammation and the response of the adaptive immune system in form of B cells and T lymphocytes (Kohl, 2006; Medzhitov and Janeway, 2002; Ogden and Elkon, 2006; Carroll, 2004; Kemper and Atkinson, 2007; Morgan, 1999; Muller-Eberhard, 1986; Ricklin et al., 2010).  Complement controls homeostasis and multiple reactions in the vertebrate organism including defense against microbial infections (Diaz-Guillen et al., 1999; Mastellos and Lambris, 2002; Nordahl et al., 2004; Ricklin et al., 2010).  In consequence defective control of the spontaneous self amplifying cascade or regulation is assocd. with numerous human disorders (Ricklin and Lambris, 2007; Skerka and Zipfel, 2008; Zipfel et al., 2006).  Understanding the exact action and regulation of this sophisticated homeotic cascade system is relevant to understand disease pathol. of various complement assocd. human disorders.  Furthermore this knowledge is relevant for a better diagnosis and appropriate therapy.  At present diagnosis of C3 glomerulopathy is primarily based on the kidney biopsy, and histol., immmunohistol. and electron microscopical evaluation (D'Agati and Bomback, 2012; Fakhouri et al., 2010; Medjeral-Thomas et al., 2014a,b; Sethi et al., 2012b).  The challenge is to define the actual cause of the diverse glomerular changes or damages, to define how C3 deposition results in the reported glomerular changes, the location of the cell damage and the formation of deposits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8QCPsOB4vn7Vg90H21EOLACvtfcHk0lhgVhcD8yqqCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsl2iurs%253D&md5=1a159357102c43ade839bb2d3bc86d2d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2015.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2015.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DZipfel%26aufirst%3DP.%2BF.%26aulast%3DSkerka%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DWiech%26aufirst%3DT.%26aulast%3DGoodship%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DFremeaux-Bacchi%26aufirst%3DV.%26aulast%3DNester%26aufirst%3DC.%26aulast%3Dde%2BC%25C3%25B3rdoba%26aufirst%3DS.%2BR.%26aulast%3DNoris%26aufirst%3DM.%26aulast%3DPickering%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DR.%26atitle%3DThe%2520role%2520of%2520complement%2520in%2520C3%2520glomerulopathy%26jtitle%3DMol.%2520Immunol.%26date%3D2015%26volume%3D67%26spage%3D21%26epage%3D30%26doi%3D10.1016%2Fj.molimm.2015.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, S. J.</span></span> <span> </span><span class="NLM_article-title">Age-related macular degeneration: genome-wide association studies to translation</span>. <i>Genet. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">283</span>â <span class="NLM_lpage">289</span>, <span class="refDoi">Â DOI: 10.1038/gim.2015.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1038%2Fgim.2015.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=26020418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1KhsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=283-289&author=J.+R.+M.+Blackauthor=S.+J.+Clark&title=Age-related+macular+degeneration%3A+genome-wide+association+studies+to+translation&doi=10.1038%2Fgim.2015.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Age-related macular degeneration: genome-wide association studies to translation</span></div><div class="casAuthors">Black, James R. M.; Clark, Simon J.</div><div class="citationInfo"><span class="NLM_cas:title">Genetics in Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">283-289</span>CODEN:
                <span class="NLM_cas:coden">GEMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1098-3600</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In recent years, genome-wide assocn. studies (GWAS), which are able to analyze the contribution to disease of genetic variations that are common within a population, have attracted considerable investment.  Despite identifying genetic variants for many conditions, they have been criticized for yielding data with minimal clin. utility.  However, in this regard, age-related macular degeneration (AMD), the most common form of blindness in the Western world, is a striking exception.  Through GWAS, common genetic variants at a no. of loci have been discovered.  Two loci in particular, including genes of the complement cascade on chromosome 1 and the ARMS2/HTRA1 genes on chromosome 10, have been shown to convey significantly increased susceptibility to developing AMD.  Today, although it is possible to screen individuals for a genetic predisposition to the disease, effective interventional strategies for those at risk of developing AMD are scarce.  Ongoing research in this area is nonetheless promising.  After providing brief overviews of AMD and common disease genetics, we outline the main recent advances in the understanding of AMD, particularly those made through GWAS.  Finally, the true merit of these findings and their current and potential translational value is examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMAZHKfsCpKbVg90H21EOLACvtfcHk0liHJ5RNYUvN5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1KhsbY%253D&md5=c079a08ac4b8e7ebd5209fdd787516ba</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fgim.2015.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fgim.2015.70%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DJ.%2BR.%2BM.%26aulast%3DClark%26aufirst%3DS.%2BJ.%26atitle%3DAge-related%2520macular%2520degeneration%253A%2520genome-wide%2520association%2520studies%2520to%2520translation%26jtitle%3DGenet.%2520Med.%26date%3D2016%26volume%3D18%26spage%3D283%26epage%3D289%26doi%3D10.1038%2Fgim.2015.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, J. R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Hollander, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seddon, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaroop, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stambolian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atsuhiro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Othman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortvely, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalmers, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhillon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueffing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. F.</span></span> <span> </span><span class="NLM_article-title">Complement factor D in age-related macular degeneration</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">8828</span>â <span class="NLM_lpage">8834</span>, <span class="refDoi">Â DOI: 10.1167/iovs.11-7933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1167%2Fiovs.11-7933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=22003108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFak" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=8828-8834&author=C.+M.+Stantonauthor=J.+R.+W.+Yatesauthor=A.+I.+den+Hollanderauthor=J.+M.+Seddonauthor=A.+Swaroopauthor=D.+Stambolianauthor=S.+Fauserauthor=C.+Hoyngauthor=Y.+Yuauthor=K.+Atsuhiroauthor=K.+Branhamauthor=M.+Othmanauthor=W.+Chenauthor=E.+Kortvelyauthor=K.+Chalmersauthor=C.+Haywardauthor=A.+T.+Mooreauthor=B.+Dhillonauthor=M.+Ueffingauthor=A.+F.+Wright&title=Complement+factor+D+in+age-related+macular+degeneration&doi=10.1167%2Fiovs.11-7933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Complement factor D in age-related macular degeneration</span></div><div class="casAuthors">Stanton, Chloe M.; Yates, John R. W.; den Hollander, Anneke I.; Seddon, Johanna M.; Swaroop, Anand; Stambolian, Dwight; Fauser, Sascha; Hoyng, Carel; Yu, Yi; Atsuhiro, Kanda; Branham, Kari; Othman, Mohammad; Chen, Wei; Kortvely, Elod; Chalmers, Kevin; Hayward, Caroline; Moore, Anthony T.; Dhillon, Baljean; Ueffing, Marius; Wright, Alan F.</div><div class="citationInfo"><span class="NLM_cas:title">Investigative Ophthalmology & Visual Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8828-8834</span>CODEN:
                <span class="NLM_cas:coden">IOVSDA</span>;
        ISSN:<span class="NLM_cas:issn">1552-5783</span>.
    
            (<span class="NLM_cas:orgname">Association for Research in Vision and Ophthalmology</span>)
        </div><div class="casAbstract">The aim was to examine the role of complement factor D (CFD) in age-related macular degeneration (AMD) by anal. of genetic assocn., copy no. variation, and plasma CFD concns.  Single nucleotide polymorphisms (SNPs) in the CFD gene were genotyped and the results analyzed by binary logistic regression.  CFD gene copy no. was analyzed by gene copy no. assay.  Plasma CFD was measured by an ELISA.  Genetic assocn. was found between CFD gene SNP rs3826945 and AMD (odds ratio 1.44; P = 0.028) in a small discovery case-control series (462 cases and 325 controls) and replicated in a combined cohorts meta-anal. of 4765 cases and 2693 controls, with an odds ratio of 1.11 (P = 0.032), with the assocn. almost confined to females.  Copy no. variation in the CFD gene was identified in 13 out of 640 samples examd. but there was no difference in frequency between AMD cases (1.3%) and controls (2.7%).  Plasma CFD concn. was measured in 751 AMD cases and 474 controls and found to be elevated in AMD cases (P = 0.00025).  The odds ratio for those in the highest vs. lowest quartile for plasma CFD was 1.81.  The difference in plasma CFD was again almost confined to females.  CFD regulates activation of the alternative complement pathway, which is implicated in AMD pathogenesis.  The authors found evidence for genetic assocn. between a CFD gene SNP and AMD and a significant increase in plasma CFD concn. in AMD cases compared with controls, consistent with a role for CFD in AMD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnBpjxif6xU7Vg90H21EOLACvtfcHk0liHJ5RNYUvN5w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFak&md5=b47917e1546614269e59ced0df775883</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1167%2Fiovs.11-7933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.11-7933%26sid%3Dliteratum%253Aachs%26aulast%3DStanton%26aufirst%3DC.%2BM.%26aulast%3DYates%26aufirst%3DJ.%2BR.%2BW.%26aulast%3Dden%2BHollander%26aufirst%3DA.%2BI.%26aulast%3DSeddon%26aufirst%3DJ.%2BM.%26aulast%3DSwaroop%26aufirst%3DA.%26aulast%3DStambolian%26aufirst%3DD.%26aulast%3DFauser%26aufirst%3DS.%26aulast%3DHoyng%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DAtsuhiro%26aufirst%3DK.%26aulast%3DBranham%26aufirst%3DK.%26aulast%3DOthman%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DKortvely%26aufirst%3DE.%26aulast%3DChalmers%26aufirst%3DK.%26aulast%3DHayward%26aufirst%3DC.%26aulast%3DMoore%26aufirst%3DA.%2BT.%26aulast%3DDhillon%26aufirst%3DB.%26aulast%3DUeffing%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DA.%2BF.%26atitle%3DComplement%2520factor%2520D%2520in%2520age-related%2520macular%2520degeneration%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2011%26volume%3D52%26spage%3D8828%26epage%3D8834%26doi%3D10.1167%2Fiovs.11-7933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudisser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbieri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fettis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussauge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flohr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risitano, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span> <span> </span><span class="NLM_article-title">Small-molecule factor D inhibitors targeting the alternative complement pathway</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1105</span>â <span class="NLM_lpage">1110</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.2208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1038%2Fnchembio.2208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=27775713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslehur3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=1105-1110&author=J.+Maibaumauthor=S.+M.+Liaoauthor=A.+Vulpettiauthor=N.+Ostermannauthor=S.+Randlauthor=S.+Rudisserauthor=E.+Lorthioisauthor=P.+Erbelauthor=B.+Kinzelauthor=F.+A.+Kolbauthor=S.+Barbieriauthor=J.+Wagnerauthor=C.+Durandauthor=K.+Fettisauthor=S.+Dussaugeauthor=N.+Hughesauthor=O.+Delgadoauthor=U.+Hommelauthor=T.+Gouldauthor=A.+Mac+Sweeneyauthor=B.+Gerhartzauthor=F.+Cuminauthor=S.+Flohrauthor=A.+Schubartauthor=B.+Jaffeeauthor=R.+Harrisonauthor=A.+M.+Risitanoauthor=J.+Ederauthor=K.+Anderson&title=Small-molecule+factor+D+inhibitors+targeting+the+alternative+complement+pathway&doi=10.1038%2Fnchembio.2208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule factor D inhibitors targeting the alternative complement pathway</span></div><div class="casAuthors">Maibaum, Jurgen; Liao, Sha-Mei; Vulpetti, Anna; Ostermann, Nils; Randl, Stefan; Rudisser, Simon; Lorthiois, Edwige; Erbel, Paul; Kinzel, Bernd; Kolb, Fabrice A.; Barbieri, Samuel; Wagner, Julia; Durand, Corinne; Fettis, Kamal; Dussauge, Solene; Hughes, Nicola; Delgado, Omar; Hommel, Ulrich; Gould, Ty; Mac Sweeney, Aengus; Gerhartz, Bernd; Cumin, Frederic; Flohr, Stefanie; Schubart, Anna; Jaffee, Bruce; Harrison, Richard; Risitano, Antonio Maria; Eder, Jorg; Anderson, Karen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1105-1110</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Complement is a key component of the innate immune system, recognizing pathogens and promoting their elimination.  Complement component 3 (C3) is the central component of the system.  Activation of C3 can be initiated by three distinct routes-the classical, the lectin and the alternative pathways-with the alternative pathway also acting as an amplification loop for the other two pathways.  The protease factor D (FD) is essential for this amplification process, which, when dysregulated, predisposes individuals to diverse disorders including age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH).  Here the authors describe the identification of potent and selective small-mol. inhibitors of FD.  These inhibitors efficiently block alternative pathway (AP) activation and prevent both C3 deposition onto, and lysis of, PNH erythrocytes.  Their oral administration inhibited lipopolysaccharide-induced AP activation in FD-humanized mice.  These data demonstrate the feasibility of inhibiting the AP with small-mol. antagonists and support the development of FD inhibitors for the treatment of complement-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp28_wznUz9QLVg90H21EOLACvtfcHk0liXxrt7OekGWg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslehur3P&md5=270ea1f129b3e25c22680e74f82ffc36</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2208%26sid%3Dliteratum%253Aachs%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DS.%2BM.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DRudisser%26aufirst%3DS.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DKinzel%26aufirst%3DB.%26aulast%3DKolb%26aufirst%3DF.%2BA.%26aulast%3DBarbieri%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DDurand%26aufirst%3DC.%26aulast%3DFettis%26aufirst%3DK.%26aulast%3DDussauge%26aufirst%3DS.%26aulast%3DHughes%26aufirst%3DN.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DGerhartz%26aufirst%3DB.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DFlohr%26aufirst%3DS.%26aulast%3DSchubart%26aufirst%3DA.%26aulast%3DJaffee%26aufirst%3DB.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DRisitano%26aufirst%3DA.%2BM.%26aulast%3DEder%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DK.%26atitle%3DSmall-molecule%2520factor%2520D%2520inhibitors%2520targeting%2520the%2520alternative%2520complement%2520pathway%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D1105%26epage%3D1110%26doi%3D10.1038%2Fnchembio.2208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudisser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salem, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span> <span> </span><span class="NLM_article-title">Structure-based library design and fragment screening for the identification of reversible complement factor D protease inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1946</span>â <span class="NLM_lpage">1958</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01684</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01684" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFWhsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1946-1958&author=A.+Vulpettiauthor=S.+Randlauthor=S.+Rudisserauthor=N.+Ostermannauthor=P.+Erbelauthor=A.+Mac+Sweeneyauthor=T.+Zollerauthor=B.+Salemauthor=B.+Gerhartzauthor=F.+Cuminauthor=U.+Hommelauthor=C.+Dalvitauthor=E.+Lorthioisauthor=J.+Maibaum&title=Structure-based+library+design+and+fragment+screening+for+the+identification+of+reversible+complement+factor+D+protease+inhibitors&doi=10.1021%2Facs.jmedchem.6b01684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Library Design and Fragment Screening for the Identification of Reversible Complement Factor D Protease Inhibitors</span></div><div class="casAuthors">Vulpetti, Anna; Randl, Stefan; Rudisser, Simon; Ostermann, Nils; Erbel, Paul; Mac Sweeney, Aengus; Zoller, Thomas; Salem, Bahaa; Gerhartz, Bernd; Cumin, Frederic; Hommel, Ulrich; Dalvit, Claudio; Lorthiois, Edwige; Maibaum, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1946-1958</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chronic dysregulation of alternative complement pathway activation has been assocd. with diverse clin. disorders including age-related macular degeneration and paroxysmal nocturnal hemoglobinurea.  Factor D is a trypsin-like serine protease with a narrow specificity for arginine in the P1 position, which catalyzes the first enzymic reaction of the amplification loop of the alternative pathway.  In this paper, the authors describe two hit finding approaches leading to the discovery of new chem. matter for this pivotal protease of the complement system: in silico active site mapping for hot spots identification to guide rational structure-based design and NMR screening of focused and diverse fragment libraries.  The wealth of information gathered by these complementary approaches enabled the identification of ligands binding to different sub-pockets of the latent Factor D conformation and was instrumental for understanding the binding requirements for the generation of the first known potent noncovalent reversible Factor D inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPFgFvVDvCyrVg90H21EOLACvtfcHk0ljCOk7JvsngHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFWhsL8%253D&md5=179ea6dc5fb9ccb60931da60f23e6381</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01684%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DRudisser%26aufirst%3DS.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DZoller%26aufirst%3DT.%26aulast%3DSalem%26aufirst%3DB.%26aulast%3DGerhartz%26aufirst%3DB.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DStructure-based%2520library%2520design%2520and%2520fragment%2520screening%2520for%2520the%2520identification%2520of%2520reversible%2520complement%2520factor%2520D%2520protease%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1946%26epage%3D1958%26doi%3D10.1021%2Facs.jmedchem.6b01684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudisser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussauge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fettis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Erkenez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwieg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argikar, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Bonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flohr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent and selective small-molecule reversible factor D inhibitors demonstrating alternative complement pathway inhibition in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5717</span>â <span class="NLM_lpage">5735</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00425</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00425" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVSqur%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5717-5735&author=E.+Lorthioisauthor=K.+Andersonauthor=A.+Vulpettiauthor=O.+Rogelauthor=F.+Cuminauthor=N.+Ostermannauthor=S.+Steinbacherauthor=A.+Mac+Sweeneyauthor=O.+Delgadoauthor=S.+M.+Liaoauthor=S.+Randlauthor=S.+Rudisserauthor=S.+Dussaugeauthor=K.+Fettisauthor=L.+Kiefferauthor=A.+de+Erkenezauthor=L.+Yangauthor=C.+Hartwiegauthor=U.+A.+Argikarauthor=L.+R.+La+Bonteauthor=R.+Newtonauthor=V.+Kansaraauthor=S.+Flohrauthor=U.+Hommelauthor=B.+Jaffeeauthor=J.+Maibaum&title=Discovery+of+highly+potent+and+selective+small-molecule+reversible+factor+D+inhibitors+demonstrating+alternative+complement+pathway+inhibition+in+vivo&doi=10.1021%2Facs.jmedchem.7b00425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent and Selective Small-Molecule Reversible Factor D Inhibitors Demonstrating Alternative Complement Pathway Inhibition in Vivo</span></div><div class="casAuthors">Lorthiois, Edwige; Anderson, Karen; Vulpetti, Anna; Rogel, Olivier; Cumin, Frederic; Ostermann, Nils; Steinbacher, Stefan; Mac Sweeney, Aengus; Delgado, Omar; Liao, Sha-Mei; Randl, Stefan; Rudisser, Simon; Dussauge, Solene; Fettis, Kamal; Kieffer, Laurence; de Erkenez, Andrea; Yang, Louis; Hartwieg, Constanze; Argikar, Upendra A.; La Bonte, Laura R.; Newton, Ronald; Kansara, Viral; Flohr, Stefanie; Hommel, Ulrich; Jaffee, Bruce; Maibaum, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5717-5735</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The highly specific S1 serine protease Factor D (FD) plays a central role in the amplification of the complement alternative pathway (AP) of the innate immune system.  Genetic assocns. in humans have implicated AP activation in age-related macular degeneration (AMD), and AP dysfunction predisposes individuals to disorders such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).  The combination of structure-based hit identification and subsequent optimization of the center (S)-proline-based lead I has led to the discovery of noncovalent reversible and selective human Factor D (FD) inhibitors with drug-like properties.  The orally bioavailable compd. II exerted excellent potency in 50% human whole blood in vitro and blocked AP activity ex vivo after oral administration to monkeys as demonstrated by inhibition of membrane attack complex (MAC) formation.  Inhibitor II demonstrated sustained oral and ocular efficacy in a model of lipopolysaccharide (LPS)-induced systemic AP activation in mice expressing human FD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjw5U9LMzdzLVg90H21EOLACvtfcHk0ljCOk7JvsngHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVSqur%252FN&md5=06e969052e0b3ad2ca70f523eec1b63a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00425%26sid%3Dliteratum%253Aachs%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DRogel%26aufirst%3DO.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DLiao%26aufirst%3DS.%2BM.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DRudisser%26aufirst%3DS.%26aulast%3DDussauge%26aufirst%3DS.%26aulast%3DFettis%26aufirst%3DK.%26aulast%3DKieffer%26aufirst%3DL.%26aulast%3Dde%2BErkenez%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DHartwieg%26aufirst%3DC.%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26aulast%3DLa%2BBonte%26aufirst%3DL.%2BR.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DKansara%26aufirst%3DV.%26aulast%3DFlohr%26aufirst%3DS.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DJaffee%26aufirst%3DB.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520and%2520selective%2520small-molecule%2520reversible%2520factor%2520D%2520inhibitors%2520demonstrating%2520alternative%2520complement%2520pathway%2520inhibition%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5717%26epage%3D5735%26doi%3D10.1021%2Facs.jmedchem.7b00425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudisser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and design of first benzylamine-based ligands binding to an unlocked conformation of the complement factor D</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">490</span>â <span class="NLM_lpage">495</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.8b00104</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00104" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC1cXot1Cjs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=490-495&author=A.+Vulpettiauthor=N.+Ostermannauthor=S.+Randlauthor=T.+Yoonauthor=A.+Mac+Sweeneyauthor=F.+Cuminauthor=E.+Lorthioisauthor=S.+Rudisserauthor=P.+Erbelauthor=J.+Maibaum&title=Discovery+and+design+of+first+benzylamine-based+ligands+binding+to+an+unlocked+conformation+of+the+complement+factor+D&doi=10.1021%2Facsmedchemlett.8b00104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Design of First Benzylamine-Based Ligands Binding to an Unlocked Conformation of the Complement Factor D</span></div><div class="casAuthors">Vulpetti, Anna; Ostermann, Nils; Randl, Stefan; Yoon, Taeyoung; MacSweeney, Aengus; Cumin, Frederic; Lorthiois, Edwige; Rudisser, Simon; Erbel, Paul; Maibaum, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">490-495</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Complement Factor D, a serine protease of the S1 family and key component of the alternative pathway amplification loop, represents a promising target for the treatment of several prevalent and rare diseases linked to the innate immune system.  Previously reported FD inhibitors have been shown to bind to the FD active site in its self-inhibited conformation characterized by the presence of a salt bridge at the bottom of the S1 pocket between Asp189 and Arg218.  We report herein a new set of small-mol. FD ligands that harbor a basic S1 binding moiety directly binding to the carboxylate of Asp189, thereby displacing the Asp189-Arg218 ionic interaction and significantly changing the conformation of the self-inhibitory loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRdpNj9LCQYrVg90H21EOLACvtfcHk0lhacjMwxwAZ2w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXot1Cjs74%253D&md5=c24dccac197253f882e3a38a86a597ed</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00104%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DT.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DRudisser%26aufirst%3DS.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520design%2520of%2520first%2520benzylamine-based%2520ligands%2520binding%2520to%2520an%2520unlocked%2520conformation%2520of%2520the%2520complement%2520factor%2520D%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D490%26epage%3D495%26doi%3D10.1021%2Facsmedchemlett.8b00104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podos, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanassi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrycki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodsky, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajari, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocinsky, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geffner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phadke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of complement alternative pathway by ACH-4471, the first clinical investigational orally-administered inhibitor of complement factor D</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">200</span>â <span class="NLM_lpage">201</span>, <span class="refDoi">Â DOI: 10.1016/j.molimm.2017.06.226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1016%2Fj.molimm.2017.06.226" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2017&pages=200-201&author=M.+J.+Huangauthor=W.+G.+Yangauthor=S.+D.+Podosauthor=G.+W.+Yangauthor=Y.+S.+Zhaoauthor=J.+A.+Thanassiauthor=D.+Patelauthor=J.+Fabryckiauthor=A.+Luuauthor=M.+Galvanauthor=X.+Yuanauthor=R.+Brodskyauthor=I.+Ajariauthor=J.+Laheyauthor=H.+Kocinskyauthor=M.+Geffnerauthor=A.+Phadkeauthor=J.+Wilesauthor=J.+Barrish&title=Inhibition+of+complement+alternative+pathway+by+ACH-4471%2C+the+first+clinical+investigational+orally-administered+inhibitor+of+complement+factor+D&doi=10.1016%2Fj.molimm.2017.06.226"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2017.06.226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2017.06.226%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DM.%2BJ.%26aulast%3DYang%26aufirst%3DW.%2BG.%26aulast%3DPodos%26aufirst%3DS.%2BD.%26aulast%3DYang%26aufirst%3DG.%2BW.%26aulast%3DZhao%26aufirst%3DY.%2BS.%26aulast%3DThanassi%26aufirst%3DJ.%2BA.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DFabrycki%26aufirst%3DJ.%26aulast%3DLuu%26aufirst%3DA.%26aulast%3DGalvan%26aufirst%3DM.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DBrodsky%26aufirst%3DR.%26aulast%3DAjari%26aufirst%3DI.%26aulast%3DLahey%26aufirst%3DJ.%26aulast%3DKocinsky%26aufirst%3DH.%26aulast%3DGeffner%26aufirst%3DM.%26aulast%3DPhadke%26aufirst%3DA.%26aulast%3DWiles%26aufirst%3DJ.%26aulast%3DBarrish%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520complement%2520alternative%2520pathway%2520by%2520ACH-4471%252C%2520the%2520first%2520clinical%2520investigational%2520orally-administered%2520inhibitor%2520of%2520complement%2520factor%2520D%26jtitle%3DMol.%2520Immunol.%26date%3D2017%26volume%3D89%26spage%3D200%26epage%3D201%26doi%3D10.1016%2Fj.molimm.2017.06.226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kocinsky, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apelian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulawski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geffner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de
Kar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetzels, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, T.</span></span> <span> </span><span class="NLM_article-title">Factor D inhibition with ACH-4471 to reduce complement alternative pathway hyperactivity and proteinuria in C3 glomerulopathy: Preliminary proof of concept data</span>. <i>Nephrol., Dial., Transplant.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>, <span class="NLM_elocation-id">i322</span> <span class="refDoi">Â DOI: 10.1093/ndt/gfy104.SaO018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1093%2Fndt%2Fgfy104.SaO018" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&author=H.+Kocinskyauthor=C.+Kelleherauthor=D.+Apelianauthor=A.+Bulawskiauthor=M.+Geffnerauthor=M.+J.+Huangauthor=J.+Priceauthor=J.+N.+Yangauthor=W.+G.+Yangauthor=Y.+S.+Zhaoauthor=N.+van+de%0AKarauthor=J.+Wetzelsauthor=K.+Boumanauthor=T.+Cookauthor=T.+Barbour&title=Factor+D+inhibition+with+ACH-4471+to+reduce+complement+alternative+pathway+hyperactivity+and+proteinuria+in+C3+glomerulopathy%3A+Preliminary+proof+of+concept+data&doi=10.1093%2Fndt%2Fgfy104.SaO018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fndt%2Fgfy104.SaO018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252Fgfy104.SaO018%26sid%3Dliteratum%253Aachs%26aulast%3DKocinsky%26aufirst%3DH.%26aulast%3DKelleher%26aufirst%3DC.%26aulast%3DApelian%26aufirst%3DD.%26aulast%3DBulawski%26aufirst%3DA.%26aulast%3DGeffner%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DM.%2BJ.%26aulast%3DPrice%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DJ.%2BN.%26aulast%3DYang%26aufirst%3DW.%2BG.%26aulast%3DZhao%26aufirst%3DY.%2BS.%26aulast%3Dvan%2Bde%2BKar%26aufirst%3DN.%26aulast%3DWetzels%26aufirst%3DJ.%26aulast%3DBouman%26aufirst%3DK.%26aulast%3DCook%26aufirst%3DT.%26aulast%3DBarbour%26aufirst%3DT.%26atitle%3DFactor%2520D%2520inhibition%2520with%2520ACH-4471%2520to%2520reduce%2520complement%2520alternative%2520pathway%2520hyperactivity%2520and%2520proteinuria%2520in%2520C3%2520glomerulopathy%253A%2520Preliminary%2520proof%2520of%2520concept%2520data%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D2018%26volume%3D33%26doi%3D10.1093%2Fndt%2Fgfy104.SaO018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stiefl, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gedeck, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindvall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buenemann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyakov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tommasi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Drie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vash, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raush, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totrov, M.</span></span> <span> </span><span class="NLM_article-title">FOCUS - development of a global communication and modeling platform for applied and computational medicinal chemists</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">896</span>â <span class="NLM_lpage">908</span>, <span class="refDoi">Â DOI: 10.1021/ci500598e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVShtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=896-908&author=N.+Stieflauthor=P.+Gedeckauthor=D.+Chinauthor=P.+Huntauthor=M.+Lindvallauthor=K.+Spiegelauthor=C.+Springerauthor=S.+Billerauthor=C.+Buenemannauthor=T.+Kanazawaauthor=M.+Katoauthor=R.+Lewisauthor=E.+Martinauthor=V.+Polyakovauthor=R.+Tommasiauthor=J.+van+Drieauthor=B.+Vashauthor=L.+Whiteheadauthor=Y.+J.+Xuauthor=R.+Abagyanauthor=E.+Raushauthor=M.+Totrov&title=FOCUS+-+development+of+a+global+communication+and+modeling+platform+for+applied+and+computational+medicinal+chemists&doi=10.1021%2Fci500598e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">FOCUS - Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal Chemists</span></div><div class="casAuthors">Stiefl, Nikolaus; Gedeck, Peter; Chin, Donovan; Hunt, Peter; Lindvall, Mika; Spiegel, Katrin; Springer, Clayton; Biller, Scott; Buenemann, Christoph; Kanazawa, Takanori; Kato, Mitsunori; Lewis, Richard; Martin, Eric; Polyakov, Valery; Tommasi, Ruben; van Drie, John; Vash, Brian; Whitehead, Lewis; Xu, Yongjin; Abagyan, Ruben; Raush, Eugene; Totrov, Max</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">896-908</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Communication of data and ideas within a medicinal chem. project on a global as well as local level is a crucial aspect in the drug design cycle.  Over a time frame of eight years, we built and optimized FOCUS, a platform to produce, visualize, and share information on various aspects of a drug discovery project such as cheminformatics, data anal., structural information, and design.  FOCUS is tightly integrated with internal services that involve-among others-data retrieval systems and in-silico models and provides easy access to automated modeling procedures such as pharmacophore searches, R-group anal., and similarity searches.  In addn., an interactive 3D editor was developed to assist users in the generation and docking of close analogs of a known lead.  In this paper, we will specifically conc. on issues we faced during development, deployment, and maintenance of the software and how we continually adapted the software in order to improve usability.  We will provide usage examples to highlight the functionality as well as limitations of FOCUS at the various stages of the development process.  We aim to make the discussion as independent of the software platform as possible, so that our experiences can be of more general value to the drug discovery community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozGiXPjxVBHrVg90H21EOLACvtfcHk0litA-GU-kyiUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVShtr8%253D&md5=00541e43a6212701678a400e36996caf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fci500598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500598e%26sid%3Dliteratum%253Aachs%26aulast%3DStiefl%26aufirst%3DN.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DChin%26aufirst%3DD.%26aulast%3DHunt%26aufirst%3DP.%26aulast%3DLindvall%26aufirst%3DM.%26aulast%3DSpiegel%26aufirst%3DK.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DBiller%26aufirst%3DS.%26aulast%3DBuenemann%26aufirst%3DC.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DPolyakov%26aufirst%3DV.%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3Dvan%2BDrie%26aufirst%3DJ.%26aulast%3DVash%26aufirst%3DB.%26aulast%3DWhitehead%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DY.%2BJ.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DRaush%26aufirst%3DE.%26aulast%3DTotrov%26aufirst%3DM.%26atitle%3DFOCUS%2520-%2520development%2520of%2520a%2520global%2520communication%2520and%2520modeling%2520platform%2520for%2520applied%2520and%2520computational%2520medicinal%2520chemists%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26spage%3D896%26epage%3D908%26doi%3D10.1021%2Fci500598e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span> <i>SchrÃ¶dinger Release 2012</i>, Glide
5.8; <span class="NLM_publisher-name">SchrÃ¶dinger, LLC</span>: <span class="NLM_publisher-loc">New York,
NY</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Release+2012%2C+Glide%0A5.8%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C%0ANY%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSchr%25C3%25B6dinger%2520Release%25202012%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kohrt, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipski, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cody, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Huis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapundalo, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiya-Cork, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leadley, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKnight, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaiz, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Light, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmunds, J. J.</span></span> <span> </span><span class="NLM_article-title">The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">4752</span>â <span class="NLM_lpage">4756</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2005.07.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1016%2Fj.bmcl.2005.07.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=16125385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVanu7zM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4752-4756&author=J.+T.+Kohrtauthor=K.+J.+Filipskiauthor=W.+L.+Codyauthor=C.+Caiauthor=D.+A.+Dudleyauthor=C.+A.+Van+Huisauthor=J.+A.+Willardsenauthor=S.+T.+Rapundaloauthor=K.+Saiya-Corkauthor=R.+J.+Leadleyauthor=L.+Narasimhanauthor=E.+Zhangauthor=M.+Whitlowauthor=M.+Adlerauthor=K.+McLeanauthor=Y.+L.+Chouauthor=C.+McKnightauthor=D.+O.+Arnaizauthor=K.+J.+Shawauthor=D.+R.+Lightauthor=J.+J.+Edmunds&title=The+discovery+of+fluoropyridine-based+inhibitors+of+the+factor+VIIa%2FTF+complex&doi=10.1016%2Fj.bmcl.2005.07.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex</span></div><div class="casAuthors">Kohrt, Jeffrey T.; Filipski, Kevin J.; Cody, Wayne L.; Cai, Cuiman; Dudley, Danette A.; Van Huis, Chad A.; Willardsen, J. Adam; Rapundalo, Stephen T.; Saiya-Cork, Kamlai; Leadley, Robert J.; Narasimhan, Lakshmi; Zhang, Erli; Whitlow, Marc; Adler, Marc; McLean, Kirk; Chou, Yuo-Ling; McKnight, Cecile; Arnaiz, Damian O.; Shaw, Kenneth J.; Light, David R.; Edmunds, Jeremy J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4752-4756</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The activated Factor VII/tissue factor complex (FVIIa/TF) plays a key role in the formation of blood clots.  Inhibition of this complex may lead to new antithrombotic drugs.  An X-ray crystal structure of a fluoropyridine-based FVIIa/TF inhibitor bound in the active site of the enzyme complex suggested that incorporation of substitution at the 5-position of the hydroxybenzoic acid side chain could lead to the formation of more potent inhibitors through interactions with the S1'/S2' pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPXXiEgbcYurVg90H21EOLACvtfcHk0litA-GU-kyiUg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVanu7zM&md5=e50b3a1dfc4f93a22f1f970a13907e0a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.07.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.07.059%26sid%3Dliteratum%253Aachs%26aulast%3DKohrt%26aufirst%3DJ.%2BT.%26aulast%3DFilipski%26aufirst%3DK.%2BJ.%26aulast%3DCody%26aufirst%3DW.%2BL.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DDudley%26aufirst%3DD.%2BA.%26aulast%3DVan%2BHuis%26aufirst%3DC.%2BA.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DRapundalo%26aufirst%3DS.%2BT.%26aulast%3DSaiya-Cork%26aufirst%3DK.%26aulast%3DLeadley%26aufirst%3DR.%2BJ.%26aulast%3DNarasimhan%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DWhitlow%26aufirst%3DM.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DMcLean%26aufirst%3DK.%26aulast%3DChou%26aufirst%3DY.%2BL.%26aulast%3DMcKnight%26aufirst%3DC.%26aulast%3DArnaiz%26aufirst%3DD.%2BO.%26aulast%3DShaw%26aufirst%3DK.%2BJ.%26aulast%3DLight%26aufirst%3DD.%2BR.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520discovery%2520of%2520fluoropyridine-based%2520inhibitors%2520of%2520the%2520factor%2520VIIa%252FTF%2520complex%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4752%26epage%3D4756%26doi%3D10.1016%2Fj.bmcl.2005.07.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaiz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gualtieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huwe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Light, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukovich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, J.</span></span> <span> </span><span class="NLM_article-title">Identification of orally bioavailable, non-amidine inhibitors of urokinase plasminogen activator (uPA)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5712</span>â <span class="NLM_lpage">5715</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2009.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1016%2Fj.bmcl.2009.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=19703768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFakur3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5712-5715&author=C.+W.+Westauthor=M.+Adlerauthor=D.+Arnaizauthor=D.+Chenauthor=K.+Chuauthor=G.+Gualtieriauthor=E.+Hoauthor=C.+Huweauthor=D.+Lightauthor=G.+Phillipsauthor=R.+Pulkauthor=D.+Sukovichauthor=M.+Whitlowauthor=S.+Yuanauthor=J.+Bryant&title=Identification+of+orally+bioavailable%2C+non-amidine+inhibitors+of+urokinase+plasminogen+activator+%28uPA%29&doi=10.1016%2Fj.bmcl.2009.08.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA)</span></div><div class="casAuthors">West, Christopher W.; Adler, Marc; Arnaiz, Danny; Chen, Deborah; Chu, Kieu; Gualtieri, Giovanna; Ho, Elena; Huwe, Christoph; Light, David; Phillips, Gary; Pulk, Rebecca; Sukovich, Drew; Whitlow, Marc; Yuan, Shendong; Bryant, Judi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5712-5715</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this Letter the synthesis and evaluation of a series of non-amidine inhibitors of Urokinase Plasminogen Activator (uPA) are reported.  Starting from compd. I, a significant change provided compds. in which the amidine, binding in the S1 pocket, was replaced with a primary amine.  Further modifications led to the identification of potent, selective, and orally bioavailable uPA inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZYJuZGz1EJLVg90H21EOLACvtfcHk0lj7I6PbwzfZQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFakur3P&md5=ca3529dc06e384edeea54b6b62b25252</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DC.%2BW.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DArnaiz%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DK.%26aulast%3DGualtieri%26aufirst%3DG.%26aulast%3DHo%26aufirst%3DE.%26aulast%3DHuwe%26aufirst%3DC.%26aulast%3DLight%26aufirst%3DD.%26aulast%3DPhillips%26aufirst%3DG.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DSukovich%26aufirst%3DD.%26aulast%3DWhitlow%26aufirst%3DM.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DBryant%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520orally%2520bioavailable%252C%2520non-amidine%2520inhibitors%2520of%2520urokinase%2520plasminogen%2520activator%2520%2528uPA%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5712%26epage%3D5715%26doi%3D10.1016%2Fj.bmcl.2009.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greco, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Garavilla, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minor, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cera, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantwell, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savvides, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damiano, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maryanoff, B. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1727</span>â <span class="NLM_lpage">1730</span>, <span class="refDoi">Â DOI: 10.1021/jm0700619</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0700619" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivF2isb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1727-1730&author=M.+N.+Grecoauthor=M.+J.+Hawkinsauthor=E.+T.+Powellauthor=R.+Haroldauthor=L.+de+Garavillaauthor=J.+Hallauthor=L.+K.+Minorauthor=Y.+Wangauthor=T.+W.+Corcoranauthor=E.+Di+Ceraauthor=A.+M.+Cantwellauthor=S.+N.+Savvidesauthor=B.+P.+Damianoauthor=B.+E.+Maryanoff&title=Discovery+of+potent%2C+selective%2C+orally+active%2C+nonpeptide+inhibitors+of+human+mast+cell+chymase&doi=10.1021%2Fjm0700619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Selective, Orally Active, Nonpeptide Inhibitors of Human Mast Cell Chymase</span></div><div class="casAuthors">Greco, Michael N.; Hawkins, Michael J.; Powell, Eugene T.; Almond, Harold R., Jr.; De Garavilla, Lawrence; Hall, Jeffrey; Minor, Lisa K.; Wang, Yuanping; Corcoran, Thomas W.; Di Cera, Enrico; Cantwell, Angelene M.; Savvides, Savvas N.; Damiano, Bruce P.; Maryanoff, Bruce E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1727-1730</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of Î²-carboxamido-phosphon(in)ic acids, e.g., I, II, and III, was identified as a new structural motif for obtaining potent inhibitors of human mast cell chymase.  For example, 1-naphthyl deriv. I had an IC50 value of 29 nM and (E)-styryl deriv. II had an IC50 value of 3.5 nM.  An X-ray structure for IÂ·chymase revealed key interactions within the enzyme active site.  I was selective for inhibiting chymase vs. eight serine proteases.  III was orally bioavailable in rats (F = 39%), and orally efficacious in a hamster model of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcqGFCHhLjK7Vg90H21EOLACvtfcHk0liCUrEe21Fs4g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivF2isb0%253D&md5=f81cddf73934642d0ffad18cfe389c39</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0700619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0700619%26sid%3Dliteratum%253Aachs%26aulast%3DGreco%26aufirst%3DM.%2BN.%26aulast%3DHawkins%26aufirst%3DM.%2BJ.%26aulast%3DPowell%26aufirst%3DE.%2BT.%26aulast%3DHarold%26aufirst%3DR.%26aulast%3Dde%2BGaravilla%26aufirst%3DL.%26aulast%3DHall%26aufirst%3DJ.%26aulast%3DMinor%26aufirst%3DL.%2BK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCorcoran%26aufirst%3DT.%2BW.%26aulast%3DDi%2BCera%26aufirst%3DE.%26aulast%3DCantwell%26aufirst%3DA.%2BM.%26aulast%3DSavvides%26aufirst%3DS.%2BN.%26aulast%3DDamiano%26aufirst%3DB.%2BP.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26atitle%3DDiscovery%2520of%2520potent%252C%2520selective%252C%2520orally%2520active%252C%2520nonpeptide%2520inhibitors%2520of%2520human%2520mast%2520cell%2520chymase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1727%26epage%3D1730%26doi%3D10.1021%2Fjm0700619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span>; <span class="NLM_string-name">Bannister, T.</span>; <span class="NLM_string-name">Noll, R.</span>; <span class="NLM_string-name">Jin, L.</span>; <span class="NLM_string-name">Rynkiewicz, M.</span>; <span class="NLM_string-name">Bibbins, F.</span>; <span class="NLM_string-name">Magee, S.</span>; <span class="NLM_string-name">Gorga, J.</span>; <span class="NLM_string-name">Babine, R. E.</span>; <span class="NLM_string-name">Strickler, J. E.</span>; <span class="NLM_string-name">Meyers, H. V.</span>; <span class="NLM_string-name">Abdel-Meguid, S. S.</span></span> <i>PDB ID 1ZSJ, Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with N-(7-Carbamimidoyl-naphthalen-1-yl)-3-hydroxy-2-methyl-benzamide</i>, <span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=Z.+Guo&author=T.+Bannister&author=R.+Noll&author=L.+Jin&author=M.+Rynkiewicz&author=F.+Bibbins&author=S.+Magee&author=J.+Gorga&author=R.+E.+Babine&author=J.+E.+Strickler&author=H.+V.+Meyers&author=S.+S.+Abdel-Meguid&title=PDB+ID+1ZSJ%2C+Crystal+Structure+of+the+Catalytic+Domain+of+Coagulation+Factor+XI+in+Complex+with+N-%287-Carbamimidoyl-naphthalen-1-yl%29-3-hydroxy-2-methyl-benzamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DZ.%26jtitle%3DPDB%2520ID%25201ZSJ%252C%2520Crystal%2520Structure%2520of%2520the%2520Catalytic%2520Domain%2520of%2520Coagulation%2520Factor%2520XI%2520in%2520Complex%2520with%2520N-%25287-Carbamimidoyl-naphthalen-1-yl%2529-3-hydroxy-2-methyl-benzamide%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M.
E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengeler, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirschbein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehoux, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janc, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gjerstad, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graupe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estiarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataramani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperandio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, B. A.</span></span> <span> </span><span class="NLM_article-title">Structure-guided design of peptide-based tryptase inhibitors</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">5964</span>â <span class="NLM_lpage">5973</span>, <span class="refDoi">Â DOI: 10.1021/bi060173m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi060173m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1Gntbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=5964-5973&author=M.%0AE.+McGrathauthor=P.+A.+Sprengelerauthor=B.+Hirschbeinauthor=J.+R.+Somozaauthor=I.+Lehouxauthor=J.+W.+Jancauthor=E.+Gjerstadauthor=M.+Graupeauthor=A.+Estiarteauthor=C.+Venkataramaniauthor=Y.+Liuauthor=R.+Yeeauthor=J.+D.+Hoauthor=M.+J.+Greenauthor=C.+S.+Leeauthor=L.+Liuauthor=V.+Taiauthor=J.+Spencerauthor=D.+Sperandioauthor=B.+A.+Katz&title=Structure-guided+design+of+peptide-based+tryptase+inhibitors&doi=10.1021%2Fbi060173m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Design of Peptide-Based Tryptase Inhibitors</span></div><div class="casAuthors">McGrath, Mary E.; Sprengeler, Paul A.; Hirschbein, Bernard; Somoza, John R.; Lehoux, Isabelle; Janc, James W.; Gjerstad, Erik; Graupe, Michael; Estiarte, Angeles; Venkataramani, Chandru; Liu, Yang; Yee, Robb; Ho, Joseph D.; Green, Michael J.; Lee, Chang-Sun; Liu, Liang; Tai, Vincent; Spencer, Jeffrey; Sperandio, David; Katz, Bradley A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5964-5973</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Improved peptide-based inhibitors of human Î²-tryptase were discovered using information gleaned from tripeptide library screening and structure-guided design methods, including fragment screening.  These efforts sought to improve this class of inhibitors by replacing the traditional Lys or Arg P1 element.  The optimized compds. display low nanomolar potency against the mast cell target and several hundred-fold selectivity with respect to serine protease off targets.  Thus, replacement of Lys/Arg at P1 in a peptide-like scaffold does not need to be accompanied by a loss in target affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnQNi6oSHnXbVg90H21EOLACvtfcHk0lgu5uIBpoegFA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1Gntbk%253D&md5=4a501b87490f5cfe72d57516d39cac94</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi060173m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi060173m%26sid%3Dliteratum%253Aachs%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DHirschbein%26aufirst%3DB.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DLehoux%26aufirst%3DI.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DGjerstad%26aufirst%3DE.%26aulast%3DGraupe%26aufirst%3DM.%26aulast%3DEstiarte%26aufirst%3DA.%26aulast%3DVenkataramani%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYee%26aufirst%3DR.%26aulast%3DHo%26aufirst%3DJ.%2BD.%26aulast%3DGreen%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DTai%26aufirst%3DV.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DSperandio%26aufirst%3DD.%26aulast%3DKatz%26aufirst%3DB.%2BA.%26atitle%3DStructure-guided%2520design%2520of%2520peptide-based%2520tryptase%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D5964%26epage%3D5973%26doi%3D10.1021%2Fbi060173m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.</span>; <span class="NLM_string-name">Yuan, C.</span>; <span class="NLM_string-name">Jiang, L.</span>; <span class="NLM_string-name">Huang, M.</span></span> <i>PDB ID 2O8W; Crystal Structure and Binding Epitopes of Urokinase-Type Plasminogen Activator (C122A/N145Q/S195A) in Complex with Inhibitors</i>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=G.+Zhao&author=C.+Yuan&author=L.+Jiang&author=M.+Huang&title=PDB+ID+2O8W%3B+Crystal+Structure+and+Binding+Epitopes+of+Urokinase-Type+Plasminogen+Activator+%28C122A%2FN145Q%2FS195A%29+in+Complex+with+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DG.%26jtitle%3DPDB%2520ID%25202O8W%253B%2520Crystal%2520Structure%2520and%2520Binding%2520Epitopes%2520of%2520Urokinase-Type%2520Plasminogen%2520Activator%2520%2528C122A%252FN145Q%252FS195A%2529%2520in%2520Complex%2520with%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A.
E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shockcor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espina, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orwat, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gant, L.-S.</span></span> <span> </span><span class="NLM_article-title">Disposition of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2â²(methylsulfonyl)-[1,1â³-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC 423) by novel metabolic pathways. Characterization of unusual metabolites by liquid chromatography/mass spectrometry and NMR</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">48</span>â <span class="NLM_lpage">62</span>, <span class="refDoi">Â DOI: 10.1021/tx0101191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx0101191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=48-62&author=A.%0AE.+Mutlibauthor=J.+Shockcorauthor=S.+Y.+Chenauthor=R.+J.+Espinaauthor=D.+J.+Pintoauthor=M.+J.+Orwatauthor=S.+R.+Prakashauthor=L.-S.+Gant&title=Disposition+of+1-%5B3-%28aminomethyl%29phenyl%5D-N-%5B3-fluoro-2%E2%80%B2%28methylsulfonyl%29-%5B1%2C1%E2%80%B3-biphenyl%5D-4-yl%5D-3-%28trifluoromethyl%29-1H-pyrazole-5-carboxamide+%28DPC+423%29+by+novel+metabolic+pathways.+Characterization+of+unusual+metabolites+by+liquid+chromatography%2Fmass+spectrometry+and+NMR&doi=10.1021%2Ftx0101191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Ftx0101191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx0101191%26sid%3Dliteratum%253Aachs%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DShockcor%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%2BY.%26aulast%3DEspina%26aufirst%3DR.%2BJ.%26aulast%3DPinto%26aufirst%3DD.%2BJ.%26aulast%3DOrwat%26aufirst%3DM.%2BJ.%26aulast%3DPrakash%26aufirst%3DS.%2BR.%26aulast%3DGant%26aufirst%3DL.-S.%26atitle%3DDisposition%2520of%25201-%255B3-%2528aminomethyl%2529phenyl%255D-N-%255B3-fluoro-2%25E2%2580%25B2%2528methylsulfonyl%2529-%255B1%252C1%25E2%2580%25B3-biphenyl%255D-4-yl%255D-3-%2528trifluoromethyl%2529-1H-pyrazole-5-carboxamide%2520%2528DPC%2520423%2529%2520by%2520novel%2520metabolic%2520pathways.%2520Characterization%2520of%2520unusual%2520metabolites%2520by%2520liquid%2520chromatography%252Fmass%2520spectrometry%2520and%2520NMR%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26spage%3D48%26epage%3D62%26doi%3D10.1021%2Ftx0101191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schramm, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triebwasser, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raychaudhuri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seddon, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, J. P.</span></span> <span> </span><span class="NLM_article-title">Genetic variants in the complement system predisposing to age-related macular degeneration: A review</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">118</span>â <span class="NLM_lpage">125</span>, <span class="refDoi">Â DOI: 10.1016/j.molimm.2014.06.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1016%2Fj.molimm.2014.06.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=25034031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFGjs7vK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2014&pages=118-125&author=E.+C.+Schrammauthor=S.+J.+Clarkauthor=M.+P.+Triebwasserauthor=S.+Raychaudhuriauthor=J.+M.+Seddonauthor=J.+P.+Atkinson&title=Genetic+variants+in+the+complement+system+predisposing+to+age-related+macular+degeneration%3A+A+review&doi=10.1016%2Fj.molimm.2014.06.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic variants in the complement system predisposing to age-related macular degeneration</span></div><div class="casAuthors">Schramm, Elizabeth C.; Clark, Simon J.; Triebwasser, Michael P.; Raychaudhuri, Soumya; Seddon, Johanna M.; Atkinson, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">118-125</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Age-related macular degeneration (AMD) is a major cause of visual impairment in the western world.  It is characterized by the presence of lipoproteinaceous deposits (drusen) in the inner layers of the retina.  Immunohistochem. studies identified deposition of complement proteins in the drusen as well as in the choroid.  In the last decade, genetic studies have linked both common and rare variants in genes of the complement system to increased risk of development of AMD.  Here, we review the variants described to date and discuss the functional implications of dysregulation of the alternative pathway of complement in AMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw5ZQzYfD307Vg90H21EOLACvtfcHk0lifHf4l93Uu0g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFGjs7vK&md5=8b8ec6496b04e1a7748b2817045d2eb1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2014.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2014.06.032%26sid%3Dliteratum%253Aachs%26aulast%3DSchramm%26aufirst%3DE.%2BC.%26aulast%3DClark%26aufirst%3DS.%2BJ.%26aulast%3DTriebwasser%26aufirst%3DM.%2BP.%26aulast%3DRaychaudhuri%26aufirst%3DS.%26aulast%3DSeddon%26aufirst%3DJ.%2BM.%26aulast%3DAtkinson%26aufirst%3DJ.%2BP.%26atitle%3DGenetic%2520variants%2520in%2520the%2520complement%2520system%2520predisposing%2520to%2520age-related%2520macular%2520degeneration%253A%2520A%2520review%26jtitle%3DMol.%2520Immunol.%26date%3D2014%26volume%3D61%26spage%3D118%26epage%3D125%26doi%3D10.1016%2Fj.molimm.2014.06.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Will-Orrego, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffee, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dryja, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S. M.</span></span> <span> </span><span class="NLM_article-title">Induction of ocular complement activation by inflammatory stimuli and intraocular inhibition of complement factor D in animal models</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">940</span>â <span class="NLM_lpage">951</span>, <span class="refDoi">Â DOI: 10.1167/iovs.17-22605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1167%2Fiovs.17-22605" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2018&pages=940-951&author=M.+A.+Crowleyauthor=O.+Delgadoauthor=A.+Will-Orregoauthor=N.+M.+Buchananauthor=K.+Andersonauthor=B.+D.+Jaffeeauthor=T.+P.+Dryjaauthor=S.+M.+Liao&title=Induction+of+ocular+complement+activation+by+inflammatory+stimuli+and+intraocular+inhibition+of+complement+factor+D+in+animal+models&doi=10.1167%2Fiovs.17-22605"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1167%2Fiovs.17-22605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.17-22605%26sid%3Dliteratum%253Aachs%26aulast%3DCrowley%26aufirst%3DM.%2BA.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DWill-Orrego%26aufirst%3DA.%26aulast%3DBuchanan%26aufirst%3DN.%2BM.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DJaffee%26aufirst%3DB.%2BD.%26aulast%3DDryja%26aufirst%3DT.%2BP.%26aulast%3DLiao%26aufirst%3DS.%2BM.%26atitle%3DInduction%2520of%2520ocular%2520complement%2520activation%2520by%2520inflammatory%2520stimuli%2520and%2520intraocular%2520inhibition%2520of%2520complement%2520factor%2520D%2520in%2520animal%2520models%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2018%26volume%3D59%26spage%3D940%26epage%3D951%26doi%3D10.1167%2Fiovs.17-22605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span> <i>SchrÃ¶dinger Release 2012</i>; <span class="NLM_publisher-name">SchrÃ¶dinger,
LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Release+2012%3B+Schr%C3%B6dinger%2C%0ALLC%3A+New+York%2C+NY%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSchr%25C3%25B6dinger%2520Release%25202012%26pub%3DSchr%25C3%25B6dinger%252C%250ALLC%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Kuei-Ju Cheng, Chien-Ming Hsieh, Kunal Nepali, <span class="NLM_string-name hlFld-ContribAuthor">Jing-Ping Liou</span>. </span><span class="cited-content_cbyCitation_article-title">Ocular Disease Therapeutics: Design and Delivery of Drugs for Diseases of the Eye. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10533-10593. <a href="https://doi.org/10.1021/acs.jmedchem.9b01033" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01033%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOcular%252BDisease%252BTherapeutics%25253A%252BDesign%252Band%252BDelivery%252Bof%252BDrugs%252Bfor%252BDiseases%252Bof%252Bthe%252BEye%26aulast%3DCheng%26aufirst%3DKuei-Ju%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D28062019%26date%3D02062020%26volume%3D63%26issue%3D19%26spage%3D10533%26epage%3D10593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Juraj Velcicky, Rainer Wilcken, Simona Cotesta, Philipp Janser, Achim Schlapbach, Trixie Wagner, Philippe Piechon, Frederic Villard, Rochdi Bouhelal, Fabian Piller, Stephanie Harlfinger, Rowan Stringer, Dominique Fehlmann, Klemens Kaupmann, Amanda Littlewood-Evans, Matthias Haffke, <span class="NLM_string-name hlFld-ContribAuthor">Nina Gommermann</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Optimization of Novel SUCNR1 Inhibitors: Design of Zwitterionic Derivatives with a Salt Bridge for the Improvement of Oral Exposure. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9856-9875. <a href="https://doi.org/10.1021/acs.jmedchem.0c01020" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01020%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BOptimization%252Bof%252BNovel%252BSUCNR1%252BInhibitors%25253A%252BDesign%252Bof%252BZwitterionic%252BDerivatives%252Bwith%252Ba%252BSalt%252BBridge%252Bfor%252Bthe%252BImprovement%252Bof%252BOral%252BExposure%26aulast%3DVelcicky%26aufirst%3DJuraj%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15062020%26date%3D28082020%26volume%3D63%26issue%3D17%26spage%3D9856%26epage%3D9875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Edwige Lorthiois, James Roache, David Barnes-Seeman, Eva Altmann, Ulrich Hassiepen, Gordon Turner, Rohit Duvadie, Viktor Hornak, Rajeshri G. Karki, Nikolaus Schiering, Wilhelm A. Weihofen, Francesca Perruccio, Amy Calhoun, Tanzina Fazal, Darija Dedic, Corinne Durand, Solene Dussauge, Kamal Fettis, Fabien Tritsch, Celine Dentel, Adelaide Druet, Donglei Liu, Louise Kirman, Julie Lachal, Kenji Namoto, Douglas Bevan, Rose Mo, Gabriela Monnet, Lionel Muller, Richard Zessis, Xueming Huang, Loren Lindsley, Treeve Currie, Yu-Hsin Chiu, Cary Fridrich, Peter Delgado, Shuangxi Wang, Micah Hollis-Symynkywicz, Joerg Berghausen, Eric Williams, Hong Liu, Guiqing Liang, Hyungchul Kim, Peter Hoffmann, Andreas Hein, Paul Ramage, Allan DâArcy, Stefanie Harlfinger, Martin Renatus, Simon Ruedisser, David Feldman, Jason Elliott, Richard Sedrani, Juergen Maibaum, <span class="NLM_string-name hlFld-ContribAuthor">Christopher M. Adams</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8088-8113. <a href="https://doi.org/10.1021/acs.jmedchem.0c00279" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00279%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Band%252BPreclinical%252BCharacterization%252Bof%252BSelective%252Band%252BOrally%252BBioavailable%252BFactor%252BXIa%252BInhibitors%25253A%252BDemonstrating%252Bthe%252BPower%252Bof%252Ban%252BIntegrated%252BS1%252BProtease%252BFamily%252BApproach%26aulast%3DLorthiois%26aufirst%3DEdwige%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14022020%26date%3D21072020%26date%3D17062020%26volume%3D63%26issue%3D15%26spage%3D8088%26epage%3D8113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nello Mainolfi, Takeru Ehara, Rajeshri G. Karki, Karen Anderson, Aengus Mac Sweeney, Sha-Mei Liao, Upendra A. Argikar, Keith Jendza, Chun Zhang, James Powers, Daniel W. Klosowski, Maura Crowley, Toshio Kawanami, Jian Ding, Myriam April, Cornelia Forster, Michael Serrano-Wu, Michael Capparelli, Rrezarta Ramqaj, Catherine Solovay, Frederic Cumin, Thomas M. Smith, Luciana Ferrara, Wendy Lee, Debby Long, Melissa Prentiss, Andrea De Erkenez, Louis Yang, Fang Liu, Holger Sellner, Finton Sirockin, Eric Valeur, Paulus Erbel, Daniela Ostermeier, Paul Ramage, Bernd Gerhartz, Anna Schubart, Stefanie Flohr, Nathalie Gradoux, Roland Feifel, Barbara Vogg, Christian Wiesmann, JÃ¼rgen Maibaum, JÃ¶rg Eder, Richard Sedrani, Richard A. Harrison, Muneto Mogi, Bruce D. Jaffee, <span class="NLM_string-name hlFld-ContribAuthor">Christopher M. Adams</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5697-5722. <a href="https://doi.org/10.1021/acs.jmedchem.9b01870" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01870</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01870%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-%252528%2525282S%25252C4S%252529-4-Ethoxy-1-%252528%2525285-methoxy-7-methyl-1H-indol-4-yl%252529methyl%252529piperidin-2-yl%252529benzoic%252BAcid%252B%252528LNP023%252529%25252C%252Ba%252BFactor%252BB%252BInhibitor%252BSpecifically%252BDesigned%252BTo%252BBe%252BApplicable%252Bto%252BTreating%252Ba%252BDiverse%252BArray%252Bof%252BComplement%252BMediated%252BDiseases%26aulast%3DMainolfi%26aufirst%3DNello%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D11112019%26date%3D19022020%26volume%3D63%26issue%3D11%26spage%3D5697%26epage%3D5722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiye  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Pathogenesis of age-related macular degeneration. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2022,</strong>,, 129-163. <a href="https://doi.org/10.1016/B978-0-12-822061-0.00002-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-822061-0.00002-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-822061-0.00002-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-822061-0.00002-5%26sid%3Dliteratum%253Aachs%26atitle%3DPathogenesis%252Bof%252Bage-related%252Bmacular%252Bdegeneration%26aulast%3DLi%26aufirst%3DWeiye%26date%3D2022%26spage%3D129%26epage%3D163%26pub%3DElsevier%26atitle%3DAge-Related%252BMacular%252BDegeneration%26date%3D2022%26volume%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin J.  Kim</span>, <span class="hlFld-ContribAuthor ">Dimitrios C.  Mastellos</span>, <span class="hlFld-ContribAuthor ">Yafeng  Li</span>, <span class="hlFld-ContribAuthor ">Joshua L.  Dunaief</span>, <span class="hlFld-ContribAuthor ">John D.  Lambris</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions. </span><span class="cited-content_cbyCitation_journal-name">Progress in Retinal and Eye Research</span><span> <strong>2021,</strong> <em>83 </em>, 100936. <a href="https://doi.org/10.1016/j.preteyeres.2020.100936" title="DOI URL">https://doi.org/10.1016/j.preteyeres.2020.100936</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.preteyeres.2020.100936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.preteyeres.2020.100936%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Retinal%2520and%2520Eye%2520Research%26atitle%3DTargeting%252Bcomplement%252Bcomponents%252BC3%252Band%252BC5%252Bfor%252Bthe%252Bretina%25253A%252BKey%252Bconcepts%252Band%252Blingering%252Bquestions%26aulast%3DKim%26aufirst%3DBenjamin%2BJ.%26date%3D2021%26volume%3D83%26spage%3D100936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicole  Aaron</span>, <span class="hlFld-ContribAuthor ">Michael J  Kraakman</span>, <span class="hlFld-ContribAuthor ">Qiuzhong  Zhou</span>, <span class="hlFld-ContribAuthor ">Qiongming  Liu</span>, <span class="hlFld-ContribAuthor ">Samantha  Costa</span>, <span class="hlFld-ContribAuthor ">Jing  Yang</span>, <span class="hlFld-ContribAuthor ">Longhua  Liu</span>, <span class="hlFld-ContribAuthor ">Lexiang  Yu</span>, <span class="hlFld-ContribAuthor ">Liheng  Wang</span>, <span class="hlFld-ContribAuthor ">Ying  He</span>, <span class="hlFld-ContribAuthor ">Lihong  Fan</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Hirakawa</span>, <span class="hlFld-ContribAuthor ">Lei  Ding</span>, <span class="hlFld-ContribAuthor ">James  Lo</span>, <span class="hlFld-ContribAuthor ">Weidong  Wang</span>, <span class="hlFld-ContribAuthor ">Baohong  Zhao</span>, <span class="hlFld-ContribAuthor ">Edward  Guo</span>, <span class="hlFld-ContribAuthor ">Lei  Sun</span>, <span class="hlFld-ContribAuthor ">Cliff J  Rosen</span>, <span class="hlFld-ContribAuthor ">Li  Qiang</span>. </span><span class="cited-content_cbyCitation_article-title">Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2021,</strong> <em>10 </em><a href="https://doi.org/10.7554/eLife.69209" title="DOI URL">https://doi.org/10.7554/eLife.69209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.69209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.69209%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DAdipsin%252Bpromotes%252Bbone%252Bmarrow%252Badiposity%252Bby%252Bpriming%252Bmesenchymal%252Bstem%252Bcells%26aulast%3DAaron%26aufirst%3DNicole%26date%3D2021%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Blake  Rushing</span>, <span class="hlFld-ContribAuthor ">Denise  Rohlik</span>, <span class="hlFld-ContribAuthor ">Sourav  Roy</span>, <span class="hlFld-ContribAuthor ">D.  Skaff</span>, <span class="hlFld-ContribAuthor ">Brandon  Garcia</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Initiator Protease of the Classical Pathway of Complement Using Fragment-Based Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (17)
                                     , 4016. <a href="https://doi.org/10.3390/molecules25174016" title="DOI URL">https://doi.org/10.3390/molecules25174016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25174016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25174016%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DTargeting%252Bthe%252BInitiator%252BProtease%252Bof%252Bthe%252BClassical%252BPathway%252Bof%252BComplement%252BUsing%252BFragment-Based%252BDrug%252BDiscovery%26aulast%3DRushing%26aufirst%3DBlake%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D17%26spage%3D4016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0015.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic representation of the alternative complement pathway (AP) from initiation to cell lysis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of benzylamine-based FD inhibitors.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. FD conformational change upon a substrate or benzylamine binding. Crystal structure of inactive FD (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FBE">5FBE</a>.pdb,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> white) is shown relative to active FD (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FUT">6FUT</a>.pdb,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> green). The substrate binding sites are labeled S1âS2â². Salt bridge between Arg218 and Asp189 is shown in black dotted lines. His57, Asp102, and Ser195 form the catalytic triad. Inhibitors bound with FD in the crystal structures are not shown for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding mode of <b>3</b> complexed with FD (a) 3D-editor generated orientation of <b>3</b> (green) shown relative to X-ray of <b>1</b> (cyan, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FUT">6FUT</a>.pdb<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a>). Alternate positions of succinic acid co-crystallized with <b>1</b> are shown in two shades of orange. (b) Crystal structure <b>3</b> (yellow) illustrating a productive arrangement of the catalytic triad residues His57, Asp102, and Ser195. The ligand-binding pocket is shown in gray and H-bonding interactions are shown as back dotted lines. The sidechain of Arg218 has shifted upon binding of <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Crystal structure of <b>3</b> bound with FD (yellow and white carbons) and FXIa<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (green carbons). Only selected residues in the ligand-binding pocket are shown. FD residues are labeled in black and FXIa in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray of <b>12</b> (yellow) complexed with FD (white). The ligand-binding pocket is shown in gray and H-bonding interactions are shown as black dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Inhibitor <b>12</b> tested at 3 and 10 mg/kg in the human FD knock-in mouse pharmacodynamic model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Concentration vs time profile for <b>12</b> in the retina, PEC, and plasma and PK parameters after a single dose (PO 10 mg/kg) in brown Norway rats. DN = dose normalized.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/medium/jm-2019-00271x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0009.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Ocular efficacy of <b>12</b> after a single oral dose in a model where AP is activated locally via intravitreal injection; efficacy assessments were made 4 h post-intravitreal injection.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00271/20190502/images/large/jm-2019-00271x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00271&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i52">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83506" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83506" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 27 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thurman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holers, V. M.</span></span> <span> </span><span class="NLM_article-title">The central role of the alternative complement pathway in human disease</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">1305</span>â <span class="NLM_lpage">1310</span>, <span class="refDoi">Â DOI: 10.4049/jimmunol.176.3.1305</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.4049%2Fjimmunol.176.3.1305" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=16424154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFyjug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=1305-1310&author=J.+M.+Thurmanauthor=V.+M.+Holers&title=The+central+role+of+the+alternative+complement+pathway+in+human+disease&doi=10.4049%2Fjimmunol.176.3.1305"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Central Role of the Alternative Complement Pathway in Human Disease</span></div><div class="casAuthors">Thurman, Joshua M.; Holers, V. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1305-1310</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">A review.  The complement system is increasingly recognized as important in the pathogenesis of tissue injury in vivo following immune, ischemic, or infectious insults.  Within the complement system, three pathways are capable of initiating the processes that result in C3 activation: classical, alternative, and lectin.  Although the roles that proinflammatory peptides and complexes generated during complement activation play in mediating disease processes have been studied extensively, the relative contributions of the three activating pathways is less well understood.  Herein we examine recent evidence that the alternative complement pathway plays a key and, in most instances, obligate role in generating proinflammatory complement activation products in vivo.  In addn., we discuss new concepts regarding the mechanisms by which the alternative pathway is activated in vivo, as recent clin. findings and exptl. results have provided evidence that continuous active control of this pathway is necessary to prevent unintended targeting and injury to self tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_FVfCz2QYDrVg90H21EOLACvtfcHk0ljlKRKtDHquVQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFyjug%253D%253D&md5=f6db4b8f56a8a99d3a74acc8de1298b0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.176.3.1305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.176.3.1305%26sid%3Dliteratum%253Aachs%26aulast%3DThurman%26aufirst%3DJ.%2BM.%26aulast%3DHolers%26aufirst%3DV.%2BM.%26atitle%3DThe%2520central%2520role%2520of%2520the%2520alternative%2520complement%2520pathway%2520in%2520human%2520disease%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D176%26spage%3D1305%26epage%3D1310%26doi%3D10.4049%2Fjimmunol.176.3.1305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lesavre, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullereberhard, H. J.</span></span> <span> </span><span class="NLM_article-title">Mechanism of action of factor-D of alternative complement pathway</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">1498</span>â <span class="NLM_lpage">1509</span>, <span class="refDoi">Â DOI: 10.1084/jem.148.6.1498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1084%2Fjem.148.6.1498" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=1978&pages=1498-1509&author=P.+H.+Lesavreauthor=H.+J.+Mullereberhard&title=Mechanism+of+action+of+factor-D+of+alternative+complement+pathway&doi=10.1084%2Fjem.148.6.1498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1084%2Fjem.148.6.1498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.148.6.1498%26sid%3Dliteratum%253Aachs%26aulast%3DLesavre%26aufirst%3DP.%2BH.%26aulast%3DMullereberhard%26aufirst%3DH.%2BJ.%26atitle%3DMechanism%2520of%2520action%2520of%2520factor-D%2520of%2520alternative%2520complement%2520pathway%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1978%26volume%3D148%26spage%3D1498%26epage%3D1509%26doi%3D10.1084%2Fjem.148.6.1498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volanakis, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayana, S. V. L.</span></span> <span> </span><span class="NLM_article-title">Complement factor D, a novel serine protease</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">553</span>â <span class="NLM_lpage">564</span>, <span class="refDoi">Â DOI: 10.1002/pro.5560050401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1002%2Fpro.5560050401" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=8845746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADyaK28XitFShu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1996&pages=553-564&author=J.+E.+Volanakisauthor=S.+V.+L.+Narayana&title=Complement+factor+D%2C+a+novel+serine+protease&doi=10.1002%2Fpro.5560050401"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Complement factor D, a novel serine protease</span></div><div class="casAuthors">Volanakis, John E.; Narayana, Sthanam V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">553-64</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">A review with many refs.  Factor D is unique among serine proteases in that it requires neither enzymic cleavage for expression of proteolytic activity nor inactivation by a serpin for its control.  Regulation of factor D activity is instead attained by a novel mechanism that depends on reversible conformational changes for expression and control of catalytic activity.  These conformational changes are believed to be induced by the single natural substrate, C3bB, and to result in realignment of the catalytic triad, the specificity pocket, and the nonspecific substrate binding site, all of which have atypical conformations.  Mutational studies have defined structural determinants responsible for these unique structural features of factor D and for the resultant low reactivity with synthetic esters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR-WO4fTyq7LVg90H21EOLACvtfcHk0lgLtWn2RzaqcQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitFShu7g%253D&md5=d55e7afa5c827b02023dd94994690eaa</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560050401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560050401%26sid%3Dliteratum%253Aachs%26aulast%3DVolanakis%26aufirst%3DJ.%2BE.%26aulast%3DNarayana%26aufirst%3DS.%2BV.%2BL.%26atitle%3DComplement%2520factor%2520D%252C%2520a%2520novel%2520serine%2520protease%26jtitle%3DProtein%2520Sci.%26date%3D1996%26volume%3D5%26spage%3D553%26epage%3D564%26doi%3D10.1002%2Fpro.5560050401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holers, V. M.</span></span> <span> </span><span class="NLM_article-title">The spectrum of complement alternative pathway-mediated diseases</span>. <i>Immunol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>223</i></span>,  <span class="NLM_fpage">300</span>â <span class="NLM_lpage">316</span>, <span class="refDoi">Â DOI: 10.1111/j.1600-065X.2008.00641.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1111%2Fj.1600-065X.2008.00641.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=18613844" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlGltr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2008&pages=300-316&author=V.+M.+Holers&title=The+spectrum+of+complement+alternative+pathway-mediated+diseases&doi=10.1111%2Fj.1600-065X.2008.00641.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The spectrum of complement alternative pathway-mediated diseases</span></div><div class="casAuthors">Holers, V. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">300-316</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  The complement system has once again come into prominence in the therapeutic development arena.  The recent approval of an inhibitory monoclonal antibody, eculizumab, which is directed against complement component C5 for the disease paroxysmal nocturnal hemoglobinuria has provided the initial validation of this system as a therapeutic target.  Preclin. studies using animal models and human-derived samples demonstrate that inhibition of complement ameliorates many inflammatory and autoimmune disease manifestations.  Major efforts continue to define the most optimal means to block complement activation in a cost-effective manner.  Because the system is initiated through three pathways and generates at least six immunoregulatory and pro-inflammatory mediators, there is substantial complexity to this problem.  One pathway, designated the alternative pathway, has recently been shown to play a particularly important role in preclin. disease models.  Further evidence of the importance of the alternative pathway has been provided by studies of human diseases, where mutations or dysfunctional polymorphisms that promote activation of this pathway are highly assocd. with the diseases atypical hemolytic uremic syndrome, dense deposit disease, and age-related macular degeneration.  This article reviews evidence in support of the essential role of the alternative pathway in the generation of tissue injury and the rationale for development of therapies that modulate its activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3u8J-53XDOrVg90H21EOLACvtfcHk0lgLtWn2RzaqcQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlGltr4%253D&md5=41da6ad206500c88595f6d8cba76ce50</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00641.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00641.x%26sid%3Dliteratum%253Aachs%26aulast%3DHolers%26aufirst%3DV.%2BM.%26atitle%3DThe%2520spectrum%2520of%2520complement%2520alternative%2520pathway-mediated%2520diseases%26jtitle%3DImmunol.%2520Rev.%26date%3D2008%26volume%3D223%26spage%3D300%26epage%3D316%26doi%3D10.1111%2Fj.1600-065X.2008.00641.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Risitano, A. M.</span></span> <span> </span><span class="NLM_article-title">Paroxysmal Nocturnal Hemoglobinuria and the Complement System: Recent Insights and Novel Anticomplement Strategies</span>. In  <i>Complement Therapeutics</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambris, J.</span>, <span class="NLM_string-name">Holers, V.</span>, <span class="NLM_string-name">Ricklin, D.</span></span>, Eds.; <span class="NLM_series">Advances in Experimental Medicine and Biology</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Boston</span>, <span class="NLM_year">2013</span>; Vol.  <span class="NLM_volume">735</span>, pp  <span class="NLM_fpage">155</span>â <span class="NLM_lpage">172</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1007%2F978-1-4614-4118-2_10" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=155-172&author=A.+M.+Risitanoauthor=J.+Lambris&author=V.+Holers&author=D.+Ricklin&title=Complement+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2F978-1-4614-4118-2_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4614-4118-2_10%26sid%3Dliteratum%253Aachs%26aulast%3DRisitano%26aufirst%3DA.%2BM.%26atitle%3DParoxysmal%2520Nocturnal%2520Hemoglobinuria%2520and%2520the%2520Complement%2520System%253A%2520Recent%2520Insights%2520and%2520Novel%2520Anticomplement%2520Strategies%26btitle%3DComplement%2520Therapeutics%26aulast%3DLambris%26aufirst%3DJ.%26pub%3DSpringer%26date%3D2013%26volume%3D735%26spage%3D155%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zipfel, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">JÃ³zsi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skerka, C.</span></span> <span> </span><span class="NLM_article-title">Complement and diseases: Defective alternative pathway control results in kidney and eye diseases</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">97</span>â <span class="NLM_lpage">106</span>, <span class="refDoi">Â DOI: 10.1016/j.molimm.2005.06.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1016%2Fj.molimm.2005.06.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=16026839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A280%3ADC%252BD2MzosFyiuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2006&pages=97-106&author=P.+F.+Zipfelauthor=S.+Heinenauthor=M.+J%C3%B3zsiauthor=C.+Skerka&title=Complement+and+diseases%3A+Defective+alternative+pathway+control+results+in+kidney+and+eye+diseases&doi=10.1016%2Fj.molimm.2005.06.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Complement and diseases: defective alternative pathway control results in kidney and eye diseases</span></div><div class="casAuthors">Zipfel Peter F; Heinen Stefan; Jozsi Mihaly; Skerka Christine</div><div class="citationInfo"><span class="NLM_cas:title">Molecular immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">97-106</span>
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    </div><div class="casAbstract">The complement system is a central part of innate immunity and in its normal setting aimed to recognize and eliminate microbes.  For elimination toxic activation products are generated locally and are reported directly of the surface of the invading microbe.  A deregulation of the alternative pathway results in defective recognition and toxic activation products can be formed on the surface of host tissues and structures.  Recent studies have shown that mutated or defective regulators of the alternative pathway of complement are associated with auto immune diseases of the kidney, including the atypical form of hemolytic uremic syndrome (HUS), membranoproliferative glomerulonephritis (MPGN) and also of the eye, such as age-related macular degeneration (ARMD).  Current research provides clues how mutations occurring in genes coding for single complement components or the inactivation of single regulators lead to defective alternative pathway amplification, via the convertase C3bBb.  These scenarios explain how defects of a single regulator lead to local, organ specific damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR5HinA2w0N1Ff1XRtfYM0dfW6udTcc2eaXz0-E3oMNw7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MzosFyiuw%253D%253D&md5=648b06395eccfac4995174522bd2ee8e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2005.06.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2005.06.015%26sid%3Dliteratum%253Aachs%26aulast%3DZipfel%26aufirst%3DP.%2BF.%26aulast%3DHeinen%26aufirst%3DS.%26aulast%3DJ%25C3%25B3zsi%26aufirst%3DM.%26aulast%3DSkerka%26aufirst%3DC.%26atitle%3DComplement%2520and%2520diseases%253A%2520Defective%2520alternative%2520pathway%2520control%2520results%2520in%2520kidney%2520and%2520eye%2520diseases%26jtitle%3DMol.%2520Immunol.%26date%3D2006%26volume%3D43%26spage%3D97%26epage%3D106%26doi%3D10.1016%2Fj.molimm.2005.06.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zipfel, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skerka, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiech, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodship, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fremeaux-Bacchi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nester, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de CÃ³rdoba, S.
R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noris, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickering, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span> <span> </span><span class="NLM_article-title">The role of complement in C3 glomerulopathy</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">21</span>â <span class="NLM_lpage">30</span>, <span class="refDoi">Â DOI: 10.1016/j.molimm.2015.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1016%2Fj.molimm.2015.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=25929733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsl2iurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=21-30&author=P.+F.+Zipfelauthor=C.+Skerkaauthor=Q.+Chenauthor=T.+Wiechauthor=T.+Goodshipauthor=S.+Johnsonauthor=V.+Fremeaux-Bacchiauthor=C.+Nesterauthor=S.%0AR.+de+C%C3%B3rdobaauthor=M.+Norisauthor=M.+Pickeringauthor=R.+Smith&title=The+role+of+complement+in+C3+glomerulopathy&doi=10.1016%2Fj.molimm.2015.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The role of complement in C3 glomerulopathy</span></div><div class="casAuthors">Zipfel, Peter F.; Skerka, Christine; Chen, Qian; Wiech, Thorsten; Goodship, Tim; Johnson, Sally; Fremeaux-Bacchi, Veronique; Nester, Clara; Cordoba, Santiago Rodriguez de; Noris, Marina; Pickering, Matthew; Smith, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-30</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  C3 glomerulopathy describes a spectrum of disorders with glomerular pathol. assocd. with C3 cleavage product deposition and with defective complement action and regulation (Fakhouri et al., 2010; Sethi et al., 2012b).  Kidney biopsies from these patients show glomerular accumulation or deposition of C3 cleavage fragments, but no or minor deposition of Igs (Appel et al., 2005; D'Agati and Bomback, 2012; Servais et al., 2007; Sethi and Fervenza, 2011).  At present the current situation asks for a better definition of the underlining disease mechanisms, for precise biomarkers, and for a treatment for this disease.  The complement system is a self activating and propelling enzymic cascade type system in which inactive, sol. plasma components are activated spontaneously and lead into an amplification loop (Zipfel and Skerka, 2009).  Activation of the alternative pathway is spontaneous, occurs by default, and cascade progression leads to amplification by complement activators.  The system however is self-controlled by multiple regulators and inhibitors, like Factor H that control cascade progression in fluid phase and on surfaces.  The activated complement system generates a series of potent effector components and activation products, which damage foreign-, as well as modified self cells, recruit innate immune cells to the site of action, coordinate inflammation and the response of the adaptive immune system in form of B cells and T lymphocytes (Kohl, 2006; Medzhitov and Janeway, 2002; Ogden and Elkon, 2006; Carroll, 2004; Kemper and Atkinson, 2007; Morgan, 1999; Muller-Eberhard, 1986; Ricklin et al., 2010).  Complement controls homeostasis and multiple reactions in the vertebrate organism including defense against microbial infections (Diaz-Guillen et al., 1999; Mastellos and Lambris, 2002; Nordahl et al., 2004; Ricklin et al., 2010).  In consequence defective control of the spontaneous self amplifying cascade or regulation is assocd. with numerous human disorders (Ricklin and Lambris, 2007; Skerka and Zipfel, 2008; Zipfel et al., 2006).  Understanding the exact action and regulation of this sophisticated homeotic cascade system is relevant to understand disease pathol. of various complement assocd. human disorders.  Furthermore this knowledge is relevant for a better diagnosis and appropriate therapy.  At present diagnosis of C3 glomerulopathy is primarily based on the kidney biopsy, and histol., immmunohistol. and electron microscopical evaluation (D'Agati and Bomback, 2012; Fakhouri et al., 2010; Medjeral-Thomas et al., 2014a,b; Sethi et al., 2012b).  The challenge is to define the actual cause of the diverse glomerular changes or damages, to define how C3 deposition results in the reported glomerular changes, the location of the cell damage and the formation of deposits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8QCPsOB4vn7Vg90H21EOLACvtfcHk0lik2-lqxz6Tmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsl2iurs%253D&md5=1a159357102c43ade839bb2d3bc86d2d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2015.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2015.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DZipfel%26aufirst%3DP.%2BF.%26aulast%3DSkerka%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DWiech%26aufirst%3DT.%26aulast%3DGoodship%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DS.%26aulast%3DFremeaux-Bacchi%26aufirst%3DV.%26aulast%3DNester%26aufirst%3DC.%26aulast%3Dde%2BC%25C3%25B3rdoba%26aufirst%3DS.%2BR.%26aulast%3DNoris%26aufirst%3DM.%26aulast%3DPickering%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DR.%26atitle%3DThe%2520role%2520of%2520complement%2520in%2520C3%2520glomerulopathy%26jtitle%3DMol.%2520Immunol.%26date%3D2015%26volume%3D67%26spage%3D21%26epage%3D30%26doi%3D10.1016%2Fj.molimm.2015.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Black, J. R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, S. J.</span></span> <span> </span><span class="NLM_article-title">Age-related macular degeneration: genome-wide association studies to translation</span>. <i>Genet. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">283</span>â <span class="NLM_lpage">289</span>, <span class="refDoi">Â DOI: 10.1038/gim.2015.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1038%2Fgim.2015.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=26020418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1KhsbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=283-289&author=J.+R.+M.+Blackauthor=S.+J.+Clark&title=Age-related+macular+degeneration%3A+genome-wide+association+studies+to+translation&doi=10.1038%2Fgim.2015.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Age-related macular degeneration: genome-wide association studies to translation</span></div><div class="casAuthors">Black, James R. M.; Clark, Simon J.</div><div class="citationInfo"><span class="NLM_cas:title">Genetics in Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">283-289</span>CODEN:
                <span class="NLM_cas:coden">GEMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1098-3600</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In recent years, genome-wide assocn. studies (GWAS), which are able to analyze the contribution to disease of genetic variations that are common within a population, have attracted considerable investment.  Despite identifying genetic variants for many conditions, they have been criticized for yielding data with minimal clin. utility.  However, in this regard, age-related macular degeneration (AMD), the most common form of blindness in the Western world, is a striking exception.  Through GWAS, common genetic variants at a no. of loci have been discovered.  Two loci in particular, including genes of the complement cascade on chromosome 1 and the ARMS2/HTRA1 genes on chromosome 10, have been shown to convey significantly increased susceptibility to developing AMD.  Today, although it is possible to screen individuals for a genetic predisposition to the disease, effective interventional strategies for those at risk of developing AMD are scarce.  Ongoing research in this area is nonetheless promising.  After providing brief overviews of AMD and common disease genetics, we outline the main recent advances in the understanding of AMD, particularly those made through GWAS.  Finally, the true merit of these findings and their current and potential translational value is examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMAZHKfsCpKbVg90H21EOLACvtfcHk0lik2-lqxz6Tmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1KhsbY%253D&md5=c079a08ac4b8e7ebd5209fdd787516ba</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fgim.2015.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fgim.2015.70%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DJ.%2BR.%2BM.%26aulast%3DClark%26aufirst%3DS.%2BJ.%26atitle%3DAge-related%2520macular%2520degeneration%253A%2520genome-wide%2520association%2520studies%2520to%2520translation%26jtitle%3DGenet.%2520Med.%26date%3D2016%26volume%3D18%26spage%3D283%26epage%3D289%26doi%3D10.1038%2Fgim.2015.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yates, J. R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Hollander, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seddon, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaroop, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stambolian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoyng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atsuhiro, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Othman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortvely, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalmers, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhillon, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueffing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, A. F.</span></span> <span> </span><span class="NLM_article-title">Complement factor D in age-related macular degeneration</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">8828</span>â <span class="NLM_lpage">8834</span>, <span class="refDoi">Â DOI: 10.1167/iovs.11-7933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1167%2Fiovs.11-7933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=22003108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC38XmsFak" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=8828-8834&author=C.+M.+Stantonauthor=J.+R.+W.+Yatesauthor=A.+I.+den+Hollanderauthor=J.+M.+Seddonauthor=A.+Swaroopauthor=D.+Stambolianauthor=S.+Fauserauthor=C.+Hoyngauthor=Y.+Yuauthor=K.+Atsuhiroauthor=K.+Branhamauthor=M.+Othmanauthor=W.+Chenauthor=E.+Kortvelyauthor=K.+Chalmersauthor=C.+Haywardauthor=A.+T.+Mooreauthor=B.+Dhillonauthor=M.+Ueffingauthor=A.+F.+Wright&title=Complement+factor+D+in+age-related+macular+degeneration&doi=10.1167%2Fiovs.11-7933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Complement factor D in age-related macular degeneration</span></div><div class="casAuthors">Stanton, Chloe M.; Yates, John R. W.; den Hollander, Anneke I.; Seddon, Johanna M.; Swaroop, Anand; Stambolian, Dwight; Fauser, Sascha; Hoyng, Carel; Yu, Yi; Atsuhiro, Kanda; Branham, Kari; Othman, Mohammad; Chen, Wei; Kortvely, Elod; Chalmers, Kevin; Hayward, Caroline; Moore, Anthony T.; Dhillon, Baljean; Ueffing, Marius; Wright, Alan F.</div><div class="citationInfo"><span class="NLM_cas:title">Investigative Ophthalmology & Visual Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8828-8834</span>CODEN:
                <span class="NLM_cas:coden">IOVSDA</span>;
        ISSN:<span class="NLM_cas:issn">1552-5783</span>.
    
            (<span class="NLM_cas:orgname">Association for Research in Vision and Ophthalmology</span>)
        </div><div class="casAbstract">The aim was to examine the role of complement factor D (CFD) in age-related macular degeneration (AMD) by anal. of genetic assocn., copy no. variation, and plasma CFD concns.  Single nucleotide polymorphisms (SNPs) in the CFD gene were genotyped and the results analyzed by binary logistic regression.  CFD gene copy no. was analyzed by gene copy no. assay.  Plasma CFD was measured by an ELISA.  Genetic assocn. was found between CFD gene SNP rs3826945 and AMD (odds ratio 1.44; P = 0.028) in a small discovery case-control series (462 cases and 325 controls) and replicated in a combined cohorts meta-anal. of 4765 cases and 2693 controls, with an odds ratio of 1.11 (P = 0.032), with the assocn. almost confined to females.  Copy no. variation in the CFD gene was identified in 13 out of 640 samples examd. but there was no difference in frequency between AMD cases (1.3%) and controls (2.7%).  Plasma CFD concn. was measured in 751 AMD cases and 474 controls and found to be elevated in AMD cases (P = 0.00025).  The odds ratio for those in the highest vs. lowest quartile for plasma CFD was 1.81.  The difference in plasma CFD was again almost confined to females.  CFD regulates activation of the alternative complement pathway, which is implicated in AMD pathogenesis.  The authors found evidence for genetic assocn. between a CFD gene SNP and AMD and a significant increase in plasma CFD concn. in AMD cases compared with controls, consistent with a role for CFD in AMD pathogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnBpjxif6xU7Vg90H21EOLACvtfcHk0lik2-lqxz6Tmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmsFak&md5=b47917e1546614269e59ced0df775883</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1167%2Fiovs.11-7933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.11-7933%26sid%3Dliteratum%253Aachs%26aulast%3DStanton%26aufirst%3DC.%2BM.%26aulast%3DYates%26aufirst%3DJ.%2BR.%2BW.%26aulast%3Dden%2BHollander%26aufirst%3DA.%2BI.%26aulast%3DSeddon%26aufirst%3DJ.%2BM.%26aulast%3DSwaroop%26aufirst%3DA.%26aulast%3DStambolian%26aufirst%3DD.%26aulast%3DFauser%26aufirst%3DS.%26aulast%3DHoyng%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DAtsuhiro%26aufirst%3DK.%26aulast%3DBranham%26aufirst%3DK.%26aulast%3DOthman%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DKortvely%26aufirst%3DE.%26aulast%3DChalmers%26aufirst%3DK.%26aulast%3DHayward%26aufirst%3DC.%26aulast%3DMoore%26aufirst%3DA.%2BT.%26aulast%3DDhillon%26aufirst%3DB.%26aulast%3DUeffing%26aufirst%3DM.%26aulast%3DWright%26aufirst%3DA.%2BF.%26atitle%3DComplement%2520factor%2520D%2520in%2520age-related%2520macular%2520degeneration%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2011%26volume%3D52%26spage%3D8828%26epage%3D8834%26doi%3D10.1167%2Fiovs.11-7933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudisser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbieri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fettis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussauge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flohr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risitano, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span> <span> </span><span class="NLM_article-title">Small-molecule factor D inhibitors targeting the alternative complement pathway</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1105</span>â <span class="NLM_lpage">1110</span>, <span class="refDoi">Â DOI: 10.1038/nchembio.2208</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1038%2Fnchembio.2208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=27775713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslehur3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=1105-1110&author=J.+Maibaumauthor=S.+M.+Liaoauthor=A.+Vulpettiauthor=N.+Ostermannauthor=S.+Randlauthor=S.+Rudisserauthor=E.+Lorthioisauthor=P.+Erbelauthor=B.+Kinzelauthor=F.+A.+Kolbauthor=S.+Barbieriauthor=J.+Wagnerauthor=C.+Durandauthor=K.+Fettisauthor=S.+Dussaugeauthor=N.+Hughesauthor=O.+Delgadoauthor=U.+Hommelauthor=T.+Gouldauthor=A.+Mac+Sweeneyauthor=B.+Gerhartzauthor=F.+Cuminauthor=S.+Flohrauthor=A.+Schubartauthor=B.+Jaffeeauthor=R.+Harrisonauthor=A.+M.+Risitanoauthor=J.+Ederauthor=K.+Anderson&title=Small-molecule+factor+D+inhibitors+targeting+the+alternative+complement+pathway&doi=10.1038%2Fnchembio.2208"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule factor D inhibitors targeting the alternative complement pathway</span></div><div class="casAuthors">Maibaum, Jurgen; Liao, Sha-Mei; Vulpetti, Anna; Ostermann, Nils; Randl, Stefan; Rudisser, Simon; Lorthiois, Edwige; Erbel, Paul; Kinzel, Bernd; Kolb, Fabrice A.; Barbieri, Samuel; Wagner, Julia; Durand, Corinne; Fettis, Kamal; Dussauge, Solene; Hughes, Nicola; Delgado, Omar; Hommel, Ulrich; Gould, Ty; Mac Sweeney, Aengus; Gerhartz, Bernd; Cumin, Frederic; Flohr, Stefanie; Schubart, Anna; Jaffee, Bruce; Harrison, Richard; Risitano, Antonio Maria; Eder, Jorg; Anderson, Karen</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1105-1110</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Complement is a key component of the innate immune system, recognizing pathogens and promoting their elimination.  Complement component 3 (C3) is the central component of the system.  Activation of C3 can be initiated by three distinct routes-the classical, the lectin and the alternative pathways-with the alternative pathway also acting as an amplification loop for the other two pathways.  The protease factor D (FD) is essential for this amplification process, which, when dysregulated, predisposes individuals to diverse disorders including age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH).  Here the authors describe the identification of potent and selective small-mol. inhibitors of FD.  These inhibitors efficiently block alternative pathway (AP) activation and prevent both C3 deposition onto, and lysis of, PNH erythrocytes.  Their oral administration inhibited lipopolysaccharide-induced AP activation in FD-humanized mice.  These data demonstrate the feasibility of inhibiting the AP with small-mol. antagonists and support the development of FD inhibitors for the treatment of complement-mediated diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp28_wznUz9QLVg90H21EOLACvtfcHk0lgfKF255lLGXw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslehur3P&md5=270ea1f129b3e25c22680e74f82ffc36</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2208%26sid%3Dliteratum%253Aachs%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DS.%2BM.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DRudisser%26aufirst%3DS.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DKinzel%26aufirst%3DB.%26aulast%3DKolb%26aufirst%3DF.%2BA.%26aulast%3DBarbieri%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DDurand%26aufirst%3DC.%26aulast%3DFettis%26aufirst%3DK.%26aulast%3DDussauge%26aufirst%3DS.%26aulast%3DHughes%26aufirst%3DN.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DGould%26aufirst%3DT.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DGerhartz%26aufirst%3DB.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DFlohr%26aufirst%3DS.%26aulast%3DSchubart%26aufirst%3DA.%26aulast%3DJaffee%26aufirst%3DB.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DRisitano%26aufirst%3DA.%2BM.%26aulast%3DEder%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DK.%26atitle%3DSmall-molecule%2520factor%2520D%2520inhibitors%2520targeting%2520the%2520alternative%2520complement%2520pathway%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D12%26spage%3D1105%26epage%3D1110%26doi%3D10.1038%2Fnchembio.2208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudisser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salem, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerhartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span> <span> </span><span class="NLM_article-title">Structure-based library design and fragment screening for the identification of reversible complement factor D protease inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1946</span>â <span class="NLM_lpage">1958</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.6b01684</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01684" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFWhsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1946-1958&author=A.+Vulpettiauthor=S.+Randlauthor=S.+Rudisserauthor=N.+Ostermannauthor=P.+Erbelauthor=A.+Mac+Sweeneyauthor=T.+Zollerauthor=B.+Salemauthor=B.+Gerhartzauthor=F.+Cuminauthor=U.+Hommelauthor=C.+Dalvitauthor=E.+Lorthioisauthor=J.+Maibaum&title=Structure-based+library+design+and+fragment+screening+for+the+identification+of+reversible+complement+factor+D+protease+inhibitors&doi=10.1021%2Facs.jmedchem.6b01684"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Library Design and Fragment Screening for the Identification of Reversible Complement Factor D Protease Inhibitors</span></div><div class="casAuthors">Vulpetti, Anna; Randl, Stefan; Rudisser, Simon; Ostermann, Nils; Erbel, Paul; Mac Sweeney, Aengus; Zoller, Thomas; Salem, Bahaa; Gerhartz, Bernd; Cumin, Frederic; Hommel, Ulrich; Dalvit, Claudio; Lorthiois, Edwige; Maibaum, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1946-1958</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chronic dysregulation of alternative complement pathway activation has been assocd. with diverse clin. disorders including age-related macular degeneration and paroxysmal nocturnal hemoglobinurea.  Factor D is a trypsin-like serine protease with a narrow specificity for arginine in the P1 position, which catalyzes the first enzymic reaction of the amplification loop of the alternative pathway.  In this paper, the authors describe two hit finding approaches leading to the discovery of new chem. matter for this pivotal protease of the complement system: in silico active site mapping for hot spots identification to guide rational structure-based design and NMR screening of focused and diverse fragment libraries.  The wealth of information gathered by these complementary approaches enabled the identification of ligands binding to different sub-pockets of the latent Factor D conformation and was instrumental for understanding the binding requirements for the generation of the first known potent noncovalent reversible Factor D inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPFgFvVDvCyrVg90H21EOLACvtfcHk0lgfKF255lLGXw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFWhsL8%253D&md5=179ea6dc5fb9ccb60931da60f23e6381</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01684%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DRudisser%26aufirst%3DS.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DZoller%26aufirst%3DT.%26aulast%3DSalem%26aufirst%3DB.%26aulast%3DGerhartz%26aufirst%3DB.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DDalvit%26aufirst%3DC.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DStructure-based%2520library%2520design%2520and%2520fragment%2520screening%2520for%2520the%2520identification%2520of%2520reversible%2520complement%2520factor%2520D%2520protease%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1946%26epage%3D1958%26doi%3D10.1021%2Facs.jmedchem.6b01684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogel, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudisser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussauge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fettis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Erkenez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartwieg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argikar, U. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Bonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flohr, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of highly potent and selective small-molecule reversible factor D inhibitors demonstrating alternative complement pathway inhibition in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5717</span>â <span class="NLM_lpage">5735</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b00425</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00425" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVSqur%252FN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5717-5735&author=E.+Lorthioisauthor=K.+Andersonauthor=A.+Vulpettiauthor=O.+Rogelauthor=F.+Cuminauthor=N.+Ostermannauthor=S.+Steinbacherauthor=A.+Mac+Sweeneyauthor=O.+Delgadoauthor=S.+M.+Liaoauthor=S.+Randlauthor=S.+Rudisserauthor=S.+Dussaugeauthor=K.+Fettisauthor=L.+Kiefferauthor=A.+de+Erkenezauthor=L.+Yangauthor=C.+Hartwiegauthor=U.+A.+Argikarauthor=L.+R.+La+Bonteauthor=R.+Newtonauthor=V.+Kansaraauthor=S.+Flohrauthor=U.+Hommelauthor=B.+Jaffeeauthor=J.+Maibaum&title=Discovery+of+highly+potent+and+selective+small-molecule+reversible+factor+D+inhibitors+demonstrating+alternative+complement+pathway+inhibition+in+vivo&doi=10.1021%2Facs.jmedchem.7b00425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent and Selective Small-Molecule Reversible Factor D Inhibitors Demonstrating Alternative Complement Pathway Inhibition in Vivo</span></div><div class="casAuthors">Lorthiois, Edwige; Anderson, Karen; Vulpetti, Anna; Rogel, Olivier; Cumin, Frederic; Ostermann, Nils; Steinbacher, Stefan; Mac Sweeney, Aengus; Delgado, Omar; Liao, Sha-Mei; Randl, Stefan; Rudisser, Simon; Dussauge, Solene; Fettis, Kamal; Kieffer, Laurence; de Erkenez, Andrea; Yang, Louis; Hartwieg, Constanze; Argikar, Upendra A.; La Bonte, Laura R.; Newton, Ronald; Kansara, Viral; Flohr, Stefanie; Hommel, Ulrich; Jaffee, Bruce; Maibaum, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5717-5735</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The highly specific S1 serine protease Factor D (FD) plays a central role in the amplification of the complement alternative pathway (AP) of the innate immune system.  Genetic assocns. in humans have implicated AP activation in age-related macular degeneration (AMD), and AP dysfunction predisposes individuals to disorders such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).  The combination of structure-based hit identification and subsequent optimization of the center (S)-proline-based lead I has led to the discovery of noncovalent reversible and selective human Factor D (FD) inhibitors with drug-like properties.  The orally bioavailable compd. II exerted excellent potency in 50% human whole blood in vitro and blocked AP activity ex vivo after oral administration to monkeys as demonstrated by inhibition of membrane attack complex (MAC) formation.  Inhibitor II demonstrated sustained oral and ocular efficacy in a model of lipopolysaccharide (LPS)-induced systemic AP activation in mice expressing human FD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjw5U9LMzdzLVg90H21EOLACvtfcHk0ljyjglzJvLgVQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVSqur%252FN&md5=06e969052e0b3ad2ca70f523eec1b63a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00425%26sid%3Dliteratum%253Aachs%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DRogel%26aufirst%3DO.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DLiao%26aufirst%3DS.%2BM.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DRudisser%26aufirst%3DS.%26aulast%3DDussauge%26aufirst%3DS.%26aulast%3DFettis%26aufirst%3DK.%26aulast%3DKieffer%26aufirst%3DL.%26aulast%3Dde%2BErkenez%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DHartwieg%26aufirst%3DC.%26aulast%3DArgikar%26aufirst%3DU.%2BA.%26aulast%3DLa%2BBonte%26aufirst%3DL.%2BR.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DKansara%26aufirst%3DV.%26aulast%3DFlohr%26aufirst%3DS.%26aulast%3DHommel%26aufirst%3DU.%26aulast%3DJaffee%26aufirst%3DB.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520highly%2520potent%2520and%2520selective%2520small-molecule%2520reversible%2520factor%2520D%2520inhibitors%2520demonstrating%2520alternative%2520complement%2520pathway%2520inhibition%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5717%26epage%3D5735%26doi%3D10.1021%2Facs.jmedchem.7b00425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vulpetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostermann, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mac Sweeney, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudisser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maibaum, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and design of first benzylamine-based ligands binding to an unlocked conformation of the complement factor D</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">490</span>â <span class="NLM_lpage">495</span>, <span class="refDoi">Â DOI: 10.1021/acsmedchemlett.8b00104</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00104" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC1cXot1Cjs74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=490-495&author=A.+Vulpettiauthor=N.+Ostermannauthor=S.+Randlauthor=T.+Yoonauthor=A.+Mac+Sweeneyauthor=F.+Cuminauthor=E.+Lorthioisauthor=S.+Rudisserauthor=P.+Erbelauthor=J.+Maibaum&title=Discovery+and+design+of+first+benzylamine-based+ligands+binding+to+an+unlocked+conformation+of+the+complement+factor+D&doi=10.1021%2Facsmedchemlett.8b00104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Design of First Benzylamine-Based Ligands Binding to an Unlocked Conformation of the Complement Factor D</span></div><div class="casAuthors">Vulpetti, Anna; Ostermann, Nils; Randl, Stefan; Yoon, Taeyoung; MacSweeney, Aengus; Cumin, Frederic; Lorthiois, Edwige; Rudisser, Simon; Erbel, Paul; Maibaum, Jurgen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">490-495</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Complement Factor D, a serine protease of the S1 family and key component of the alternative pathway amplification loop, represents a promising target for the treatment of several prevalent and rare diseases linked to the innate immune system.  Previously reported FD inhibitors have been shown to bind to the FD active site in its self-inhibited conformation characterized by the presence of a salt bridge at the bottom of the S1 pocket between Asp189 and Arg218.  We report herein a new set of small-mol. FD ligands that harbor a basic S1 binding moiety directly binding to the carboxylate of Asp189, thereby displacing the Asp189-Arg218 ionic interaction and significantly changing the conformation of the self-inhibitory loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRdpNj9LCQYrVg90H21EOLACvtfcHk0ljyjglzJvLgVQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXot1Cjs74%253D&md5=c24dccac197253f882e3a38a86a597ed</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00104%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DRandl%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DT.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DRudisser%26aufirst%3DS.%26aulast%3DErbel%26aufirst%3DP.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520design%2520of%2520first%2520benzylamine-based%2520ligands%2520binding%2520to%2520an%2520unlocked%2520conformation%2520of%2520the%2520complement%2520factor%2520D%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2018%26volume%3D9%26spage%3D490%26epage%3D495%26doi%3D10.1021%2Facsmedchemlett.8b00104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podos, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thanassi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabrycki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodsky, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajari, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocinsky, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geffner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phadke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of complement alternative pathway by ACH-4471, the first clinical investigational orally-administered inhibitor of complement factor D</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">200</span>â <span class="NLM_lpage">201</span>, <span class="refDoi">Â DOI: 10.1016/j.molimm.2017.06.226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1016%2Fj.molimm.2017.06.226" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2017&pages=200-201&author=M.+J.+Huangauthor=W.+G.+Yangauthor=S.+D.+Podosauthor=G.+W.+Yangauthor=Y.+S.+Zhaoauthor=J.+A.+Thanassiauthor=D.+Patelauthor=J.+Fabryckiauthor=A.+Luuauthor=M.+Galvanauthor=X.+Yuanauthor=R.+Brodskyauthor=I.+Ajariauthor=J.+Laheyauthor=H.+Kocinskyauthor=M.+Geffnerauthor=A.+Phadkeauthor=J.+Wilesauthor=J.+Barrish&title=Inhibition+of+complement+alternative+pathway+by+ACH-4471%2C+the+first+clinical+investigational+orally-administered+inhibitor+of+complement+factor+D&doi=10.1016%2Fj.molimm.2017.06.226"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2017.06.226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2017.06.226%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DM.%2BJ.%26aulast%3DYang%26aufirst%3DW.%2BG.%26aulast%3DPodos%26aufirst%3DS.%2BD.%26aulast%3DYang%26aufirst%3DG.%2BW.%26aulast%3DZhao%26aufirst%3DY.%2BS.%26aulast%3DThanassi%26aufirst%3DJ.%2BA.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DFabrycki%26aufirst%3DJ.%26aulast%3DLuu%26aufirst%3DA.%26aulast%3DGalvan%26aufirst%3DM.%26aulast%3DYuan%26aufirst%3DX.%26aulast%3DBrodsky%26aufirst%3DR.%26aulast%3DAjari%26aufirst%3DI.%26aulast%3DLahey%26aufirst%3DJ.%26aulast%3DKocinsky%26aufirst%3DH.%26aulast%3DGeffner%26aufirst%3DM.%26aulast%3DPhadke%26aufirst%3DA.%26aulast%3DWiles%26aufirst%3DJ.%26aulast%3DBarrish%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520complement%2520alternative%2520pathway%2520by%2520ACH-4471%252C%2520the%2520first%2520clinical%2520investigational%2520orally-administered%2520inhibitor%2520of%2520complement%2520factor%2520D%26jtitle%3DMol.%2520Immunol.%26date%3D2017%26volume%3D89%26spage%3D200%26epage%3D201%26doi%3D10.1016%2Fj.molimm.2017.06.226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kocinsky, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelleher, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apelian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulawski, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geffner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de
Kar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetzels, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbour, T.</span></span> <span> </span><span class="NLM_article-title">Factor D inhibition with ACH-4471 to reduce complement alternative pathway hyperactivity and proteinuria in C3 glomerulopathy: Preliminary proof of concept data</span>. <i>Nephrol., Dial., Transplant.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>33</i></span>, <span class="NLM_elocation-id">i322</span> <span class="refDoi">Â DOI: 10.1093/ndt/gfy104.SaO018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1093%2Fndt%2Fgfy104.SaO018" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2018&author=H.+Kocinskyauthor=C.+Kelleherauthor=D.+Apelianauthor=A.+Bulawskiauthor=M.+Geffnerauthor=M.+J.+Huangauthor=J.+Priceauthor=J.+N.+Yangauthor=W.+G.+Yangauthor=Y.+S.+Zhaoauthor=N.+van+de%0AKarauthor=J.+Wetzelsauthor=K.+Boumanauthor=T.+Cookauthor=T.+Barbour&title=Factor+D+inhibition+with+ACH-4471+to+reduce+complement+alternative+pathway+hyperactivity+and+proteinuria+in+C3+glomerulopathy%3A+Preliminary+proof+of+concept+data&doi=10.1093%2Fndt%2Fgfy104.SaO018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fndt%2Fgfy104.SaO018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fndt%252Fgfy104.SaO018%26sid%3Dliteratum%253Aachs%26aulast%3DKocinsky%26aufirst%3DH.%26aulast%3DKelleher%26aufirst%3DC.%26aulast%3DApelian%26aufirst%3DD.%26aulast%3DBulawski%26aufirst%3DA.%26aulast%3DGeffner%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DM.%2BJ.%26aulast%3DPrice%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DJ.%2BN.%26aulast%3DYang%26aufirst%3DW.%2BG.%26aulast%3DZhao%26aufirst%3DY.%2BS.%26aulast%3Dvan%2Bde%2BKar%26aufirst%3DN.%26aulast%3DWetzels%26aufirst%3DJ.%26aulast%3DBouman%26aufirst%3DK.%26aulast%3DCook%26aufirst%3DT.%26aulast%3DBarbour%26aufirst%3DT.%26atitle%3DFactor%2520D%2520inhibition%2520with%2520ACH-4471%2520to%2520reduce%2520complement%2520alternative%2520pathway%2520hyperactivity%2520and%2520proteinuria%2520in%2520C3%2520glomerulopathy%253A%2520Preliminary%2520proof%2520of%2520concept%2520data%26jtitle%3DNephrol.%252C%2520Dial.%252C%2520Transplant.%26date%3D2018%26volume%3D33%26doi%3D10.1093%2Fndt%2Fgfy104.SaO018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stiefl, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gedeck, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindvall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buenemann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polyakov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tommasi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Drie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vash, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abagyan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raush, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totrov, M.</span></span> <span> </span><span class="NLM_article-title">FOCUS - development of a global communication and modeling platform for applied and computational medicinal chemists</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">896</span>â <span class="NLM_lpage">908</span>, <span class="refDoi">Â DOI: 10.1021/ci500598e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVShtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=896-908&author=N.+Stieflauthor=P.+Gedeckauthor=D.+Chinauthor=P.+Huntauthor=M.+Lindvallauthor=K.+Spiegelauthor=C.+Springerauthor=S.+Billerauthor=C.+Buenemannauthor=T.+Kanazawaauthor=M.+Katoauthor=R.+Lewisauthor=E.+Martinauthor=V.+Polyakovauthor=R.+Tommasiauthor=J.+van+Drieauthor=B.+Vashauthor=L.+Whiteheadauthor=Y.+J.+Xuauthor=R.+Abagyanauthor=E.+Raushauthor=M.+Totrov&title=FOCUS+-+development+of+a+global+communication+and+modeling+platform+for+applied+and+computational+medicinal+chemists&doi=10.1021%2Fci500598e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">FOCUS - Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal Chemists</span></div><div class="casAuthors">Stiefl, Nikolaus; Gedeck, Peter; Chin, Donovan; Hunt, Peter; Lindvall, Mika; Spiegel, Katrin; Springer, Clayton; Biller, Scott; Buenemann, Christoph; Kanazawa, Takanori; Kato, Mitsunori; Lewis, Richard; Martin, Eric; Polyakov, Valery; Tommasi, Ruben; van Drie, John; Vash, Brian; Whitehead, Lewis; Xu, Yongjin; Abagyan, Ruben; Raush, Eugene; Totrov, Max</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">896-908</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Communication of data and ideas within a medicinal chem. project on a global as well as local level is a crucial aspect in the drug design cycle.  Over a time frame of eight years, we built and optimized FOCUS, a platform to produce, visualize, and share information on various aspects of a drug discovery project such as cheminformatics, data anal., structural information, and design.  FOCUS is tightly integrated with internal services that involve-among others-data retrieval systems and in-silico models and provides easy access to automated modeling procedures such as pharmacophore searches, R-group anal., and similarity searches.  In addn., an interactive 3D editor was developed to assist users in the generation and docking of close analogs of a known lead.  In this paper, we will specifically conc. on issues we faced during development, deployment, and maintenance of the software and how we continually adapted the software in order to improve usability.  We will provide usage examples to highlight the functionality as well as limitations of FOCUS at the various stages of the development process.  We aim to make the discussion as independent of the software platform as possible, so that our experiences can be of more general value to the drug discovery community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozGiXPjxVBHrVg90H21EOLACvtfcHk0lg6E_6_PvfIfA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVShtr8%253D&md5=00541e43a6212701678a400e36996caf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fci500598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500598e%26sid%3Dliteratum%253Aachs%26aulast%3DStiefl%26aufirst%3DN.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DChin%26aufirst%3DD.%26aulast%3DHunt%26aufirst%3DP.%26aulast%3DLindvall%26aufirst%3DM.%26aulast%3DSpiegel%26aufirst%3DK.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DBiller%26aufirst%3DS.%26aulast%3DBuenemann%26aufirst%3DC.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DPolyakov%26aufirst%3DV.%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3Dvan%2BDrie%26aufirst%3DJ.%26aulast%3DVash%26aufirst%3DB.%26aulast%3DWhitehead%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DY.%2BJ.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DRaush%26aufirst%3DE.%26aulast%3DTotrov%26aufirst%3DM.%26atitle%3DFOCUS%2520-%2520development%2520of%2520a%2520global%2520communication%2520and%2520modeling%2520platform%2520for%2520applied%2520and%2520computational%2520medicinal%2520chemists%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26spage%3D896%26epage%3D908%26doi%3D10.1021%2Fci500598e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span> <i>SchrÃ¶dinger Release 2012</i>, Glide
5.8; <span class="NLM_publisher-name">SchrÃ¶dinger, LLC</span>: <span class="NLM_publisher-loc">New York,
NY</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Release+2012%2C+Glide%0A5.8%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C%0ANY%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSchr%25C3%25B6dinger%2520Release%25202012%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kohrt, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filipski, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cody, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Huis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willardsen, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapundalo, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiya-Cork, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leadley, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKnight, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaiz, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Light, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmunds, J. J.</span></span> <span> </span><span class="NLM_article-title">The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">4752</span>â <span class="NLM_lpage">4756</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2005.07.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1016%2Fj.bmcl.2005.07.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=16125385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVanu7zM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4752-4756&author=J.+T.+Kohrtauthor=K.+J.+Filipskiauthor=W.+L.+Codyauthor=C.+Caiauthor=D.+A.+Dudleyauthor=C.+A.+Van+Huisauthor=J.+A.+Willardsenauthor=S.+T.+Rapundaloauthor=K.+Saiya-Corkauthor=R.+J.+Leadleyauthor=L.+Narasimhanauthor=E.+Zhangauthor=M.+Whitlowauthor=M.+Adlerauthor=K.+McLeanauthor=Y.+L.+Chouauthor=C.+McKnightauthor=D.+O.+Arnaizauthor=K.+J.+Shawauthor=D.+R.+Lightauthor=J.+J.+Edmunds&title=The+discovery+of+fluoropyridine-based+inhibitors+of+the+factor+VIIa%2FTF+complex&doi=10.1016%2Fj.bmcl.2005.07.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of fluoropyridine-based inhibitors of the Factor VIIa/TF complex</span></div><div class="casAuthors">Kohrt, Jeffrey T.; Filipski, Kevin J.; Cody, Wayne L.; Cai, Cuiman; Dudley, Danette A.; Van Huis, Chad A.; Willardsen, J. Adam; Rapundalo, Stephen T.; Saiya-Cork, Kamlai; Leadley, Robert J.; Narasimhan, Lakshmi; Zhang, Erli; Whitlow, Marc; Adler, Marc; McLean, Kirk; Chou, Yuo-Ling; McKnight, Cecile; Arnaiz, Damian O.; Shaw, Kenneth J.; Light, David R.; Edmunds, Jeremy J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4752-4756</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The activated Factor VII/tissue factor complex (FVIIa/TF) plays a key role in the formation of blood clots.  Inhibition of this complex may lead to new antithrombotic drugs.  An X-ray crystal structure of a fluoropyridine-based FVIIa/TF inhibitor bound in the active site of the enzyme complex suggested that incorporation of substitution at the 5-position of the hydroxybenzoic acid side chain could lead to the formation of more potent inhibitors through interactions with the S1'/S2' pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPXXiEgbcYurVg90H21EOLACvtfcHk0lgpGfbl0ucmvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVanu7zM&md5=e50b3a1dfc4f93a22f1f970a13907e0a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.07.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.07.059%26sid%3Dliteratum%253Aachs%26aulast%3DKohrt%26aufirst%3DJ.%2BT.%26aulast%3DFilipski%26aufirst%3DK.%2BJ.%26aulast%3DCody%26aufirst%3DW.%2BL.%26aulast%3DCai%26aufirst%3DC.%26aulast%3DDudley%26aufirst%3DD.%2BA.%26aulast%3DVan%2BHuis%26aufirst%3DC.%2BA.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DRapundalo%26aufirst%3DS.%2BT.%26aulast%3DSaiya-Cork%26aufirst%3DK.%26aulast%3DLeadley%26aufirst%3DR.%2BJ.%26aulast%3DNarasimhan%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DE.%26aulast%3DWhitlow%26aufirst%3DM.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DMcLean%26aufirst%3DK.%26aulast%3DChou%26aufirst%3DY.%2BL.%26aulast%3DMcKnight%26aufirst%3DC.%26aulast%3DArnaiz%26aufirst%3DD.%2BO.%26aulast%3DShaw%26aufirst%3DK.%2BJ.%26aulast%3DLight%26aufirst%3DD.%2BR.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520discovery%2520of%2520fluoropyridine-based%2520inhibitors%2520of%2520the%2520factor%2520VIIa%252FTF%2520complex%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4752%26epage%3D4756%26doi%3D10.1016%2Fj.bmcl.2005.07.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">West, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaiz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gualtieri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huwe, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Light, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukovich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlow, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, J.</span></span> <span> </span><span class="NLM_article-title">Identification of orally bioavailable, non-amidine inhibitors of urokinase plasminogen activator (uPA)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">5712</span>â <span class="NLM_lpage">5715</span>, <span class="refDoi">Â DOI: 10.1016/j.bmcl.2009.08.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1016%2Fj.bmcl.2009.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=19703768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFakur3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5712-5715&author=C.+W.+Westauthor=M.+Adlerauthor=D.+Arnaizauthor=D.+Chenauthor=K.+Chuauthor=G.+Gualtieriauthor=E.+Hoauthor=C.+Huweauthor=D.+Lightauthor=G.+Phillipsauthor=R.+Pulkauthor=D.+Sukovichauthor=M.+Whitlowauthor=S.+Yuanauthor=J.+Bryant&title=Identification+of+orally+bioavailable%2C+non-amidine+inhibitors+of+urokinase+plasminogen+activator+%28uPA%29&doi=10.1016%2Fj.bmcl.2009.08.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA)</span></div><div class="casAuthors">West, Christopher W.; Adler, Marc; Arnaiz, Danny; Chen, Deborah; Chu, Kieu; Gualtieri, Giovanna; Ho, Elena; Huwe, Christoph; Light, David; Phillips, Gary; Pulk, Rebecca; Sukovich, Drew; Whitlow, Marc; Yuan, Shendong; Bryant, Judi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5712-5715</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this Letter the synthesis and evaluation of a series of non-amidine inhibitors of Urokinase Plasminogen Activator (uPA) are reported.  Starting from compd. I, a significant change provided compds. in which the amidine, binding in the S1 pocket, was replaced with a primary amine.  Further modifications led to the identification of potent, selective, and orally bioavailable uPA inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZYJuZGz1EJLVg90H21EOLACvtfcHk0lgpGfbl0ucmvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFakur3P&md5=ca3529dc06e384edeea54b6b62b25252</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DWest%26aufirst%3DC.%2BW.%26aulast%3DAdler%26aufirst%3DM.%26aulast%3DArnaiz%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DChu%26aufirst%3DK.%26aulast%3DGualtieri%26aufirst%3DG.%26aulast%3DHo%26aufirst%3DE.%26aulast%3DHuwe%26aufirst%3DC.%26aulast%3DLight%26aufirst%3DD.%26aulast%3DPhillips%26aufirst%3DG.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DSukovich%26aufirst%3DD.%26aulast%3DWhitlow%26aufirst%3DM.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DBryant%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520orally%2520bioavailable%252C%2520non-amidine%2520inhibitors%2520of%2520urokinase%2520plasminogen%2520activator%2520%2528uPA%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5712%26epage%3D5715%26doi%3D10.1016%2Fj.bmcl.2009.08.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greco, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harold, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Garavilla, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minor, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corcoran, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Cera, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantwell, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savvides, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damiano, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maryanoff, B. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1727</span>â <span class="NLM_lpage">1730</span>, <span class="refDoi">Â DOI: 10.1021/jm0700619</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0700619" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivF2isb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1727-1730&author=M.+N.+Grecoauthor=M.+J.+Hawkinsauthor=E.+T.+Powellauthor=R.+Haroldauthor=L.+de+Garavillaauthor=J.+Hallauthor=L.+K.+Minorauthor=Y.+Wangauthor=T.+W.+Corcoranauthor=E.+Di+Ceraauthor=A.+M.+Cantwellauthor=S.+N.+Savvidesauthor=B.+P.+Damianoauthor=B.+E.+Maryanoff&title=Discovery+of+potent%2C+selective%2C+orally+active%2C+nonpeptide+inhibitors+of+human+mast+cell+chymase&doi=10.1021%2Fjm0700619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent, Selective, Orally Active, Nonpeptide Inhibitors of Human Mast Cell Chymase</span></div><div class="casAuthors">Greco, Michael N.; Hawkins, Michael J.; Powell, Eugene T.; Almond, Harold R., Jr.; De Garavilla, Lawrence; Hall, Jeffrey; Minor, Lisa K.; Wang, Yuanping; Corcoran, Thomas W.; Di Cera, Enrico; Cantwell, Angelene M.; Savvides, Savvas N.; Damiano, Bruce P.; Maryanoff, Bruce E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1727-1730</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of Î²-carboxamido-phosphon(in)ic acids, e.g., I, II, and III, was identified as a new structural motif for obtaining potent inhibitors of human mast cell chymase.  For example, 1-naphthyl deriv. I had an IC50 value of 29 nM and (E)-styryl deriv. II had an IC50 value of 3.5 nM.  An X-ray structure for IÂ·chymase revealed key interactions within the enzyme active site.  I was selective for inhibiting chymase vs. eight serine proteases.  III was orally bioavailable in rats (F = 39%), and orally efficacious in a hamster model of inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcqGFCHhLjK7Vg90H21EOLACvtfcHk0li-rHdAWhxoRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivF2isb0%253D&md5=f81cddf73934642d0ffad18cfe389c39</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0700619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0700619%26sid%3Dliteratum%253Aachs%26aulast%3DGreco%26aufirst%3DM.%2BN.%26aulast%3DHawkins%26aufirst%3DM.%2BJ.%26aulast%3DPowell%26aufirst%3DE.%2BT.%26aulast%3DHarold%26aufirst%3DR.%26aulast%3Dde%2BGaravilla%26aufirst%3DL.%26aulast%3DHall%26aufirst%3DJ.%26aulast%3DMinor%26aufirst%3DL.%2BK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DCorcoran%26aufirst%3DT.%2BW.%26aulast%3DDi%2BCera%26aufirst%3DE.%26aulast%3DCantwell%26aufirst%3DA.%2BM.%26aulast%3DSavvides%26aufirst%3DS.%2BN.%26aulast%3DDamiano%26aufirst%3DB.%2BP.%26aulast%3DMaryanoff%26aufirst%3DB.%2BE.%26atitle%3DDiscovery%2520of%2520potent%252C%2520selective%252C%2520orally%2520active%252C%2520nonpeptide%2520inhibitors%2520of%2520human%2520mast%2520cell%2520chymase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1727%26epage%3D1730%26doi%3D10.1021%2Fjm0700619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span>; <span class="NLM_string-name">Bannister, T.</span>; <span class="NLM_string-name">Noll, R.</span>; <span class="NLM_string-name">Jin, L.</span>; <span class="NLM_string-name">Rynkiewicz, M.</span>; <span class="NLM_string-name">Bibbins, F.</span>; <span class="NLM_string-name">Magee, S.</span>; <span class="NLM_string-name">Gorga, J.</span>; <span class="NLM_string-name">Babine, R. E.</span>; <span class="NLM_string-name">Strickler, J. E.</span>; <span class="NLM_string-name">Meyers, H. V.</span>; <span class="NLM_string-name">Abdel-Meguid, S. S.</span></span> <i>PDB ID 1ZSJ, Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with N-(7-Carbamimidoyl-naphthalen-1-yl)-3-hydroxy-2-methyl-benzamide</i>, <span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=Z.+Guo&author=T.+Bannister&author=R.+Noll&author=L.+Jin&author=M.+Rynkiewicz&author=F.+Bibbins&author=S.+Magee&author=J.+Gorga&author=R.+E.+Babine&author=J.+E.+Strickler&author=H.+V.+Meyers&author=S.+S.+Abdel-Meguid&title=PDB+ID+1ZSJ%2C+Crystal+Structure+of+the+Catalytic+Domain+of+Coagulation+Factor+XI+in+Complex+with+N-%287-Carbamimidoyl-naphthalen-1-yl%29-3-hydroxy-2-methyl-benzamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DZ.%26jtitle%3DPDB%2520ID%25201ZSJ%252C%2520Crystal%2520Structure%2520of%2520the%2520Catalytic%2520Domain%2520of%2520Coagulation%2520Factor%2520XI%2520in%2520Complex%2520with%2520N-%25287-Carbamimidoyl-naphthalen-1-yl%2529-3-hydroxy-2-methyl-benzamide%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGrath, M.
E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sprengeler, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirschbein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somoza, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehoux, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janc, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gjerstad, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graupe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estiarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataramani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tai, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperandio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katz, B. A.</span></span> <span> </span><span class="NLM_article-title">Structure-guided design of peptide-based tryptase inhibitors</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">5964</span>â <span class="NLM_lpage">5973</span>, <span class="refDoi">Â DOI: 10.1021/bi060173m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi060173m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BD28Xjs1Gntbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=5964-5973&author=M.%0AE.+McGrathauthor=P.+A.+Sprengelerauthor=B.+Hirschbeinauthor=J.+R.+Somozaauthor=I.+Lehouxauthor=J.+W.+Jancauthor=E.+Gjerstadauthor=M.+Graupeauthor=A.+Estiarteauthor=C.+Venkataramaniauthor=Y.+Liuauthor=R.+Yeeauthor=J.+D.+Hoauthor=M.+J.+Greenauthor=C.+S.+Leeauthor=L.+Liuauthor=V.+Taiauthor=J.+Spencerauthor=D.+Sperandioauthor=B.+A.+Katz&title=Structure-guided+design+of+peptide-based+tryptase+inhibitors&doi=10.1021%2Fbi060173m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Design of Peptide-Based Tryptase Inhibitors</span></div><div class="casAuthors">McGrath, Mary E.; Sprengeler, Paul A.; Hirschbein, Bernard; Somoza, John R.; Lehoux, Isabelle; Janc, James W.; Gjerstad, Erik; Graupe, Michael; Estiarte, Angeles; Venkataramani, Chandru; Liu, Yang; Yee, Robb; Ho, Joseph D.; Green, Michael J.; Lee, Chang-Sun; Liu, Liang; Tai, Vincent; Spencer, Jeffrey; Sperandio, David; Katz, Bradley A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5964-5973</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Improved peptide-based inhibitors of human Î²-tryptase were discovered using information gleaned from tripeptide library screening and structure-guided design methods, including fragment screening.  These efforts sought to improve this class of inhibitors by replacing the traditional Lys or Arg P1 element.  The optimized compds. display low nanomolar potency against the mast cell target and several hundred-fold selectivity with respect to serine protease off targets.  Thus, replacement of Lys/Arg at P1 in a peptide-like scaffold does not need to be accompanied by a loss in target affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnQNi6oSHnXbVg90H21EOLACvtfcHk0li-rHdAWhxoRg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xjs1Gntbk%253D&md5=4a501b87490f5cfe72d57516d39cac94</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fbi060173m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi060173m%26sid%3Dliteratum%253Aachs%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DSprengeler%26aufirst%3DP.%2BA.%26aulast%3DHirschbein%26aufirst%3DB.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DLehoux%26aufirst%3DI.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DGjerstad%26aufirst%3DE.%26aulast%3DGraupe%26aufirst%3DM.%26aulast%3DEstiarte%26aufirst%3DA.%26aulast%3DVenkataramani%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DYee%26aufirst%3DR.%26aulast%3DHo%26aufirst%3DJ.%2BD.%26aulast%3DGreen%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DC.%2BS.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DTai%26aufirst%3DV.%26aulast%3DSpencer%26aufirst%3DJ.%26aulast%3DSperandio%26aufirst%3DD.%26aulast%3DKatz%26aufirst%3DB.%2BA.%26atitle%3DStructure-guided%2520design%2520of%2520peptide-based%2520tryptase%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D5964%26epage%3D5973%26doi%3D10.1021%2Fbi060173m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, G.</span>; <span class="NLM_string-name">Yuan, C.</span>; <span class="NLM_string-name">Jiang, L.</span>; <span class="NLM_string-name">Huang, M.</span></span> <i>PDB ID 2O8W; Crystal Structure and Binding Epitopes of Urokinase-Type Plasminogen Activator (C122A/N145Q/S195A) in Complex with Inhibitors</i>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=G.+Zhao&author=C.+Yuan&author=L.+Jiang&author=M.+Huang&title=PDB+ID+2O8W%3B+Crystal+Structure+and+Binding+Epitopes+of+Urokinase-Type+Plasminogen+Activator+%28C122A%2FN145Q%2FS195A%29+in+Complex+with+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DG.%26jtitle%3DPDB%2520ID%25202O8W%253B%2520Crystal%2520Structure%2520and%2520Binding%2520Epitopes%2520of%2520Urokinase-Type%2520Plasminogen%2520Activator%2520%2528C122A%252FN145Q%252FS195A%2529%2520in%2520Complex%2520with%2520Inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mutlib, A.
E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shockcor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espina, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orwat, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gant, L.-S.</span></span> <span> </span><span class="NLM_article-title">Disposition of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2â²(methylsulfonyl)-[1,1â³-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC 423) by novel metabolic pathways. Characterization of unusual metabolites by liquid chromatography/mass spectrometry and NMR</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">48</span>â <span class="NLM_lpage">62</span>, <span class="refDoi">Â DOI: 10.1021/tx0101191</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx0101191" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2002&pages=48-62&author=A.%0AE.+Mutlibauthor=J.+Shockcorauthor=S.+Y.+Chenauthor=R.+J.+Espinaauthor=D.+J.+Pintoauthor=M.+J.+Orwatauthor=S.+R.+Prakashauthor=L.-S.+Gant&title=Disposition+of+1-%5B3-%28aminomethyl%29phenyl%5D-N-%5B3-fluoro-2%E2%80%B2%28methylsulfonyl%29-%5B1%2C1%E2%80%B3-biphenyl%5D-4-yl%5D-3-%28trifluoromethyl%29-1H-pyrazole-5-carboxamide+%28DPC+423%29+by+novel+metabolic+pathways.+Characterization+of+unusual+metabolites+by+liquid+chromatography%2Fmass+spectrometry+and+NMR&doi=10.1021%2Ftx0101191"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Ftx0101191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx0101191%26sid%3Dliteratum%253Aachs%26aulast%3DMutlib%26aufirst%3DA.%2BE.%26aulast%3DShockcor%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DS.%2BY.%26aulast%3DEspina%26aufirst%3DR.%2BJ.%26aulast%3DPinto%26aufirst%3DD.%2BJ.%26aulast%3DOrwat%26aufirst%3DM.%2BJ.%26aulast%3DPrakash%26aufirst%3DS.%2BR.%26aulast%3DGant%26aufirst%3DL.-S.%26atitle%3DDisposition%2520of%25201-%255B3-%2528aminomethyl%2529phenyl%255D-N-%255B3-fluoro-2%25E2%2580%25B2%2528methylsulfonyl%2529-%255B1%252C1%25E2%2580%25B3-biphenyl%255D-4-yl%255D-3-%2528trifluoromethyl%2529-1H-pyrazole-5-carboxamide%2520%2528DPC%2520423%2529%2520by%2520novel%2520metabolic%2520pathways.%2520Characterization%2520of%2520unusual%2520metabolites%2520by%2520liquid%2520chromatography%252Fmass%2520spectrometry%2520and%2520NMR%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2002%26volume%3D15%26spage%3D48%26epage%3D62%26doi%3D10.1021%2Ftx0101191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schramm, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triebwasser, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raychaudhuri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seddon, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, J. P.</span></span> <span> </span><span class="NLM_article-title">Genetic variants in the complement system predisposing to age-related macular degeneration: A review</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">118</span>â <span class="NLM_lpage">125</span>, <span class="refDoi">Â DOI: 10.1016/j.molimm.2014.06.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1016%2Fj.molimm.2014.06.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=25034031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFGjs7vK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2014&pages=118-125&author=E.+C.+Schrammauthor=S.+J.+Clarkauthor=M.+P.+Triebwasserauthor=S.+Raychaudhuriauthor=J.+M.+Seddonauthor=J.+P.+Atkinson&title=Genetic+variants+in+the+complement+system+predisposing+to+age-related+macular+degeneration%3A+A+review&doi=10.1016%2Fj.molimm.2014.06.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic variants in the complement system predisposing to age-related macular degeneration</span></div><div class="casAuthors">Schramm, Elizabeth C.; Clark, Simon J.; Triebwasser, Michael P.; Raychaudhuri, Soumya; Seddon, Johanna M.; Atkinson, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">118-125</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Age-related macular degeneration (AMD) is a major cause of visual impairment in the western world.  It is characterized by the presence of lipoproteinaceous deposits (drusen) in the inner layers of the retina.  Immunohistochem. studies identified deposition of complement proteins in the drusen as well as in the choroid.  In the last decade, genetic studies have linked both common and rare variants in genes of the complement system to increased risk of development of AMD.  Here, we review the variants described to date and discuss the functional implications of dysregulation of the alternative pathway of complement in AMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw5ZQzYfD307Vg90H21EOLACvtfcHk0ljjVjH05apf8Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFGjs7vK&md5=8b8ec6496b04e1a7748b2817045d2eb1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2014.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2014.06.032%26sid%3Dliteratum%253Aachs%26aulast%3DSchramm%26aufirst%3DE.%2BC.%26aulast%3DClark%26aufirst%3DS.%2BJ.%26aulast%3DTriebwasser%26aufirst%3DM.%2BP.%26aulast%3DRaychaudhuri%26aufirst%3DS.%26aulast%3DSeddon%26aufirst%3DJ.%2BM.%26aulast%3DAtkinson%26aufirst%3DJ.%2BP.%26atitle%3DGenetic%2520variants%2520in%2520the%2520complement%2520system%2520predisposing%2520to%2520age-related%2520macular%2520degeneration%253A%2520A%2520review%26jtitle%3DMol.%2520Immunol.%26date%3D2014%26volume%3D61%26spage%3D118%26epage%3D125%26doi%3D10.1016%2Fj.molimm.2014.06.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crowley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Will-Orrego, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchanan, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaffee, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dryja, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, S. M.</span></span> <span> </span><span class="NLM_article-title">Induction of ocular complement activation by inflammatory stimuli and intraocular inhibition of complement factor D in animal models</span>. <i>Invest. Ophthalmol. Visual Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">940</span>â <span class="NLM_lpage">951</span>, <span class="refDoi">Â DOI: 10.1167/iovs.17-22605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;key=10.1167%2Fiovs.17-22605" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2018&pages=940-951&author=M.+A.+Crowleyauthor=O.+Delgadoauthor=A.+Will-Orregoauthor=N.+M.+Buchananauthor=K.+Andersonauthor=B.+D.+Jaffeeauthor=T.+P.+Dryjaauthor=S.+M.+Liao&title=Induction+of+ocular+complement+activation+by+inflammatory+stimuli+and+intraocular+inhibition+of+complement+factor+D+in+animal+models&doi=10.1167%2Fiovs.17-22605"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1167%2Fiovs.17-22605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1167%252Fiovs.17-22605%26sid%3Dliteratum%253Aachs%26aulast%3DCrowley%26aufirst%3DM.%2BA.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DWill-Orrego%26aufirst%3DA.%26aulast%3DBuchanan%26aufirst%3DN.%2BM.%26aulast%3DAnderson%26aufirst%3DK.%26aulast%3DJaffee%26aufirst%3DB.%2BD.%26aulast%3DDryja%26aufirst%3DT.%2BP.%26aulast%3DLiao%26aufirst%3DS.%2BM.%26atitle%3DInduction%2520of%2520ocular%2520complement%2520activation%2520by%2520inflammatory%2520stimuli%2520and%2520intraocular%2520inhibition%2520of%2520complement%2520factor%2520D%2520in%2520animal%2520models%26jtitle%3DInvest.%2520Ophthalmol.%2520Visual%2520Sci.%26date%3D2018%26volume%3D59%26spage%3D940%26epage%3D951%26doi%3D10.1167%2Fiovs.17-22605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span> <i>SchrÃ¶dinger Release 2012</i>; <span class="NLM_publisher-name">SchrÃ¶dinger,
LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Schr%C3%B6dinger+Release+2012%3B+Schr%C3%B6dinger%2C%0ALLC%3A+New+York%2C+NY%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSchr%25C3%25B6dinger%2520Release%25202012%26pub%3DSchr%25C3%25B6dinger%252C%250ALLC%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FBE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5FBE','PDB','5FBE'); return false;">PDB: 5FBE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FUT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FUT','PDB','6FUT'); return false;">PDB: 6FUT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QMT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QMT','PDB','6QMT'); return false;">PDB: 6QMT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QMR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QMR','PDB','6QMR'); return false;">PDB: 6QMR</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i42"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00271">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_36366"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00271">10.1021/acs.jmedchem.9b00271</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Crystallographic structure determination of FD in complex with compounds <b>3</b> and <b>12</b>; preparation of reagents for TR-FRET assay (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00271/suppl_file/jm9b00271_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00271/suppl_file/jm9b00271_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00271/suppl_file/jm9b00271_si_001.csv">jm9b00271_si_001.csv (1.63 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00271/suppl_file/jm9b00271_si_002.pdf">jm9b00271_si_002.pdf (719.87 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for the crystal structures of FD with compounds <b>3</b> and <b>12</b> are deposited in the protein data bank with accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QMT">6QMT</a>.pdb and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QMR">6QMR</a>.pdb, respectively.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00271&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00271%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-9" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00271" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679996c4cf0821d6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
